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Chapter 1.1 
Introduction and objectives of the investigations. 
In modern society anyone is aware of the importance of relevant information 
about toxic hazards exhibited by the every day increasing number of synthetic 
chemicals and of the necessity of preventing the toxic effects during the 
production, usage, and disposal of toxic substances. Among the chemical 
compounds are medicines, flavours and fragrances (food additives), agrochemicais, 
cosmetic products and compounds used in industrial processes. Frequently human 
exposure to some of such body-foreign compounds (xenobiotics) during occupational 
practises and food intake, and via the environment is inadvertent. 
Medicines and other drugs, however, are commonly taken on purpose for their 
useful or therapeutic effects on the human-body. The human exposure to food 
additives and cosmetic products, containing either synthetic or naturally 
occurring substances is deliberate. 
Xenobiotics, which have entered the human or animal body, may undergo 
various bio-transformations. At present it is evident that enzymes involved 
in the biotransformation of xenobiotics function in an ambivalent manner. 
On one hand, the water solubility and acidity of lipid-soluble compounds is 
enhanced, thereby facilitating the excretion via the kidney or bile duct; 
on the other hand the generation of reactive electrophiIic molecules may be 
the result of metabolic activation reactions (Jefcoate 1983; Guengerich and 
Liebler 1985). In general, the metabolic transformations in organisms can be 
classified into two distinct types, viz. _i_, the reaction of functional izat ion 
(or Phase J processes), involving oxidation, reduction, or hydrolysis and j_i_ 
the conjugation reactions (or Phase IJ processes) in which a foreign compound 
or a metabolic product is combined with an endogenous molecule (Williams 1959)· 
The conjugation reactions are defined by Caldwell (1982) as a group of 
synthetic reactions in which a foreign compound or a metabolite thereof is 
covalently linked with an endogenous molecule or grouping to give a characte-
ristic product known as a conjugate. The eight major conjugation reactions 
are listed in Table 1. (Caldwell 1982). 
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Table 1. The Eight Classical Conjugation Reactions. 
Conjugating Functional groups 
Reaction agent involved 
A. Reactions involving activated conjugating agents 
Glucuronidation UDP-glucuronic -OH, 
acid _ N R 2 
Glucose conjugation UDP-glucose -OH, 
Sulfation PAPS -OH, 
Methylation S-Adenosyl- -OH, 
methionine 
Acetylation Acetyl CoA -OH, 
Cyanide detoxication Sulfane sulfur CN 
B. Reactions involving activated foreign compounds 
Glutathione conju- Glutathione 
gat i on 
Amino acid conju- Glycine 
gation Glutamine 
Orni thine 
Taurine 
DDP = Uridine diphosphate. 
PAPS = Adenosine-3-phosphate-5-phosphosulfate. 
CoA = coenzyme A. 
In living organisms the liver fulfils a prominent role in the biotransformation 
of xenobiotics and is probably the major site of metabolic activation and/or 
deactivation of foreign compounds by the functionalization and conjugation 
reactions (Lake and Gangolli 1981; Jefcoate I983). Extra-hepatic tissues, 
however, may be of some importance in the biotransformation of xenobiotic 
compounds such as environmental pollutants in air and water, food additives 
and contaminants, industrial chemicals and cigarette smoke (Vainio and 
Hietanen I98O; Rush et al. 198Ό. The sites of extrahepatic biotransformation 
of xenobiotic materials are frequently the sites of entry or excretion of the 
body, e.g. the skin, lung, kidney and gastrointestinal mucosa. 
Among the chemicals to which man is occupâtionally and environmentally 
-C00H, -NH2, 
-SH, ^C-H 
-C00H, -SH, S N H 
-NH2, -SH 
-NH2 
-NH2 
Arene oxide, epoxide, 
alkyl and aryl hal ides 
-C00H 
h 
exposed, those with potentially alkylating properties are most hazardous. 
From clinical practice and animal experiments it is known that many of these 
substances are able to cause a variety of severe toxicities, necrosis, 
allergic reactions, and even to exert mutagenic or carcinogenic effects 
(Lake and Gangolli I98I; Jefcoate 1983; Rush et al. ^ЭЪÍ^). The generally 
accepted underlying chemical mechanisms to such advert effects is a reaction 
between either a body-foreign substance itself (direct-alkylating) or a 
reactive electrophi1ic metabolite resulting of bioactivation of an initially 
chemically insert compound (indirect alkylating) with the nucleophilic groups 
or sites of important cellular macromolecules such as proteins, phospholipids, 
RNA and/or DNA. The suggested cova Vent binding to critical targets of macro-
molecules in the cell initially causes chemical lesions. There are indications 
that such lesions play an important role in the cause of tissue damage, 
allergic reactions and even cancer (Miller 1970; Ryser 1971). 
Many studies show that the organism is not completely defenceless to the 
alkylating action of electrophi1ic xenobiotics or to chemically reactive 
metabolites formed ¡ntracellularly from body-foreign compounds. One of the 
protective mechanisms the organism employs against alkylating substances is 
the inactivation (detoxification) by reaction with the endogenous glutathione, 
either spontaneously or enzymatically (Chasseaud 1979; Ketterer et al. 19θ3; 
Moldéus and Jernström 1983; Jefcoate 1983; Lake and Gangolli 1981). 
The tripeptide glutathione (GSH), p-glutamyl-cysteinyl-glycine (Fig.1) is 
probably the most abundant natural non-protein thiol (MW = 307) and it is 
found in virtually all cells, mainly in the cytosol often in high concentrations, 
e.g. in the rat liver it is 5-IO mM (Larsson et al. 1983)· The GSH capacity 
may be greater than the total GSH content of the liver or other tissue since 
it may include GSH synthesized in situ following the administration of a 
xenobiotic compound (Jollow I98O). The synthesis and degradation of GSH take 
place by reactions of the so-called y-glutamyl cycle; a series of enzyme-
catalyzed reactions (Meister I98I; Larsson et al. 1983)· A large variety of 
xenobiotics may be detoxified with the nucleophilic GSH. The cysteinyl 
residue of GSH provides a nucleophilic thiol important for detoxification of 
potentially alkylating xenobiotics (Ketterer et al. 1983). The xenobiotics 
conjugated with GSH may be classified into two groups (Jerina and Bend 1977). 
The first group include the xenobiotics able to conjugate as such; halogenated 
alkanes or arylalkanes, nitro alkanes, esters of arylsulfonic acids, halogena-
ted nitrobenzenes and α,β-unsaturated compounds with substituents polarizing 
the double bond. The second group includes xenobiotics, which require 
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GLUTATHIONE 
RX + HSCH2CHCONHCH,COOH 
I 
NHCOCH,CH2CHCOOH 
I 
N H j 
glutathione S-transferases 
RSCH2CHCONHCH2ÒOOH 
I 
NHCOCHjCHjCHCOOH 
I 
NH2 
)•_ glutamyl transpeptidase 
R S C H j C H C O N H C H j C O O H 
I 
NH2 
cystemylglycmase 
N-acetylase 
R S C H j C H C O O H > - R S C H j C H C O O H 
I I 
NH2 NHCOCH3 
MERCAPTURIC ACID 
Fig.l. G lu ta th ione con juga t ion and the biosyntheses to mercaptur ic a c i d . 
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metabolic activation to form a electrophylic metabolite, such as arene oxides 
and aliphatic or al¡cyclic epoxides. GSH not only provides the last line of 
defense against the alkylating activity of reactive electrophiles, but also 
protects cells against the action of lipid peroxides and free radicals. 
In these reaction GSH may serve as a reductant, that means GSH is oxidized to 
its disulfide (GSSG). In addition, GSH may play a crucial role in some 
important cellular processes (Larsson et al. 1983)· For example, GSH may 
facilitate amino acid transport through the γ-glutamy 1 cycle and it has a role 
in the formaldehyde dehydrogenase catalyzed conversion of formaldehyde to 
formate. 
In most cases the conjugation as well as the oxidation may occur enzymati-
cally, catalyzed by glutathione-S-transferases, although noncatalytic reactions 
with GSH may proceed rapidly due to the presence of high intracellular 
concentrations of GSH (Ketterer I982). The glutathione-S-transferases 
(EC 2.5.1.18) are a family of enzymes that are localized predominantly in the 
cytosol, however, their presence in microsomes and within the mitochondrial 
matrix has also been documented (Chasseaud 1979; Jakoby 1980). There are at 
least seven soluble isoenzymes with each a similar dimeric structure in which 
the monomers fall into three categories defined by their apparent molecular 
weights as 22,000, 23,500 and 25,000 (Ketterer 1983). It is of importance to 
know that the multiple forms of the enzyme, usually have broadly overlapping 
but not identical substrate selectivi ties and are frequently found in each 
tissue, although the glutathione-S-transferase activity is generally greater 
in hepatic than in extrahepatic tissues (Chasseaud 1979; Jakoby I98O). 
Due to the high molecular weight and amphiphilic character of a GSH 
conjugate, the elimination in the bile and faeces is prefered. However, the 
conjugates commonly undergo further biotransformation of the GSH moiety, 
leaving a cysteine derivative. In humans and some animals S-substituted 
cysteine is N-acetylated to give rise to N-acetylcysteine conjugates, which 
are known as mercapturic acids. Such ultimate products are commonly excreted 
in the urine (Chasseaud 1976). The overall scheme of mercapturic acid biosyn­
thesis can be represented as shown in figure 1. 
ACRYLIC COMPOUNDS. 
As the greater part this thesis deals with the metabolic pathways of biotrans­
formation of cyanoacrylic compounds (compound IX to XI, Fig.2), the possible 
biotransformation reactions for acrylic compounds will be briefly described. 
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Fig.2. Structures of acrylic compounds. 
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Particular attention will be given to the metabolic fate of acrylic compounds 
related to the cyanoacrylic substances (compound J to VIII, Fig.2), which 
were subjected to metabolism studies in our laboratory previously. 
On the basis of their chemical structure the acrylic compounds may belong 
to the class of direct alkylating as well as Indirect alkylating substances. 
In the preceding section is has been outlined that glutathione (GSH) plays an 
Important role in the detoxification in living organisms of chemically reactive 
compounds. This means that in the first place GSH can detoxify the unsaturated 
acrylic compound with strongly polarized electron-withdrawing substituents 
(COOR or CN) through direct addition of the nucleophile (probably GS ) to 
the electrophi1¡c ß-carbon atom of the double bond (Michael addition reaction). 
Alternatively, the acrylic compounds may also be epoxidized. The enzyme system 
generally involved in such bioactivalions is the microsomal ΡΊ50 mixed function 
oxidase system (cytochrome Ρ-Ί50). At least 13 different P-'tSO enzymes have 
been purified from rat liver and all have apparent monomeric molecular weights 
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of 'tS.OOO to 60,000, occurring in isozymic forms. A number of the different 
isozymes have different substrate specifity, although considerable overlap 
exists. The principal site of these enzymes is in all animal vertebrate species 
in the liver, but lower concentrations are also present in almost all tissues 
with the exception of skeletal muscle and erythrocyte cells (Guengerich and 
Liebler 1985). The chemically reactive epoxides obtained after the epoxidation 
of the acrylic compounds may behave as electrophi1ic intermediates (indirect 
alkylating), which can be deactivated principally with two detoxifying 
mechanisms. (Hernandez and Bend 1982). The just detoxification proceeds by 
conjugation with GSH, described previously. The second inactivation is mediated 
by the epoxide hydrolase (EC.3.3.2.3), an enzyme in the endoplasmic reticulum, 
the nucleus, and cytosol. These enzymes catalyze the conversion of epoxides to 
trans-diols, which may serve as substrates for further conjugation reactions. 
The diols formed are in most cases chemically less reactive and less toxic 
than the corresponding epoxide. A third metabolic aspect that possibly could 
be of some influence on the biotransformation of acrylates is the rate of 
alkyl ester hydrolysis. This chemical conversion is often catalyzed by the 
non-specific carboxyl-esterase enzyme (EC 3.1.1.1). In human and animal species 
the acrylates (compound I to V, Fig.2) may be hydrolysed to corresponding 
unsaturated carboxylic acids. Such acids, however, are less readily epoxidized 
and generally have a reduced propensity to conjugate with GSH. This means that 
the esterase enzyme activity present in almost all tissues of vertebrate 
species may play a crucial role in the appearance of toxic reactions. 
The results of previous investigations in the Department of Pharmacology 
of KU of Nijmegen showed that for the detoxification of acrylates (compound J 
to V; Fig.2) in rats the enzymatic hydrolysis of the ester group is very 
important (Delbressine 1981; Delbressine et al. 1981; Delbressine et al. 1982). 
Pre-administration of tri-orthotoly1-phosphate (TOTP), a carboxylesterase 
inhibitor enhanced the capacity of the acrylates to alkylate GSH in vivo, 
resulting in an increase of mercapturic acid excretion in the urine. 
The mercapturic acids found in the urine of rats were isolated, identified 
and their structures elucidated. It was concluded that these compounds arise 
from a conjugation of GSH with the acrylic esters by a Michael type reaction. 
Substituents (methyl, phenyl) at the double bond of the unsaturated ester 
result in a considerable decrease in mercapturic acid excretion. The same 
phenomenon was observed with the increase in length of the alkyl chain in 
the ester group. No mercapturic acids could be detected arising from GSH 
conjugation of epoxyesters. There was also no in vitro evidence for such 
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epoxides. Aery Ioni tri le and derivatives (VI to VIII; Fig.2) however, were 
biotransformed to electrophi1ic epoxides (Bladeren et al. 1981; Delbressine 
I98I). Two types of mercapturic acids were isolated from urine of rats and 
identified . 
Evidence was presented that one type of thioethers resulted from direct 
addition of GSH, whereas the other group of metabolites were formed via an 
intermediate epoxide. Substituents at the double bond influenced the ratio of 
the two types of mercapturic acids. On basis of the results of these investi-
gations an interaction of cyanoacrylic compounds with GSH was expected 
resulting in the urinary excretion of mercapturic acids. 
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OBJECTIVES OF THE INVESTIGATIONS 
In the last 10 years an increasing number of acrylic compounds is employed. 
Representatives of these body-foreign compounds (xenobiotics) have medical, 
cosmetica!, industrial and construction-technical applications. As raw 
materials are used: acrylates, methacrylates, phenylacrylates, aery Ioni tri le, 
acrylamide, cyanoacrylates and derivatives thereof. Such potentially alkylating 
compounds form a growing problem in medicine, industrial medicine and occupa-
tional dermatology. From clinical practice and animal experiments it is known 
that a number of the acrylic compounds are able to cause allergic reactions, 
skin irritations, severe tissue lessons and even to exert mutagenic or 
carcinogenic effects. Earlier investigations on the biotransformations of 
acrylates and aery Ioni tri le derivatives showed that the conjugation with 
glutathione constitutes apparently in an important detoxification route for 
acrylic compounds. In one case a reactive intermediate epoxide and subsequent 
glutathione conjugation could be deduced from the urinary excretion of a 
mercapturic acid. Identification of the mercapturic acids can provide infor-
mation about the metabolic routes of biotransformation of each model-compound. 
This thesis deals with the study of the metabolism of cyanoacrylic compounds 
with special emphasis on the conjugation of these potentially alkylating 
substances to the endogenous glutathione and subsequent formation of urinary 
mercapturic acid metabolites. The principal aim of the investigations was to 
examine a possible relationship between the chemical structures of the cyano-
acrylic compounds or their degradation products and the biotransformation as 
well as the toxicity of cyanoacrylic compounds after both percutaneous as 
systemic administration to the rat. The following compounds were included in 
the investigations: Chlorobenzylidene malononitri le compounds (including 
"CS-gas"), methyl 2-cyano-3-phenylacrylate and analogues, alkyl 2-cyanoacry-
lates, methyl epoxycinnamates (epoxides of methyl 3-phenylacrylates), and 
substituted benzaldehydes (degradation products of the CS-analogues and the 
methyl-2-cyano-3-phenylacrylate analogues). The experimental methodology 
developed in our laboratory for the in vivo investigation of the metabolic 
pathways of biotransformation of acrylic compounds was used. In addition, 
the bacterial mutagenicity and toxicity of various model-compounds was tested. 
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Chapter 2.1 
2-Chlorobenzylmercapturic acid, a metabolite of the riot 
control agent 2-chlorobenzylidene malononitrile (CS) 
in the rat. 
INTRODUCTION 
Ortho-chlorobenzylidene malononitrile was first prepared by Corson and 
Stoughton (1928) as one of a series of compounds in which aromatic aldehydes 
were condensed with malononitrile. They found that the compound had irritant 
properties. In 1958 it was introduced as riot control agent (CS-gas) and as a 
result of a increase of the use all over the world, interest in the toxic 
hazards and metabolic fate of this reactive unsaturated compound increased 
considi rably. 
It is known that CS as smoke or as an aerosol produces lachrymation, 
sternutation, sensory irritation of the upper respiratory tract, skin 
sensitization and irritation (Jones 1972; Beswick et al. 1972; Marrs et al. 
І983)· Because of the rapidity of onset of irritation, exposed persons are 
ordinarly forced to flee the contaminated environment before serious mucous 
membrane damage can occur (Holland and White 1972; Beswick et a ) . 1972; 
Shmunes and Taylor 1973)· 
It has been reported, that CS combines readily with plasma proteins and 
glutathione in vivo. The sulfhydryl concentrations in the plasma of dogs 
dropped rapidly after CS had been given IV (Cucinell et al. 1971). 
In vitro CS reacts very fast with the disulfhydryl form of lipoic acid and 
it is known that a decrease in glutathione concentration occurs with CS either 
spontaneously or enzymatically (Boyland and Chasseaud 1967; Cucinell et al. 
I97I). Hence, these investigators, suggested that CS could be biotransformed 
by direct addition of glutathione to the double bond of CS. 
CS, however, reacts very fast with water (Patai and Rappoport 1962) and is 
both in vivo and in vitro hydroiysed to 2-chlorobenzaldehyde and malononitrile 
(Cucinell et al. 1971; Leadbeater 1973)· From the latter cyanide is released 
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that is biotransformed to thiocyanate (see Fig. 1). Further it was established 
CI 
^г — г^ »fi 
fr =^!=—.fx ^ fr 
U ^ c r N C / C H · — ^ · " - " 
'Pig· 1. Hydrolysis of CS and subsequent biotransformation in rats 
that the benzaldehyde is mainly biotransformed to 2-chlorobenzoic acid which 
is subsequently conjugated with glycine to 2-chlorohippuric acid. The latter 
compound was the principle detectable metabolite in urine after exposure of 
rats to CS (Cucinell et al. 1971). 
Recently we found that ortho-substituted benzaldehydes can be metabolized 
to the corresponding ortho-substituted benzylmercapturic acid via reduction to 
the alcohol, sulphation to the corresponding sulphate and subsequent 
conjugation of the latter with glutathione resulting in the excretion of the 
corresponding benzylmercapturic acid (Seutter-Berlage et al. 1982, Rietveld et 
al. І98З)· Hence, we expected, 2-chlorobenzylmercapturic acid as a metabolite 
of CS in addition to the direct conjugate of CS and N-acetyl-L-cysteine. 
Von Dan i ken et al. (I98I) detected a very weak mutagenic effect of CS in 
Salmonella typhimurium TA100 and in the rat a binding to nuclear proteins, 
but no covalent binding to DNA. With regard to the long incubation time in 
aqueous solution the question arose if CS itself or perhaps one, or both, 
of its metabolites, such as 2-chlorobenzaldehyde or malononitri le showed this 
genotoxicity towards bacteria. 
MATERIALS AND METHODS 
Chemicals. N-acetyl-L~cysteine, sodium azide and glass t.l.c. plates coated 
with silica gel pF-rj. were purchased from Merck AG (Darmstadt, FRG). Diazald 
(N-methyl-N-nitroso-p-toluenesulfonamide, precursor of diazomethane), 
malononitri le, 2-bromobenzyI bromide, 2-chlorobenzaldehyde, 2-chlorobenzyl 
alcohol, dimethyl sulfoxide, and benzo(a)pyrene were obtained from Aldrich 
Europe (Beerse, Belgium). Aroclor МЧк was purchased from Litton Bionetics 
Inc. (Kensington, USA). Polyethylene glycol 300 of pharmaceutical quality was 
obtained from the St. Radboud hospital (Nijmegen, The Netherlands). All other 
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reagents and solvents were of the best available analytical grade. 
Syntheses. N-acetyl-L-cysteine methylester was prepared by methylation of 
N-acetyl-L-cysteine with diazomethane. 
2-Chloro-benzylmercapturic acid methylester was synthesized by reaction of 
2-chlorobenzy1 alcohol with HBr in toluene and reaction of the thus-obtained 
2-chlorobenzyl bromide with N-acetyl-L-cysteine methylester (Clapp and Young 
1970). 
The methylester of 2-bromobenzylmercapturiс acid was synthesized by 
reaction of 2-bromobenzyl bromide with N-acetyl-L-cysteine methylester. 
2-Chlorobenzi1idene malononitri le (CS) was synthesized by condensing 
2-chlorobenzaldehyde with malononitri le in absolute ethanol with three drops 
of pyridine as the catalyst. The compound was recrystal1ized from ethanol 
(m.p. 91»-950C) and was more than 33% pure (g.l.c). 
Animal experiments. Adult male Wlstar rats (180-200 g, about 6 weeks old), 
TNO-stock, Zeist (The Netherlands) were used. The animals were housed in 
individual stainless steel metabolism cages with free access to water and food 
(Hope Farms, Woerden, The Netherlands). Urine samples were collected in 2k h 
portions and stored at -18 С until required for analysis. 
CS was administered IP once in a dose of 12.5 mg/kg in polyethylene 
glycol 300 as a solvent. 
Chromatography. Thin-layer chromatography was performed on glass plates coated 
with 0.25 mm layer of silica gel pF^ j-r with diethyl ether as an eluent. 
Preparative chromatography was performed on 0.5 mm layers of silica gel P^JCL 
with diethyl ether as the eluent. After development of the plates, the spot of 
the reference compound, 2-chlorobenzylmercapturic acid methylester was 
detected by fluorescence quenching (25^ nm) or by spraying the dried chromato-
grams with 0.1 M КгСггОуідІасіаІ acetic acid = 1:1 (v/v) and then with 0.1 M 
АдМОз (Knight and Young 1958). 
Gas-liquid chromatography was performed on a Hewlett-Packard Model 5710A 
gas chromatography equipped with a nitrogen flame ionization detector (NFID) 
and a glass column (1.2 m χ 3 mm ID) packed with 3% 0V17 on Gaschrom Q (80-100 
mesh). The carrier gas was helium (flow rate, 30 ml/min). Temperature: 
injection port 250oC, column 200oC, detector 300oC. Under these conditions the 
retention times of 2-chlorobenzyl- and 2-bromobenzylmercapturic acid were 
11.2 and 16.4 min respectively. 
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Spectra. Mass spectra were obtained with a LKB gas chromatograph-mass 
spectrometer type 9000 equipped with a El source. The ion source temperature 
о -
1
* 
was 230 C, the electron energy 20 eV, the ion source pressure 1.5 x 10 Pa. 
The synthesized 2-chloromercapturic acid methylester and the CS sample were 
introduced by gas chromatography under the following conditions: temperature 
column ISO C, carrier gas helium, flow rate 30 ml/min. The gas Chromatograph 
was equipped with a glass column of 1.1 m χ 3 mm ID, containing 3% OV 101 on 
Gaschrom Q (80-100 mesh). 
Quantitative determination of mercapturia acid excretion in urine. Twelve male 
rats were injected IP by a single dose of CS. Urine was collected for 2h h 
and pooled. 2-BromobenzyImercapturic acid (10 ymol) was added as an internal 
standard, subsequently the urine was acidified to pH2 with 10 M HCl, saturated 
with NH4CI and continously extracted with diethyl ether for 20 h. The extract 
was concentrated by evaporation and methylated with diazomethane. 
After washing twice with a saturated NaCl soin, and subsequent drying with 
MgS0i|, the solvent was evaporated in vacuo. The resulting oil was fractionated 
(t.l.c, O.5 mm layer silica gel PF2514, diethyl ether). The u.v. positive zone 
corresponding with the R.-value of the synthetic reference substance was 
removed from the plate and the fraction was obtained by elution of the silica 
gel with methanol and evaporation of the solvent. The amount of mercapturic 
acid was determined gas chromatographically. Calibration graphs of the area 
ratio of 2-chlorobenzylmercapturic acid methylester and internal standard 
(2-bromobenzyImercapturic acid methylester) as a function of the amount of 
synthetic 2-chlorobenzylmercapturic acid, were linear from 1.0 to 16.0 ymol, 
wi th correlaiioncoeffi ei ent>0.999. 
Mutagenicity assay. The Salmone!la/microsome assay for mutagenicity was 
performed with S.typhimurium TA100, according to Ames et al. (1975)· 
The strain was obtained from TNO Delft, The Netherlands. The assays were 
performed without pre-incubation. 
In the assays without rat liver homogenate (S-9 mix) CS or one of its 
expected metabolites (2-chlorobenzaldehyde, 2-chlorobenzyl alcohol, 2-chloro-
benzyl sulphate, malononitri le and sodiumcyanide) were dissolved in maximal 
0.1 ml dimethyl sulfoxide and at least five concentrations (ranging from 0 to 
2,000 yg per plate) of each compound were tested. As a positive control sodium 
azide (1.0 yg or 2.5 yg per plate) was applied. 
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Liver homogenate of the Arocolor 1254 induced rat (S-9 mix) was used in the 
assay with bioacti vat ion. 0.5 ml S-9 mix, containing 50 ul of liver homogenate 
was used per plate. CS and 2-chlorobenzaldehyde were tested in several 
concentrations between 0 and 3,500 vg per plate. As a positive control benzo-
(a)-pyrene (5-0 pg per plate) was used. 
Bacteriotoxicity was monitored by microscopic examination of the background 
lawn of test plates. A compound was found toxic at a certain concentration 
when the background lawn of bacterial growth was sparse or absent, and plates 
crowded with small his colonies. 
RESULTS 
After a single IP administration of CS (0.07 nmol/kg, η = 12) to adult male 
rats only one mercapturic acid could be detected gas Chromatograph i cally 
(NFID). In two independent experiments the amount of urinary excreted thio-
ether was 3-5 resp. k.k% of the dose. 
The mercapturic acid of CS appeared to be N-acetyl-S-(2-chlorobenzyl)-L-
cysteine (2-chlorobenzylmercapturic acid). This was apparent from the Я-- аІие 
0.39). These chromatograms showed no additional sulfur-containing spots after 
spraying with the reagens of Knight and Young (1958). The structure of the 
mercapturic acid of CS was confirmed by synthesis and mass-spectra (see 
Table 1 and Fig. 2). 
Table 1. Relative abundance of M and prominent fragments (m/e) of the 
methylester of the reference compound, and the mercapturic acid methylester 
of CS at 20 eV by g.l.c./m.s 
Substance M Prominent fragments (M/e) 
Reference compound6 301/303 242/244 176 (100) 125/127 
2-chloro-benzylmercapturic acid (12/5) (54/21) (53/18) 
methylester 
Mercapturic acidb 301/303 242/244 I76 (100) 125/127 
methylester of CS (11/4) (62/25) (58/21) 
Relative abundance in brackets (%) 
Ь
 tR = 6.1 min, 3% OV 101 on Gaschrom Q (80-100 mesh) 
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1 0 0 1
 RELATIVE ABUNDANCE (%) 
Reference compound 
NHCOCH, 
^CH,-S-CH,-CH 
|l COOCH, 
Fig. 2. Mass spectra of methylester of 2-chlorobenzylmercapturic 
acid and of the mercapturic acid methylester of CS. 
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No mutagenic effect was detected using CS or any of the other compounds 
tested either with or without rat liver homogenate (see Table 2 and 3)• 
At concentrations of CS higher than 1,000 yg per plate a bacteriotoxicity 
appeared. With rat liver homogenate the bacteriotoxicity of CS was slightly 
stronger than without it. 
DISCUSSION 
Our results showed that after a single IP administration of CS to rats in 
the urine only one mercapturic acid could be detected gas chromatographically 
in a small quantity (3.5 resp. k.kli of the dose). By interpretation of mass-
spectra (Table 1) the mercapturic acid was identified as N-acetyl-S-(2-chloro-
benzyl)-L"cysteine (2-chlorobenzylmercapturic acid). 
It has been reported that in vivo and in vitro the breakdown of CS to 
malononitri le and 2-chlorobenzaldehyde is very rapid (Patai and Rappoport 
1962; Cucinell et al. 1971; Leadbeater 1973). Previously, we showed that 
ortho-substltuted benzaldehydes and benzyl alcohols can be transformed to the 
corresponding benzylmercapturic acids in vivo (Seutter-Berlage et al. 1982). 
Recently we reported a metabolic pathway of ortho-substituted benzaldehydes 
via benzyl alcohols and sulphate esters to the corresponding benzylmercapturic 
acids (Rietveld et al. 1983). On the basis of these findings the urinary 
excretion of N-acetyl-S-(2-chlorobenzyl)-L-cysteine no doubt results from one 
of the main intermediate metabolites of CS, viz. 2-chlorobenzaldehyde. 
From various experiments in which a sulfhydryl depletion was found due to 
CS, a direct addition reaction of SH-groups to the double bond of CS was 
postulated (see INTRODUCTION). By thin-layer chromatography no other sulphur 
containing metabolite in the urine of CS administered rats could be detected, 
consequently, the formation of a direct addition product of N-acetyl-L-cysteine 
and CS is unlikely. Apparently, the hydrolysis of CS is a much faster reaction 
in vivo than the direct addition of glutathione to CS. 
In general the living organism will be exposed to CS smoke or aerosol, so 
that inhalation and skin contact are the more common forms of exposure. 
In the here chosen way of administration there is a direct transport of CS 
through the vena porta to the liver. Leadbeater (1973) demonstrated that CS is 
absorbed from the respiratory tract into the blood. Following the respiratory 
exposure of cats and rats to particulate aerosols of CS, he found not only CS 
itself, but also two of its metabolites, 2-chlorobenzaldehyde and 2-chloro-
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ТаЬЪе 2. Number of revertants ¡η the Salmonella / microsome mutagenicity assay Induced by CS or some 
of its expected metabolites in S.typhinaœtum TA 100 without rat liver homogenate (S-9 mix). 
Assay without pre-incubation. 
compound 
CS 
2-Cl-benzaldehyde 
2-Cl-benzyl alcohol 
2-Cl-benzyl sulphate 
Malononitri le 
Sodium cyanide 
146 
177 
118 
1Ί6 
146 
146 
146 
113 
0 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
17 
39 
30 
n.d.c 
n.d. 
n.d. 
164 ± 11 
141 ± 16 
135 ± 11 
112 ± 25 
86 ± 15 
dose of compo 
125 
120 ± 8 
n.d. 
n.d. 
113 ± 29 
103 ± 10 
112 ± 11 
131 ± 26 
Τ 
und per plate (pg) 
500 
111 ± 17 
108 ± 28 
93 ± 7 
112 ± 2 
143 ± 10 
113 ± 31 
163 ± 3 
Τ 
1,000 
163 ± 28 
122 ± 31 
74 ± 8 
131 ± 3 
142 ± 8 
125 ± 11 
143 ± 7 
Τ 
2,000 
T d 
Τ 
τ 
97 ± 28 
140 ± 5 
132 ± 10 
92 ± 54 
Τ 
b pos. cont. 
1 ,686 ± 70 
1,350 ± 31 
870 ± 31 
1,686 ± 70 
1,686 ± 70 
1,686 ± 70 
1,686 ± 70 
707 ± 7 
a : mean value and standard deviation of triplicates 
b : positive control: 1.0 \ig МаМз or 2.5 ug NaNa 
с : n.d. = not determined 
d : Τ = background lawn of bacterial growth spares or absent, plates crowded with small his colonies 
Table 3. Number of revenants a in the Salmonella / microsome mutagenicity assay induced by CS and 
2-chlorobenzaldehyde in S.typhirnuriwv TA 100 with rat liver homogenate (0.5 ml S-9 mix). 
Assay without pre-incubation. 
CS 
2-Cl-benzaldehyde 
0 
109 ± ΙΊ 
109 ± Η 
125 
90 ± 8 
n.d. 
dose of 
250 
81 ± k 
n.d. 
compound per 
500 
64 ± 10 
n.d.C 
plate (yg 
1,000 
T d 
82 ± 9 
) 
1,500 
τ 
62 ± 8 
3,000 
Τ 
τ 
t b pos. cont. 
422 ± 39 
422 ± 39 
a : mean value and standard deviation of triplicates 
Ь : positive control: 5 vg benz(a)pyrene 
с : n.d. = not determined 
d : Τ = background lawn of bacterial growth sparse or absent, plates crowded with small his colonies 
benzyl malononitri le (CSH2) ¡η the blood. It has not been investigated whether 
the presence of a tissue that has to be passed, e.g. after skin contact, 
influences CS metabolism with regard to glutathione conjugation. There are 
good reasons to conclude that only a small portion of the total amount of 
2-chlorobenzaldehyde formed upon hydrolysis of CS is metabolized to a 
mercapturic acid. The remaining part will be metabolized following a different 
pathway, e.g. to the corresponding benzoic acid. 
This study includes the testresults of CS and its metabolites in the Ames 
sa 1 mone 11 a/mi сrosóme assay with S.typhimurium TA100 (see METHODS). In this 
testsystem (without preincubation) no mutagenic effect appeared for any of the 
tested substances. A strong bacteriotoxicity was revealed for higher doses of 
CS (>1,000 wg/test plate). In contrast with the results of von Däniken et al. 
(I98I) this toxicity could not be counteracted by the addition of rat liver 
microsomes. Furthermore, in the assay without metabolic activation 2-chloro-
benzaldehyde (2,000 pg per test plate) revealed a slight bactericidal effect. 
Recently Marrs et al. (19B3) reported after a longterm inhalation toxicity 
study of CS, that in mice, rats, and in guinea-pigs a dose-response correlation 
between tumours at a particular site and the CS-dose did not appear. Our 
presented data added to the results of Marrs et al. (1983) and von Däniken et 
al. (I98I) suggest that it is very unlikely that CS or any of its metabolites 
can exhibit mutagenicity or carcinogenicity in the living organism. 
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Chapter 2.2 
Glutathione conjugation of chlorobenzylidene malonitriles 
in vitro and the biotransformation to mercapturic acids in 
rats. 
INTRODUCTION 
Chlorobenzylidene malononitri les (chloroBMNs) are the main products of the 
condensation of a chlorobenzaldehyde with malononitri le. 
The most studied compound in this group of BMNs is the wellknown 2-chloroBMN 
( CS-gas ), which Is used In several countries as a riot control agent. 
2-ChloroBMN produces as smoke or as an aerosol sternutation, lachrymat¡on, 
sensory irritation of the upper respiratory tract, skin sensitization and 
irritation (Jones 1972; Beswick et al. 1972; Alarle 1973; Ballantyne et al. 
1978; Beswick 1983). 
Both Dixon (ІЭ^в) and Alarie (1973) attributed the biological activity of 
chloroBMNs to adduct formation with endogenic SH-compounds. Furthermore Alarie 
(І97З) reported that especially substitution in the ortho position of the 
benzene ring by a halogen, in particular the Cl-substituent, will increase the 
irritant activity of the BMN. The most irritating chloroBMN is 2,6-dichloroBMN. 
From their biological properties we can conclude that these substances, or one 
of their metabolites, are capable of binding covalently to proteins thus acting 
as haptene (Turk and Parker 1978). In this way a conjugate with the tripeptide 
glutathione might also be formed, resulting in the excretion of one or more 
mercapturic acids in the urine (Chasseaud 1976)· 
Indeed, for 2-chloroBMN it has been reported that it reacts with plasma 
proteins and glutathione in vitro and in vivo (Cucinell et al. 1971). Boyland 
and Chasseaud (1967) found that after incubation of rat liver homogenates with 
2-chloroBMN the glutathione concentrations in the homogenates decreases 
enzymatically as well as spontaneously. These investigators suggested that 
2-chloroBMN could be biotransformed by direct addition of glutathione to the 
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double bound, leading to a glutathione conjugate which ultimately may be 
biotransformed in vivo to a mercapturic acid along route a (see Fig. 1). 
From the work of Patai and Rappoport (1962), Cucinell et al. (1971) and 
Leadbeater (1973), however, it is known that 2-chloroBMN is hydrolysed both in 
vitro and in vivo to 2-chlorobenzaldehyde and malononitri le (see Fig. 1). In 
vivo malononitri le is further broken down to cyanide, and subsequently to thio-
cyanate (Stern et al. 1952; Frankenberg et al. 1973) whereas benzaldehydes are 
mainly biotransformed to the corresponding benzoic acids and excreted in urine, 
either directly or in conjugated form (Williams 1959; Caldwell 1982). 
Recently, we found that especially ort/io-substi tuted benzaldehydes can be 
biotransformed to the corresponding benzylmercapturic acids (Seutter-Berlage et 
al. 1982; Rietveld et al. 1983a ). In accordance herewith it was found that in 
rats in a small quantity of 2-chloroBMN is biotransformed to 2-chlorobenzyl-
mercapturic acid (Rietveld et al. 1983b ) (see Fig. 1, route b). 
On the other hand it is known from the experiments of Patai and Rappoport 
(1962) and Pritchard et al. (I967) that the rate of hydrolysis of 2-chloroBMN 
is faster than those of the related chloroBMNs. 
The aim of this study is to investigate if chloro-substitutedBMNs other than 
2-chloroBMN are also biotransformed to urinary mercapturic acids and if so to 
which type of mercapturic acids. Furthermore, the possible relationship between 
the rate of hydrolysis and the formation of mercapturic acids will be discussed. 
MATERIALS AND METHODS 
Chemicals. N-acetyl-L-cysteine, sodium borohydride, 5,5'"dithiobis-(2-nitro-
benzoic acid)=DTNB, metaphosphoric acid, Titriplex III (EDTA), trichloroacetic 
acid, Folin-Ciocalteus Phenol reagent, and glass t.l.c. plates coated with 
silicagel PF254 were purchased from Merck AG (FRG). Diazald (N-methyl-N-nitroso-
p-toluenesulfonamide, precursor of diazomethane), malononitri le, 2-chloro-, 
3-chloro-, It-chloro-, and 2,6-dichlorobenzaldehyde were supplied by Janssen 
Chimica (Beerse, Belgium). Glutathione red. and pentachlorophenol (PCP) were 
purchased from Boehringer Mannheim, FRG and Aldrich (Milw, USA) respectively. 
Polyethylene glycol 300 of pharmaceutical quality was obtained from the 
St. Radboud hospital (Nijmegen, The Netherlands). All the other reagents and 
solvents employed were of analytical grade and commercially available from 
Merck AG (FRG). Some of the above substances were redistilled or crystallized 
before use if necessary. Purity controls were performed by GLC (>37%)· 
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Fig. l. hydrolysis of chloroBMNs and subsequent biotransformation to 
mercapturic acids. 
Table 1. Synthesis of chloroBMNs 
Yield(S) m.p (0c) tr(min) 
2-ChloroBMN 
3-ChloroBMN 
it-ChloroBMN 
2,6-Dichloro BMN 
70 
75 
98 
65 
9k- 95 
113-111» 
162-163 
b79- 80 
2.9 
k.è 
5.2 
4.3 
GLC;3% 0V17 on Gaschrom Q (80-100 mesh) 
n-hexane 
Table 2. Synthesis of halobenzylmercapturic acids 
Yield m.p. 
(0C) 
Rf 
valuea 
2-Chlorobenzylmercapturic acid 94 
3-ChlorobenzyImercapturic acid 60 
it-Chlorobenzylmercapturic acid 75 
2,6-Dichlorobenzylmercapturic acid 96 
2-Bromobenzylmercapturic acid 96 
135-137 
108-109 
103-105 
141-142 
151-154 
0.32 
0.28 
0.27 
0.30 
0.28 
In dichloromethane-methanol-acetic acid = 40:4:1 (saturated separate room) 
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Syntheses. The series of chloroBMNs were synthesized by condensing malononitri le 
with the corresponding chlorobenzaldehyde in absolute ethanol with a few drops 
of pyridine as the catalyst. The unsaturated compounds were recrystai1ized from 
ethanol or n-hexane and were more than 99% pure (GLC) (Table 1). 
The N-acetyl-S halobenzyl -cysteines(halobenzyImercapturic acids) were 
synthesized by converting the halobenzyl alcohols into the corresponding benzyl-
bromides with HBr in toluene and subsequent reaction of the halobenzyl bromides 
with N-acetyl-L-cysteine (Clapp and Young 1970)(Table 2 ) . 
The methyl esters of halobenzyImercapturic acid were prepared by methylation 
with diazomethane. 
Animal experiments. Adult male Wistar rats (180-200 g about 6 weeks old), 
TNO stock, Zeist (The Netherlands) were housed in individual stainless steel 
metabolism cages with free access to water and food (Hope Farms, Woerden, The 
Netherlands). Urine samples were collected in 2it-h portions and stored at -18 С 
until required for analysis. 
The arpmatic aldehydes and alcohols were IP administered once in a dose of 
2.0 mmol/kg in polyethylene glycol 300 as a vehicle. 
The BMNs were administered IP once in a dose of 0.065 mmol/kg in the same 
solvent as the aromatic aldehydes and alcohols. In continuous administration 
(3 days a week for 3 weeks) of chloroBMNs, chlorobenzaldehydes and chlorobenzyl 
alcohols the doses were some what lower than by the single administration. 
In the inhibition studies the animals were injected IP with pentachlorophenol 
(PCP) in polyethylene glycol 300 (0.05 mmol/kg) kS min preceding administration 
of 2-chloroBMN (CS). In all experiments the animals with the solvent only 
served as control group. 
Chromatography. Thin layer chromatography of the mercapturic acids was perfor­
med on glass plates coated with a 0.25 mm layer of silica gel PF2514 with 
dichloromethane: methanol: acetic acid (Ίθ:ί·:1 = v/v/v) as an eluent. 
Preparative chromatography on behalf of the quantitative determination of 
urinary mercapturic acid was performed on 0.5 mm silica gel coated glass plates 
with diethylether as an eluent. After development of the plates, the spots of 
the reference compounds, the halobenzyImercapturic acid methylesters were 
detected under UV light {IS1* nm) or by spraying the dried chromatograms .wi th 
the reagent of Knight and Young (1958). 
Gas-liquid chromatography of the mercapturic acids was performed on a 
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Hewlett-Packard Model 5710 A gas Chromatograph equipped with a nitrogen flame 
ionization detector (NFID) and a glass column (1.2 m χ 3 mm ID) packed with 3% 
OViy on Gaschrom Q (80-100 mesh). The carrier gas was helium (flow rate, 
30 ml/min). Temperature: injection port 250 oC, column 200 oC
>
 detector 300 C. 
Under these conditions the retention times of 2-chloro-, 3-chloro-, ^t-chloro-, 
2,6-dichloro- and 2-bromobenzylmercapturic acid methylesters were 11.2, 11.4, 
12.0, 11.0 and 16.4 min., respectively. 
The purity control of the BMNs was performed on a Hewlett-Packard Model 5750 
gas Chromatograph (Alk-FID) and a glass column (1.8 m χ 4 mm ID) containing 3% 
OV 17 on Gaschrom Q 80-100 mesh. The carrier gas was helium (flow rate, 
30 ml/min). Temperature: injection port 250 oC, column 150 C, detector 300 С 
Spectra. The 70-eV mass spectra (El) were obtained with a V.G. Micromass gas 
chromatograph-mass spectrometer type 7070 F in conjuction with a V.G. data-
system 2000. The ion source temperature was 200 C, the ion source pressure 
was 3-5 x 10" 5 Pa. The synthesized methylesters of the chlorobenzylmercapturic 
acids were introduced by direct probe insertion at 40 C. The methylated 
isolated chlorobenzylmercapturic acids and the CS sample (methylated) were 
introduced by gas Chromatograph (HP 5790 A) the GC separation was carried out 
with a glass capillary column (15 m χ 0.2 mm I.D.) coated with methyls¡1 i cone 
(Η.P.) as stationary phase. A stream splitter was used for injection on the 
column. The gas Chromatograph conditions were as follows: temperature injection 
port 25O C, temperature column 150-200 C, carrier gas helium (0.7 ml/min). 
Isolation of mercapturic acids from urine. Urine 500-1000 ml was acidified to 
pH 2 with 10 M HCL and saturated with NH4C] . The urine was continuously 
extracted with diethylether during 24 h. 
The organic extract was concentrated by evaporation and then treated with 
excess diazomethane in diethylether. After washing twice with NaCl soin, and 
drying with MgSOi,, the solvent was evaporated in vacuo. The resulting brown oil 
was fractionated by column chromatography (silica gel 60) using diethylether as 
e Iuent. 
The fractions giving a positive reaction with the reagent of Knight and 
Young (I958) were combined and concentrated in vacuo. The remaining oil was 
separated on TLC plates (0.5 nm). The fractions having the R, value of the 
synthetic reference substance were removed from the plate and the compound 
isolated by extraction of the silica gel with methanol and evaporation of the 
solvent. 
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Determimtion jf пгічир"іпі.· с-id excretion in urine. 
Mc 'Λοά A ) . 
Rats were treated with a single dose of the investigated compound and 2^ h 
urines were collecLed during 3 days and diluted with water to a standard volume 
(20 ml). The amount of mercanturic acid in the urine was determined according 
to Seutter-Berlage et al. (ij/ja) ui tu the following modification: diluted 
urine samples were centrifuged at 3000 r.p.m., and the analysis was performed 
with the supernatant. One part of the supernatant was used for the determination 
of the free thiol concentration according to El Iman (1959): 0.25 ml of superna­
tant was mixed with 2 ml 0.5 M КНгРОц/МагНРОі,, pH 7-1 and 0.3 ml reagent 
solution, consisting of ΊΟ mg DTNB and 1.12 g sodium citrate.2H2O in distilled 
water (100 ml). 
The supernatant was also used for the determination of thiol concentration 
after alkaline hydrolysis. The alkaline hydrolysis was performed in brown glass 
tubes with screw cap in the following way: 1 ml supernatant was mixed with 1 ml 
2 M NaOH, sealed under nitrogen and heated in a boiling water bath for 2 h. 
The reaction mixture was cooled in ice during 10 min and neutralized with 1 ml 
2 M HCl. Subsequently, the free and the liberated thiol groups were assayed 
following the method of El Iman (1959). The difference between the latter and 
former determined amount is the number of umol SH/ml set free from thioethers 
and disulphides. 
The disulphide excretion appeared as an exogenous relatively uninfluenced 
constant background value (Seutter-Berlage 1979b). Urine samples of the control 
group of rats served as blanks. 
Standard series of synthesized reference compounds added to urine samples 
and subjected to the same procedure, gave a recovery for 2-, 3" and '•-chloro-
benzylmercapturic acid, and 2,6-dichlorobenzyImercapturic acid of 77±2%, 80±3%, 
74±2%, and 68±6£ (each value £ +SD, n=3), respectively. 
Quantitative determination of mercapturio acid excretion in urine. 
(Method B). 
Twelve male rats were injected IP with a single dose of chloroBMN. Urine was 
collected for 2*» h and pooled. 2-Broniobenzylmercapturic acid (10 umol) was 
added as an internal standard; subsequently, the urine was worked up as 
mentioned in Chapter 2.1. The amount of mercapturic acid was determined by gas 
Chromatograph. 
З^ 
Determination of enzymio glutathione conjugation. 
Enzyme source. Rats with empty stomach were decapitated between 8 and 10 a.m. 
The livers were perfused in situ with physiological saline solution, removed 
and stored on ice. For each experiment k livers were pooled in a volume of 
1.15% cold KCl solution, which was 3 times the weight of the total amount of 
liver. Then the livers were cut and homogenized with a Potter Elvehjem homoge-
nizer. The homogenate was centrifuged at 9000 g over 30 min. The supernatant 
was used as the enzyme source. The whole procedure was performed at a tempera­
ture between 0 С and 5 C, 
Determination. The reaction mixtures contained 1 mM GSH and ImM of the chloro-
BMN. The chloroBMNs were dissolved in absolute ethanol. The buffer was 0.1 M 
КНзРО^/МагНРОі^, pH 7·^· The total incubation volumes were always 1 ml; namely 
0.5 ml supernatant liver homogenate, 0.3 ml buffer and 0.2 ml ethanol. 
Mixtures were preincubated at 37 С for 5 minutes and the reaction was started 
by adding the substrate in 25 μΐ ethanol. Incubation took place at 37 С in a 
water bath for 5 min. The reaction was stopped by addition of 1.5 ml of a 
solution, consisting of k50 mg of NaCl, 25 mg of metaphosphoric acid and 3 mg 
of EDTA, dissolved In distilled water, and followed by centrifugal¡on for 
10 min at 600 g. Appropiate samples in each experiment served as blanks and 
for the determination of the non-enzymic reaction. The non-protein thiol 
concentration was determined spectrophotometricaily, according to El Iman (1959)· 
The protein content in the reaction mixture was determined by the method of 
Lowry et al. (1951) and was 10-15 mg/ml. All results are expressed as means 
±SD for the number of experiments in parentheses. 
Determination of the rates of hydrolysis of chloroBMNs. 
The rates of hydrolysis of chloroBMNs were determined according to Patai and 
Rappoport (1962). Before the measurement 0.1 M КНгРО^/МагНРОц buffer pH 7·'» and 
ethanol (PA) were mixed in such a way that in the measuring cuvette the 
ultimate proportion between buffer and ethanol is 80:20. Then the mixture was 
placed 15 min before the start of the measurement in a water bath of 37 С and 
was kept at this temperature during the entire experiment. 
An appropriate BMN solution was freshly prepared in ethanol (PA) and was 
preincubated for 15 min (37 С). The measure and reference cuvette placed in a 
Cary 118c spectrophotometer equipped with a thermostat kept on exactly 37 С 
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during the entire experiment. The reference cuvette contained buffer/ethanol 
(80:20). 
RESULTS 
In vitro the decrease in glutathione concentration was determined with 
incubation mixtures, containing chloroBMN and rat liver homogenate (9000 g) 
(Table 3). In these experiments we used absolute ethanol to dissolve the 
chloroBMNs. Further it was necessary to have a minimal 20% ethanol in the 
incubation mixtures, because the chloroBMNs crystallized out in Sörensen buffer. 
According to Viña et al. (1980), this 20% ethanol has no effect on glutathione-
s-transferase activity during incubation (5 min). 
From the data expressed in Table 3 bt appears that the percentage decrease 
of the initial amount of glutathione at physiological circumstances (37 C, 
pH 7·'·) with all the substrates was both enzymatical ly and spontaneously. 
The glutathione depletion by 2,6-dichloroBMN was largely spontaneous (38 ± 1%). 
The results obtained after determination of the rates of hydrolysis of 
chloroBMNs in a mixture of Sörensen buffer pH 7·'· and ethanol at 25 С and 37 С 
are listed in Table k (t,, pseudo first order). 
After a single IP administration of 2-chloroBMN (0.07 mmol/kg rat) to adult 
male rats an enhanced thioether excretion in the urine could be determined 
with method A. No enhancement in urinary thioether excretion was found after 
injection of the other chloroBMNs (0.07 mmol/kg rat), both with spectrophoto-
metric method А {п=Ь) and with a gas chromatographic method В (n=12) (Table 5)• 
Only one thioether could be isolated and identified with mass spectrometry 
as the N-acetyl-S-(2-chlorobenzyl)-L-cysteine. The structure was confirmed 
with synthesis and thin-layer chromatography (Table 6). There was no evidence 
for the existance of other thioethers, such as an addition product from 
N-acetyl-cysteine with 2-chloroBMN. Besides, several attempts to synthesize 
such an adduct under both basic as acidic conditions were not succesful. 
The amount of the thioether (2-chlorobenzylmercapturic acid) could be 
quantified with the gas chromatographic method В and ranged from 3·5 to k.k% 
administered dose (Table 5). 
Pretreatment of rats with PCP (pentachlorophenol, 0.05 mmol/kg rat) reduced 
the excretion of mercapturic acid by 2.5% of the dose (Method B). 
From the injected chlorobenzaldehydes (2 mmol/kg rat) only the 2- and 3" 
substituted compounds gave a mercapturic acid excretion in the urine of 7-6 
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icble Ζ. Glutathione depletion ' with rat liver homogenate in 
ethanol-buffer (20:80) at 370C. 
Compound pH 7.Uc 
Total % Non-enzymatic 
2-chIoroBMN 59i9d 26±3 
3-chloroBMN lt6±5 2^ (11 
¡•-chloroBMN 51±t( 7±1 
2,6-dichloroBMN 39^3 38+3 
a % decrease of the initial amount of glutathione 
b % decrease of the initial amount of glutathione due to the 
corresponding chlorobenzaldehydes was lower than 8% 
с Sörensen buffer 0.1 M МагНРО^/КНгРО^, pH Ί.h 
d Standard deviation (η = 2) 
Table 4. The rates of hydrolysis of chloroBMNs (~k.5 χ lu" M) 
in ethanol/buffer3 (20:80) at 250C and 37 0C. 
Compound 
2-chloroBMN 
3-chloroBMN 
It-chloroBMN 
2.6-dichloro BMN 
Τ = 250C 
Чо
х 1 0
" 
(s-1) 
8.0 
8.9 
5.6 
3-7 
tl/2 
(min) 
1Ί.5 
13.0 
20.8 
31.0 
Τ = 370C 
Ч о
х , о Ц 
(s-1) 
17-0 
18.A 
13Д 
8.6 
tl/2 
(min) 
6.8 
6.3 
8.7 
13.5 
(nm) 
305 
301 
319 
292 
a Sörensen buffer 0.1 M МагРО^/КИгРОц, pH 7.1» 
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ТлЫе С. Urinary mercapturic acid excretion 
Compound 
2-ChloroBMN 
3-ChloroBMN 
it-ChloroBMN 
2,6-DichloroBMN 
Method A 
dose % dose 
65 26.8 ± 
65 n.s. c 
65 n.s. 
65 n.s. 
+ 
12 
SEMb 
.2 
Method В 
Ζ dose 
3.5 and l».'t 
n.d.d 
n.d. 
n.d. 
2-Chlorobenzaldehyde 2000 7-6 + 1.0 
3-Chlorobenzaldehyde 2000 1.1 ± 0 . 5 
It-Chlorobenzaldehyde 2000 n.s. 
2,6-Dichlorobenzaldehyde 2000 n.s. 
2-Chlorobenzyl a l c o h o l 2000 16.8 ± 2.6 
3-Chlorobenzyl a l c o h o l 2000 1.0 ± 0.1 
'•-Chlorobenzyl a l c o h o l 2000 Ι . Ί ± 0.3 
2,6-Dich lorobenzy l a l c o h o l 2000 2-3 + 0.8 
a Dose in pmol/kg 
b Recovery c o r r e c t e d values 
с n.s. = not s i g n i f i c a n t , p > 0 . 0 5 > η = k, Students t - t e s t 
d n . d . = not d e t e c t a b l e 
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Table 6. Relative abundance3 of M+ and prominent fragments (m/e) of the methylesters of the 
chlorobenzylmercapturic acids at 70 eV 
Compound M+ Prominent fragments (m/e) 
2-Chlorobenzylmercapturi с acid 
3-Chlorobenzylmercapturic acid 
U-Chlorobenzylmercapturic acid 
301/303 iki/ikk 176 
(3/1) (39/16) (55) 
301/303 2ί)2/2Π 176 
(3/1) (30/11) (77) 
301/303 Ihl/lbh 176 
(3/1) (2V9) (53) 
2 , 6 - D i c h l o r o b e n z y l m e r c a p t u r i c a c i d 335/336/337 276/277/278 176 
(2/0.5/1) (3 i t/5/2it) (71) 
a Relative abundance in brackets (%) 
b All compounds were studied as Methylesters 
\hk 
(11) 
iv» 
(15) 
1M» 
(13) 
\kk 
(15) 
125/127 
(100/31) 
125/127 
(92/32) 
125/127 
(100/3Ό 
159/160/161 
(93/10/63) 
and 1.U of the dose, respectively (Method A, Table 5) · 
All the chlorobenzyl alcohols in this study yielded after IP administration 
to rats (2.0 mmol/kg rat) an enhanced urinary mercapturic acid excretion 
(Method A, Table 5). 
After isolation from urine all mercapturic acids were identified with mass 
spectrometry as the N-acetyl-S-(chlorobenzyl)-L-cysteine5 (Table 6 ) . 
The structures were confirmed via syntheses and thin layer chromatography. 
DISCUSSION 
The chloroBMNs in this investigation are belong to a group of unsaturated 
dinitriles, which have electron withdrawing nitrile groups adjacent to the 
carbon-carbon double bond with the consequence that endogenous nucleophilic SH 
or NH2 compounds such as proteins and enzymes can be added. In accordance 
herewith the reaction with the tripeptide glutathione (GSH) presumably occurs 
by addition of the nucleophilic GS -ion to the electrophi1¡c 0-carbon atom of 
the a.ß-double bond of the chloroBMNs (see Fig. 2, route a, compound A ) . 
(Concept of the conjugate Michael addition). 
Because of the known differences in irritation properties, probably attri-
butable to steric and electronic effects of the chloro-substituents in the 
phenyl ring of the chloroBMNs, the glutathione depletion in rat liver homoge-
nates with the various chloroBMNs as substrates was investigated. The results 
collected in Table 3 show that, the decrease of the initial amount of GSH in 
the incubation mixtures ranged from '•O to 60%, indicating a high reactivity of 
the compounds to the SH group under physiological conditions. 
Chasseaud (1973) reported, that in vitro the glutathione depletion with 
2-chloroBMN was spontaneously and enzymatically and that there was only one 
sulphur-positive reaction product (reagent of Knight and Young 1958) on the 
paper- and thin-layer chromatograms of incubation mixtures containing GSH and 
2-chloroBMN. This author also claimed that there was no hydrolytic cleavage of 
the double carbon-carbon bond during a preincubation of the chloroBMN for 30 
min at pH 7-^ and 250C. 
This latter statement is doubtful when taking into account the rates of 
hydrolysis of the various chloroBMNs under physiological conditions (see data 
collected in Table 't and those reported in the literature: Patai and Rappoport 
1962; Pritchard et al. 19б7). 
It has been proven that chlorobenzaldehydes (Fig. 2, route b, compound B) 
1*0 
^МНСОСНз 
CH2-S-CH2-CH 
^соон 
Fig. 2. The possible pathways of metabolism of chlorobenzylidene 
malononitri les (chloroBMNs) into mercapturic acids. 
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are important intermediates in the metabolism of chloroBMNs. (Cucine!1 et al. 
I97I; Leadbeater 1973)· Generally aldehydes are known to react reversibly 
with SH compounds, yielding moderately stable hemithioacetals (Fig. 2, compound 
C) at physiological pH and temperature (Kharasch et al. 1976). In this fashion, 
the chlorobenzaldehydes can contribute to a glutathione depletion during the 
incubation of the chloroBMNs with GSH. Therefore, to limit the competing hydro­
lysis of the chloroBMNs short incubation times of 5 min were taken. In experi­
ments with the corresponding chlorobenzaldehydes as substrates, it appeared 
that under the same circumstances (5 min, pH 7·^» 37 С) the percentage decrease 
of the initial amount of GSH in the incubation mixtures was not more than 8%. 
Therefore, the chlorobenzaldehydes cannot be held responsible fact the large 
decrease in glutathione concentration when the corresponding chloroBMNs are 
used as the substrates (Table 1). 
In all cases the reaction took place enzymatically as well as spontaneously, 
however, 2,6-dichloroBMN showed an almost exclusive spontaneous reactivity 
towards GSH at pH J.k. Presumably, steric hindrance caused by the two ortho-
chloro substituents strongly hampers the formation of a substrate-enzyme 
complex apparently to such an extent that the glutathione-S-transferase cata­
lyzed reaction is prevented. Conversely, the electronic effect of the two 
chloro substituents facilitates the conjugate addition at the double bond 
clearly to give a considerable glutathione depletion (see Table 3). 
It is known that if GSH binds covalently to reactive electrophilie sub­
stances in vitro, this can result in an enhancement In urinary thioether excre­
tion in vivo. However, after IP administration of the chloroBMNs to rats, 
only 2-chloroBMN gave an enhanced urinary thioether excretion, measured by 
method A and the more specific gas chromatographic method В (Table 5)· 
A thioether could be isolated and identified with mass spectrometry (Table 
6). The structure was confirmed by synthesis and appeared to be N-acetyl-S-
2-chlorobenzyl -L-cysteine (2-chlorobenzylmercapturic acid, Fig. 2, 
compound E). 
Attempts to isolate or synthesize thioethers like compound A and D (Fig. 2) 
failed. Apparently, compounds like A are not sufficiently stable and may 
either be transformed via route с and in the presence of water to the hemithio-
acetal С Probably, this is the sulphur containing reaction product of 
Chasseaud (1973). This means that in vivo a reactive electrophi1ic intermediate 
(compound between brackets, Fig. 2) can be generated and this could have 
toxicological consequences. 
k2 
2-Chlorobenzylmercapturic acid was also found in the urine of rats after 
administration of 2-chlorobenzaldehyde and 2-chlorobenzyl alcohol (Table 5. 
Seutter-Berlage et al. 1982; Rietveld et al. 1983a). These results support 
our suggestion, that in vivo 2-chloroBMN is first hydrolyzed to 2-chlorobenzal­
dehyde (Fig. 2, route a and Table k), which then is biotransformed to the 
corresponding benzylmercapturic acid (Fig. 2, route e, compound E) . 
In previous reports we showed that in particular ort/zo-subst i tuted benzal-
dehydes can be biotransformed to mercapturic acids (Seutter-Berlage et al. 
1982; Rietveld et al. 1983a) in contrast to para-substituted benzaldehydes. 
We provided evidence that, due to steric hindrance of a substituent at the 
ortho position the sequence of events is initial reduction to the correspond­
ing alcohol, then biotransformation to a compound with a good leaving group, 
presumably a sulphate ester, and subsequent reaction with glutathione to 
eventually produce the corresponding mercapturic acid (Rietveld et al. 1983a) . 
The experiment with the sulphotransferase inhibitor (PCP) support the 
suggestion that 2-chloroBMN is biotransformed to 2-chlorobenzyImercapturic 
acid E (Fig. 2) via route b and e, as the amount of urinary excreted mercap­
turic acid was decreased after pretreatment with PCP (see Results). 
Taking into account the rates of hydrolysis of the chloroBMNs in aqueous 
solutions (Table Ό and the results presented in Table 5, it is very likely 
that in vivo the initial biotransformation of 3" and 't-chloroBMN occurs in the 
same manners as for 2-chloroBMN, however, in this case not leading to mercap­
turic acid excretion in the urine of rats. 
It is striking to note that a substance having two ort^o-substituents in 
the phenyl ring, viz. 2,6-dichloroBMN and 2,6-dichlorobenzaldehyde, in an IP 
dose to rats did not lead to the corresponding benzylmercapturic acid. From 
Table 3 it appears that 2,6-dichloroBMN will be the most reactive compound 
with proteins(note that this is a non-enzymatic reaction which as such is in 
accordance with the behaviour of electrophi1ic xenobiotics with proteins)and 
furthermore, it is the most stable chloroBMN in presence of water (Table k). 
In other words it will be the best haptene in comparison with the other 
chloroBMNs in this study. 
hi 
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Chapter 2.3 
Detoxification of methyl 2-cyano-3-phenylacrylates in 
rats. 
INTRODUCTION 
Methyl 2-cyano-3-phenylacrylates (2-cyano-3-phenyIpropenoic acid methylesters, 
methyl a-cyano-cinnamates, Table 1) are the solid crystalline products of the 
Knoevenagel-Cope condensation reaction of substituted and unsubstituted 
benzaldehydes with methyl cyanoacetate (Zsolnai 1965a; Luu Due, et al. 1969)· 
These compounds are structurally related to the alkyl 2-cyanoacrylates 
(Chapter 2.Ί; Leonard et al. 1966), however, the chemical properties may be 
more similar to those of the benzylidene malononitri les (BMNs, Chapter 2.2; 
Patai and Rappoport 1962; Jones 1972). 
Several biological effects of methyl 2-cyano-3-phenylacrylates (CPAme and 
derivatives with substituents in the phenyl ring) are reported in the literature, 
such as slight fungistatic and tuberculostatic effects (Zsolnai 1965a), 
phyto-pharmacological activities (fungicide, insecticide and weed-killer; 
Da Rocha Pitta et al. ІЭ?1*), inhibitory effect on the respiration of the fungus 
Saccharomyces oerevisiae and yeast (Zsolnai 1965b). Recent experiments in vivo 
as well as in vitro showed that some CPAme's are able to react with thiol 
compounds (Rietveld et al. 1985). Bromo-substituted CPAme (Table 1) was found 
to be mutagenic in Salmonella typhimurium TA1535 in absence of metabolic 
activation system (rat liver homogenate S9) (Chapter 2.Ί; Rietveld et al. 198?). 
2-Cyano-3"phenylacrylic acid (α-cyano cinnamic acid, CPA, Table 1) and some 
of its phenyl substituted derivatives showed cytotoxicity in vitro, inhibitory 
activity in several microbiological systems and antitumor properties in vivo 
(Foley, et al. 1959; Viel and Doré 1972). CPA and A-hydroxy-CPA were potent 
inhibitors of pyruvate transport across the mitochondrial membrane and the 
cell-membrane of human erythrocytes (Halestrap and Denton 1975). 
Relatively little is known about the mechanism of toxicity and the 
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biotransformation of CPAme's. Hydrolysis catalyzed by carboxylesterase and the 
addition of SH-compounds (e.g. glutathione) to the activated double bond may be 
important in the detoxification process. The carboxyl esterase catalyzed 
hydrolysis (Heymann 1982), of CPAme's to the corresponding CPA's may be a major 
metabolic pathway. In analogy with the benzylidene malononitri les (BMNs) it is 
conceivable that in vivo cyanide release plays a role in the toxicity mechanism. 
The acute toxic cyanide will in vivo be detoxified to thiocyanate which will 
be excreted in urine (Jones 1972). Furthermore, it should be mentioned that 
the hydrolysis of CPAme's to the corresponding benzaldehydes and alkyl cyano-
acetate has been observed (Patai and Rappoport 1962). Benzaldehydes, 
particularly the ortho-substituted, ones, are biotransformed by rats via a 
minor metabolic pathway to benzylmercapturic acids (Seutter-Berlage et al. 1982). 
Structurally related 2-chloroBMN leads to excretion of 2-chlorobenzylmercapturic 
acid in urine after a single dose to rats. In view of the conceivable reactions 
of CPAme's and its metabolites conjugation with glutathione may result in 
more then one urinary thioether. 
The present study deals with the question whether or not CPAme's and CPA's 
(Table l) in rats are biotransformed to urinary thioether(s)and/or thiocyanate 
(SCN ). The effect of pretreatment with the carboxylesterase inhibitor tri-
orthotolyl phosphate (TOTP) on the in vivo biotransformation of CPAme to 
thioether(s) and SCN was also studied. In vitro the conjugation of CPAme and 
CPA with L-cysteine, N-acetyl-cysteine and glutathione was investigated. 
The in vitro conjugation with the latter SH compound was studied with and 
without enzymic system (9000 g rat liver homogenate). Furthermore, experiments 
were also performed to determine the rate of hydrolysis (in effect the retro-
condensation) of the activated double bond of the respective CPAme compounds. 
Ί8 
MATERIALS AND METHODS 
Jhemioals. Bovine serum albumin (98-99%) supplied by Sigma Chemical Company 
(St. Louis, USA). Substituted benzaldehydes, cyanoacetic acid (CA), methyl 
cyanoacetate (CAme), 1 ,Ί-phenylenediamine and arsenic(lII)oxide were obtained 
from Janssen Chimica (Beerse, Belgium). N-acetyl-L-cysteine, L-cysteine, 
5,5 -dithiobis(2-nitrobenzoic acid) = DTNB, metaphosphoric acid, Titriplex III 
(EDTA), trichloroacetic acid, Fol¡n-Ciocalteus Phenol reagent, potassium 
thiocyanate and glass TLC plates coated with silicagel pF25b were purchased 
from Merck AG (FRG). Tri-ortho-toly1 phosphate (TOTP) (98%) was obtained from 
Eastman Organic Chemicals (Rochester, N.Y, USA), glutathione red. from 
Boehringer Mannheim (FRG) and polyethylene glycol 300 of pharmaceutical quality 
from the St. Radboud Hospital (Nijmegen, The Netherlands). 
All other reagents and chemicals used were of analytical grade and were 
obtained from Merck AG (FRG). The compounds used were purified before 
administration if necessary. Purity controls were performed by GLC. 
Synthesis^ The series of methyl 2-cyano-3-phenylacrylates (CPAme's, Table 1) 
were prepared by a condensation of methyl cyanoacetate (CAme) with the 
appropiate substituted benzaldehyde in methanol with a few drops of pyridine 
as the catalyst (Zsolnai 1965). The acrylic compounds were crystallized from 
methanol to constant m.p. and were more than 99% pure (GLC). 
2-Cyano-3-phenylacry1ic acid (CPA) was prepared from freshly distilled 
benzaldehyde and cyanoacetic acid (CA) in dioxane in presence of piperidine. 
Pure acid was obtained by crystallisation from (hot) water (Moal et al. 1968) 
(Table 1). 
Animals and animal treatment. Adult male Wistar rats (Cpb: WU, 180-200 g, 
6 weeks old) from TNO stock (Zeist, The Netherlands) were used. At the 
beginning of the in vivo studies the rats were devided into groups of four 
rats each and maintained on food (Hope Farms, Woerden, The Netherlands) and 
tap water ad libitum. The animals were allowed to acclimate to individual 
stainless steel metabolism cages for minimal 7 days prior to treatment. 
The cages were placed in a temperature regulated room (22 + 2 C) with a 
relative humidity of 50 to 75% and light/dark cycle of 12 h. All the compounds 
studied were injected in the morning between 9 and 10 o'clock. Urine samples 
were collected daily and stored at -18 С until required for analysis. 
The methyl 2-cyano-3-phenylacrylates (CPAme, MeCPAme and BrCPAme) were 
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Table 1. Synthesis of methyl 2-cyano-3"phenylacrylates and 2-cyano-3"phenyl• 
acrylic acid (CPA). 
H COOR 
\ / 
С с 
о-
CN 
R 1 MW Y i e l d m.p. R, t D
C 
о (%) ( С) value (min) 
CPAme 
MeCPAme 
BrCPAme 
CPA 
СНз 
СНз 
СНз 
H 
H 
СНз 
Br 
H 
187 
201 
266 
173 
85 
53 
75 
20 
88-89 
88-89 
96-97 
181-183 
0.52a 
0.57a 
0.58a 
0.70b 
Ί.θ 
Ί.6 
8.9 
-
In diethyl ether-n-hexane =1:1 (v/v) (saturated separate room). 
In chloroform-methanol-acetic acid = 7:2:1 (v/v/v) (saturated separate room). 
C
 GLC 1% 0V17 on Gaschrom Q 80-100 mesh, T=l60OC. 
administered intraperitoneaI 1 y 0.5 (or 0.7) mmol/kg polyethylene glycol 300 
as a vehicle. 
In the carboxy1-esterase inhibition studies the animals were injected with 
TOTP, О.З'* mmol/kg (I.P.), dissolved in polyethylene glycol 300 18 h prior to 
injection (IP) with CPAme (0.25 mmol/kg in polyethylene glycol 300) and with 
CAme (0.25 or 0.5 mmol/kg in polyethylene glycol 300). 
CPA was dissolved in polyethylene glycol 300 and water (1:1, v/v) and 
administered IP in a dose of 0.5 mmol/kg. 
In all the in vivo experiments a group of four control animals received 
either polyethylene glycol 300 IP (2.5 ml/kg) or the solvent with TOTP 
pretreatment, depending on the experiment. 
Apparatus. A Hewlett-Packard Model 5750 G gas Chromatograph, equipped with a 
flame-ionization detector (FID) and a 1.2 m glass column (3mm ID) packed with 
3% OVI? on Gaschrom Q (80-100 mesh) was used. Temperatures: injection port 
250 C, detector 300 C, column ISO С The carrier gas was helium (flow rate, 
30 ml/min). 
A Waters Associates Model 't'tO high pressure liquid Chromatograph equipped 
with chromatography pump model M6OOOA and a model U6K injector. The absorbance 
detector operated at 25Ί nm. The RPI8 column used was a 15 cm χ ^.6 mm ID 
stainless steel tube, packed with Lichrosorb RPI8 (5 ym) and operated at room 
temperature. The eluent consisted of 0.01 M acetic acid - 2-propanol (87:13, 
v/v). The flow rate was 1.5 ml/min. 
Spectrophotometric measurements were performed with a Cary II8 spectro­
photometer ultraviolet/visible for the determination of rate of hydrolysis of 
2-cyano-3-phenylacrylates; a Pye Unicam SP 1750 UV spectrophotometer equipped 
with a SP I825 autocell with the variable wavelength detector set at ^12 nm 
for determination of sulphydryl-compounds, set at 500 nm for determination of 
protein content. 
Thin-layer chromatography. Analytical TLC was performed on glass plates coated 
with silica gel PF2514 layers (0.25 mm). Plates with 0.5 mm silica gel layers 
were used for preparative chromatography. After development of the plates, 
the spots of the various CPAme's were detected under UV-light (2Sh nm) (Table 1). 
The spots attributable to thioether compounds were detected by spraying with 
Knight and Young's reagent (1958) and by UV-absorption. 
51 
Петкгтгпа іж sf tor¿L ihijether ехогеіг п in urine. Rats were administered 
with a single dose (IP) of the acrylic compound concerned. 2k h Urines were 
collected over 2 or more days and diluted with distilled water to a standard 
vol urne (20 ml). 
The amount of thioether in the urine was determined according to Seutter-
Berlage et al. (1979) and Rietveld et al. (1986) (See Chapter 2.2, Method A ) . 
The results are not corrected for recovery. 
Détermination of urinary thiocyanate (SClf) excretion. The SCN excretion in 
rat urine was determined after administration of the compounds: Methyl 2-cyano-
3-phenylacrylate (CPAme), 2-cyano-3-phenylacrylic acid (CPA) and methyl 
cyanoacetate (CAme) following the procedure of Pettigrew and Fell (1972). 
In this colorimetrie method the amount of SCN" excreted in rat urine is 
measured spectrophotometrically at 520 nm. The method involves the conversion 
of SCN to cyanogen bromide with bromine water followed by the reaction of the 
thus obtained cyanogen bromide with a mixture of pyridine - 1j^-phenylene 
resulting.in a coloured pyridine-complex. Absorbance readings were taken 
within 25 min. Corrections were made for background urinary SCN content. 
Calibration graphs of absorbance readings as a function of amounts of a 
standard aqueous KSCN solution were linear from 0.5 to 50 urn KSCN. 
Determination of enzymic glutathione conjugation. A rat liver cytosolic fraction 
was used (see Chapter 2.2). Rat liver was homogenized in 1.15% cold KCl solution 
(1:3, v/v). After centrifugat¡on at 9000 g for 30 min the supernatant was used 
as the enzyme source. The reactivity of glutathione (GSH) with the various 
CPAme's and CPA was measured as described by Rietveld et al. (1986) (see 
Chapter 2.2). A 2-cyano-3-phenylacrylic compound (ImM) dissolved in absolute 
ethanol was added to a mixture of rat liver homogenate; containing 1 mM GSH, 
0.1 M Sörensen buffer (pH 7·Ό and ethanol (6:3:1, v/v/v). Incubation took 
place at 37 С and for 5 min. The protein content in the reaction mixture was 
determined by the method of Lowry et al. (1951). The amount of GSH remaining 
in the mixture was measured spectrophotometrically, according to El Iman (1959). 
Determination of spontaneous conjugation of some sulphydryl compounds. 
The amount of conjugated product was assayed indirectly by determining the 
sulphydryl-compound consumption. The spontaneous conjugation of CPAme's and 
CPA with L-cysteine and N-acetylcysteine was investigated with two different 
reaction mixtures. The first mixture (1 ml) consisted of 5 mM of L-cysteine 
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1 глМ of an acrylic compound, 0.2 ml of ethanol and 0.7 ml of 0.1 M КНгРОц/ 
Na->HP04 buffer pH 7.k. The second reaction mixture (1 ml) consisted of 5 mM of 
N-acetylcysteine, 1 mM of a compound under study and 0.9 ml of acetone. 
Both reaction mixtures were incubated at 37 С for 5 min. or for 15 min (CPA). 
The reactions were quenched by the addition of 5-7-5 ml of ice-cold KH2PO4/ 
МагНРОі, buffer (0.1 M, pH 7.Ό. After centrifugation (10.000 rpm) for 20 min 
at 't С, 250 μΐ of the supernatant was added to 2.3 ml buffered DTNB solution 
and the absorbance at ki2 nm was measured (El Iman 1959)· The results are 
expressed as means ± SD for the number of experiments in parentheses. 
Determination of the rates of hydrolysis of CPAme's. The rates of hydrolysis 
of CPAme, MeCPAme and BrCPAme were determined spectrophotometrically by a 
modification of Patai and Rappoport (1962) (see Chapter 2.2). 
Statistical evaluation. The statistical significance of differences between 
group means or means of determined values was evaluated using Student t-test. 
RESULTS 
In vivo. The thioether excretion in urine of male rats following a single IP 
administration (0.5 mmol/kg rat, n= Ό of CPAme, MeCPAme, and BrCPAme in 
polyethylene glycol 300 as solvent, are presented in Table 2. All the compounds 
studied caused only in the first 2*» h rat urine a significant increase in 
thioether excretion. The highest urinary thioether excretion was determined 
after administration of CPAme and amounted to 12.3 ± 1.2% of the dose. 
No thioethers, such as the possible addition products of N-acetyl-cysteine 
or other thiol-compounds and CPAme (or CPA) could be isolated by the procedures 
applied. There was no indication for the existence of any other stable 
thioether (e.g. benzylmercaoturic acid) in the urine of rats dosed with CPAme 
and BrCPAme. CPA could be detected by high pressure liquid chromatography 
(HPLC; eluent formic acid - methanol - water = 1:5:1^, v/v/v). CPA could be 
detected in urine of rats, after CPA administration. An attempt was made to 
prepare the anticipated mercapturic acid by an addition reaction of N-acetyl­
cysteine to CPA or CPAme using a catalytic amount of triethylamine as the base. 
However, the thioether compounds appeared to be very unstable, particulary 
during thin-layer chromatography (eluent chloroform - methanol - acetic acid 
= 7:2:1; v/v/v) and high pressure liquid chromatography (HPLC; eluent 0.01 M 
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ЧгЪІе 2. Urinary excretion of thioether after a single IP dose of methyl 
2-cyano-3-phenyl-acrylate (CPAme), methyl 2-cyano-3-(2-methylphenyI)acrylate 
(MeCPAme) and methyl 2-cyano-3-(2-bromophenylJacrylate (BrCPAme) to male ratsa. 
Compound 
CPAme 
MeCPAme 
BrCPAme 
Dose 
(mmol/kg) 
0.5 
0.5 
0.5 
Increase 
umol SH eq.in 
first 2k h 
12.3 ± 1.2 
Ί.9 ± 2.1 
7.1 ± 1.8 
i π th ioether 
% of dose 
12.3 ± 1.2 
k.S ± 2.1 
7.1 ± 1.8 
a
 Data are expressed as means ± S.E.M (n=i(). 
Significantly different (p<0.05) from the amount of thioether excreted 
endogeneously. (Students t-test). 
Table 3. Urinary thioether excretion in 2k h following a single IP administra­
tion of methyl 2-cyano-3-phenylacrylate (CPAme) and 2-cyano-3-phenylacrylic 
acid (CPA) to rats with and without previous administration of T0TPa. 
Compound Dose 
(mmol/kg) 
T0TPu Increase in thioether 
pmol SH eq.i η 
first 2k h 
% of dose 
CPAme 
CPA 
0.25 
0.5 
0.7 
0.5 
n.s. 
12.3 ± 1.2 
lit.2 ± 1.8 
Й.8 ± 1.1 
n.s. 
12.3 ± 1.2 
10.1 ± 1.3 
1Ί.8 ± 1.1 
TOTP was administered 18 h previously at О.З*· mmol/kg. 
with and without TOTP pretreatment. 
Data are expressed as means ± SEM (η=Ό. 
Maximum dose without mortality of rats. 
n.s. = not significant, ρ > 0.05 ; Students t-test. 
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Tab^e 4. Urinary excretion of thiocyanate (SCN ) by rats dosed IP with 
methyl 2-cyano-3-pheny1 aery late (CPAme), 2-cyano-3-phenylacrylic acid (CPA) 
and methyl cyanoacetate (CAme) with and without TOTP pretreatment . 
Compound 
CPAme 
CPA 
CAme 
Dose 
(mmol/kg) 
0.25e 
0.5 
0.7 
0.5 
0.25 
0.5 
0.5 
0.7 
T0TPc 
+ 
-
-
-
+ 
+ 
-
-
Increase 
μηοΐ ± S.E. 
1.5 ± 0.6 
n.s.
f 
n.s. 
n.s. 
0.9 ± O.it 
1.6 ± 0.2 
n.s. 
n.s. 
M. 
of SCN~d 
% of dose 
3.0 + 1 .2 
n.s. 
n.s. 
n.s. 
1.8 ± 0.8 
1.6 ± 0.2 
n.s. 
n.s. 
Urine was collected for a 2k h period. 
TOTP was administered 18 h previously at О.З*· mmol/kg. 
+ = with and- = without TOTP pretreatment. 
Data are expressed as means ± S.E.M. (η=4). 
Maximum dose without mortality of rats. 
n.s. = not significant, ρ > 0.05; Students t-test. 
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acetic acid - 2-propanol 87:13; v/v). In fact, regeneration of CPA (CPAme) 
and N-acetylcysteine was observed, implying that the Michael adduct(s) of the 
SH compounds is (are) reversible. 
The urinary excretion of thioethers by rats pretreated with the carboxyl-
esterase inhibitor tri-ortho-toly1 phosphate (ТОТР, О.З^ mmol/kg rat) and 
injected with CPAme (0.25 mmol/kg rat, n= 4) was not significant (Table 3)• 
Pre-administration of TOTP and higher dosages of CPAme could not be performed 
without mortality of rats. 
The results presented in Table 3 suggest that a single IP injection of 
CPA in polyethylene glycol 300 - water (1:1 = v/v) into rats (0.5 mmol/kg rat, 
n= Ό also results in an enhanced thioether excretion in the first 2k h urine. 
The total thioether amount excreted in rat urine was about 15 pmol and was 
comparable with that after the single higher dose of CPAme (0.7 mmol/kg rat, 
n= 't). 
Results of the determination of thiocyanate (SCN ) excretion in raturine 
after single IP injection of CPAme and CAme (both in polyethylene glycol 300 
as solvent) and CPA in polyethylene glycol 300 - water (1:1 = v/v) as vehicle 
are presented in Table k. These results indicate that there was no significant 
•increase in SCN excretion after the IP injection of the respective compounds 
into the animals. Pre-administration of TOTP resulted in a significant 
enhancement in SCN excretion, following a single IP dose of CPAme (0.25 mmol/ 
kg rat, n= Ό and CAme (0.25 and 0.5 mmol/kg rat) to the rats. 
In vitro. Three sulphydryl compounds, glutathione (GSH, 1 mM), L-cysteine 
(5 mM) and N-acetyl-cysteine (5 mM) were incubated with 1 mM of the 2-cyano-
acrylic compounds. The decrease in GSH concentration was determined with 
incubation mixtures, containing rat liver cytosolic fraction (9000 g). 
The results presented in Table 5 indicate that there was a total recovery 
(100%) of the initial amount of GSH, following 5 min incubation under non-
enzymatic and enzymatic conditions with CPAme's. GSH incubated with CPA 
(incubation time 15 min) at non-enzymatic circumstances, resulted in a 
decrease in the SH content of the incubation mixture. 
The conjugation of N-acetyl-cysteine and L-cysteine with the CPAme's was 
tested under non-enzymatic conditions (Table 5). A decrease in the SH concen­
tration with N-acetyl-cysteine and L-cysteine in the reaction mixture was 
observed. Conjugation of N-acetyl-cysteine and L-cysteine was, ranged from low 
to high percentage of recovery of the initial amount of SH content; CPAme, 
MeCPAme and BrCPAme. CPA depleted N-acetyl-cysteine, L-cysteine did not in 
56 
Table 5. The reaction of methyl 2-cyano-3-phenylacrylates (CPAme, MeCPAme and 
BrCPAme) and 2-cyano-3-phenylacrylic acid (CPA) with glutathione3, N-acetyl-
cysteine and L-cysteine . 
% Recovery of the initial amount of SH 
Compound Glutathione (ImM) N-Acetyl-cysteineCysteine 
(imM) Enzymatic Non-enzymatic (5mM) (5mM) 
CPAme n.s.e n.s. 91 ± 5 86 ± 2 
MeCPAme n.s. n.s. 96 ±3 93 ±2 
BrCPAme n.s. n.s. n.s. 96 ± 2 
CPAf n.s. 9 0 + 1 93 ± 2 n.s. 
a
 With rat liver homogenate (9000 g) in ethanol- 0.1M МагНРО^/КНгРОі!, 
pH7.it = І й (v/v); incubation 5 min at 370C. 
In acetone; incubation 5 min at 37 C. 
c
 In ethanol - 0.1M МагНРОі./КНгРОц, pHJ.k = 1:4 (v/v); incubation 5 min at 370C. 
Means ± standard deviation (3 experiments). 
n.s. = Not significantly different (P > 0.05) from the initial amount of SH 
(100% recovery). 
Incubation 15 min at 37 C. 
, -3 . Table 6. The rates of hydrolysis of 2-cyano-3-phenylacrylates (-3.1 x 10 M) 
in ethanol/buffer3 (20:80) at 220C and 370C. 
Compound Τ = 
Чо
 x 10
" 
(s"1) 
0.3 
0.4 
1.3 
220C 
t¿ 
(min) 
383.1 
278.5 
86.9 
Τ 
Vo x 
(s'1) 
1 .1 
1.4 
3.2 
= 
IO* 
370C 
ti 
(min) 
105.2 
82.6 
36.0 
(nm 
296 
300 
зоб 
MeCPAme 
CPAme 
BrCPAme 
a
 SSrensen b u f f e r 0.1M Ν32Ρ0ι,/ΚΗ2Ρ04, pH7.4 
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15 min (370C). 
The rates of hydrolysis of CPAme, MeCPAme and BrCPAme were determined in a 
mixture of Sörensen buffer pH 7Λ and ethanol at 22 С and 37 C. The results 
are presented in Table 6 (1С, -, tj, pseudo first order). 
DISCUSSION 
In view of the electron-withdrawing capacity of the cyanide and carboxylate 
substituents on the carbon-carbon double bond of the 2-cyano-3-phenylacryl¡c 
compounds (Table 1) it is conceivable that a Michael type addition of endoge-
nous nucleophilic SH or NH2 group of proteins and enzymes can occur in vivo. 
In agreement herewith, Viel and Doré (1972) suggested that a Michael addition 
of cellular nucleophilic groups to the activated double bonds of 2-cyano-3-
phenylacrylic acids is responsible for their cytotoxic and antitumoral 
properties. Therefore, it seems quite acceptable to postulate a direct 
addition of glutathione (GSH) to the activated double bond in the CPAme's or 
CPA's during their biotransformation, ultimately leading to an urinary 
thioether. The observation of a significant increase in thioether excretion in 
urine of rats treated with the three CPAme's (Table 2) and CPA (Table 3) is in 
agreement with this suggested metabolic pathway. 
Unfortunately, the isolation of the expected thioether adducts was unsuccess 
ful, in spite of the use of procedures for the work-up of urine extracts which 
were shown to be adequate for metabolites of similar types (Delbressine et al. 
1982; Bladeren et al. I98I; Chapter 2.2). It should be emphasized that the 
expected mercapturic acids could not be synthesized either. They are extremely 
unstable and rapidly revert to the starting acrylates (CPAme and CPA) as was 
shown by TLC and HPLC. In agreement herewith is the observation by Halestrap 
(1976) that CPA and its derivatives react reversibly with mercaptoethanol 
and cysteine in a Michael fashion. Similarly Pritchard demonstrated that 
n-butanethiol reacts rapidly and reversibly with CPAet in aqueous solution. 
Therefore, it is assumed that the isolation of the expected mercapturic acid 
is strongly hampered by their intrinsic instability. Consequently, isolation 
from urine extracts is not feasible either. There is, to a certain extend, 
ananalogy with the biotransformation of chloroBMNs (Chapter 2.2). The direct 
conjugation products ariving from a Michael addition of GSH to the electron 
deficient double bond in BMNs could not be isolated either. However, with 
these substrates another type of thioether could be isolated and identified, 
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viz. N-acetyl-S-(2-chlorobenzyl)-cysteine (Rietveld et al. 1983; Rietveld et 
al. 1987; Chapter 2.1 and 2.2). In view of the analogy in structure of the 
CPAme's and BMNs such benzylic mercapturic acid could be expected for the CPAmc's 
as well. However, no indication for the presence of such metabolites was found 
in the urine of rats dosed with CPAme and BrCPAme. Especially the urinary 
extracts containing metabolites of BrCPAme were scrutinized for benzylic type 
mercapturic acid, because with this substrate hydrolysis by double bond cleavage 
would lead to 2-bromobenzaldehyde (Rappoport 1962) of wich it is known that 
biotransformation produces benzylic mercapturic acid (Seutter-Berlage et al. 
1982; Chapter 3.1 and 3-2). 
Interesting information about the biotransformation of CPAme was obtained 
by inhibiting the carboxylesterase enzyme by means of the organophosphate, 
tri-o-tolyl phosphate (TOTP) (cf. Silver and Murphy I98I). Pretreatment of 
rats with TOTP leads to a drastic reduction of the enhanced urinary thioether 
excretion. This observation is indicative of a carboxylesterase-dependent 
reaction in the biotransformation of CPAme's into thioethers. Furthermore, 
the ester hydrolysis seems to be an essential reaction in the detoxification 
of CPAme, 'because rats pre-admiη istered with TOTP could only accept low 
dosages of CPAme without causing death (Table 3). It should be noted that a 
single dose CPA resulted in a slightly higher thioether excretion than upon 
treatment with the corresponding methyl ester (CPAme, same dose). This implies 
that in the absence of an esterase inhibitor the major pathway for the thio­
ether excretion proceeds via the thioether adduct of CPA. 
The disappearance of the enhanced in urinary thioether excretion following 
TOTP injection and CPAme administration to rats was associated with a slightly 
significant thiocyanate (SCN ) excretion in urine (Table Ό . Apparently, 
CPAme is more poisonous to rats pretreated with TOTP. As the urinary SCN 
levels are very low, cyanide release in the ratbody is presumably not the 
cause of their death. When the carboxylesterase was not inhibited, the 
injection of CPA, CPAme and CAme caused no raise in the urinary level of SCN 
(Table k). This observation suggests that under normal health conditions of 
the animals, cyanide ions are not liberated during the CPAme biotransformation. 
The results described above rules out some other theoretically conceivable 
biotransformations of CPAme. Demethoxycarbonylation of CPAme to cinnamonitri le 
could be of importance in vivo (Krapcho 1982). The same nitrile could also be 
formed from the acid CPA via decarboxylation. For instance, certain micro­
organisms were able to decarboxylate some unsaturated acids to corresponding 
olefinic compounds (Goodey and Tubb 1982). Cinnamonitri le, if formed in vivo 
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as indicated above, would be further biotransformed via multiple, competing 
metabolic pathways (Bladeren et al. 1981, Silver et al. 1982) to give thio-
cyanate and two different types of mercapturic acids as metabolites in urine. 
However, no evidence was found for the occurrence of these metabolites in the 
urine of rats dosed with CPAme (or CPA), implying that the suggested pathway 
via cinnamon!tri le does not play a role. 
As a possible bio-reaction of CPAme the epoxidation of the double bond can 
be envisaged. Such relatively stable epoxides can be obtained via organic 
synthetic procedures using sodium hypochlorite or H2O2 (Robert and Foucaud 
1969a; Robert and Foucaud 1969b). The intermediate epoxide of CPAme, if 
formed in vivo, would be biotransformed via epoxide hydrolysis and glutathione 
conjugation, in analogy with the biotransformation of cinnamon!tri le which 
proceeds via the corresponding epoxide intermediates (Bladeren et al. I98I; 
Silver et al. 1982). Hydrolysis of the epoxide of CPAme would produce a 
cyanohydrol, which ¡s known to release cyanide ¡on readily. Subsequent 
thiocyanate formation is then expected. However, no significant SCN excretion 
was observed and therefore a metabolic pathway involving the epoxide of CPAme 
and CPA seems highly unlikely. 
In in vitro experiments of CPA and CPAme in the presence of glutathione 
(GSH) and glutathione-S-transferase from rat 1 iverhomogenates (9000 g) (Table 5 ) , 
no reaction of the substrates with GSH was observed. CPA seems only to react 
with GSH in a non-enzymatic fashion (15 min incubation at 37 С and pH 7 · Ό · 
Taking into account the rates of hydrolysis of the various CPA esters (Table 6) 
and the fact that CPA is resistant to further hydrolysis (no c=c bond cleavage) 
(Lapworth and McRae 1922; Moal et al. I968), it is highly probably that in 
vivo the CPAme is bio transforma ted to the primary metabolite CPA which then is 
subsequently conjugated to GSH, ultimately result in the excretion of thio-
ethers. However, the results in Table 5 indicate that in vivo the reaction of 
CPA and its methylester with various non-protein thiol compounds, such as 
L-cysteine, cannot be excluded. It should be noted that the reaction between 
CPA and various thiol compounds is always reversibly implying that the 
urinary thioethers will be unstable. In accordance herewith the addition of 
some endogeneous thiol compounds to CPA has been reported (Halestrap and Denton 
1975; Halestrap 1976; Fig.1). 
In summary, on the basis of the results presented above and the data from 
the literature a metabolic pathway for the biotransformation of methyl 2-cyano-
3-phenylacrylate (CPAme) to thioether adducts is proposed to proceed via the 
corresponding acid CPA (route b, Fig.2). Glutathione conjugation of this acid 
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lig.l. Addition of thiol-compounds to 2-cyano-3-phenylacryIic acid (CPA), 
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Fig.?,. Proposed pathways of biotransformation of methyl 2-cyano-3-phenyl· 
acrylate (CPAme). 
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most probable plays a role in the formation of a thioether, although the 
direct addition of other non-protein thiol compounds to CPA cannot entirely 
be excluded. Ester hydrolysis seems to be important for the detoxification of 
CPAme and needs to take place before the formation of the urinary thioether 
adducts (route b, Fig.2). The carbon-carbon double bond hydrolysis of CPAme 
(route a, Fig.2) is probably in vivo a reaction of some importance, competing 
with the metabolic pathway route b (Fig.2) and resulting in the products 
benzaldehyde and methyl cyanoacetate (CAme). No evidence was found for the 
release of cyanide ion during the biotransformation processes. 
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Chapter 2.4 
Bacterial mutagenicity of some methyl 2-cyanoacrylates 
and methyl 2-cyano-3-phenylacrylates. 
INTRODUCTION 
Alkyl 2-cyanoacrylates (Table 1) are modern adhesives which are nowadays 
widely in use in the glass and the metal industry, in medicine and in the 
household and in a wide range of hobbies (Fisher 1985)· 
Polymerization of the colourless liquid alkyl 2-cyanoacrylate monomer 
proceeds in a few seconds at room temperature, without a catalyst and even in 
the presence of weak bases, such as water and alcohol (Coover and Mclntire, 
1977)· A commercial alkyl 2-cyanoacrylate adhesive is usually composed of alkyl 
2-cyanoacrylate and various additives, e.g. polymethylmethacrylate, inhibitors, 
stabilizers, colouring and thickening agents (Calnan 1979; Fisher 1985)· 
Since the first report by Nathan et al. (I960) concerning the use of alkyl 
2-cyanoacrylate as tissue adhesive, many publications on this subject have 
appeared in the field of medicine and dentistry. The adhesives butyl and 
isobutyl 2-cyanoacrylate, in particular have been found to be useful in 
repairing skin incisions and organ wounds (Matsumoto 1970), in arresting 
bleeding (Bhaskar and Frisch 1968; Grenier et al. 1983)> and in a variety of 
other clinical uses (Heiss 1970; Lenaerts et al. 1981»; Fisher 1985). 
The methyl 2-cyano-3-phenylacrylates (Table 1) are also incorporated in this 
investigation, because they are structurally related to the alkyl 2-cyanoacry-
lates. Polymerization of these cristalline compounds does not take place, 
this implies that they are more easy to handle under the chosen circumstances 
of the experiments. 
Phytopharmacological tests have indicated that certain alkyl 2-cyano-3-
phenylacrylates can be used in plant protection (Zsolnai 1965; Da Rocha Pitta 
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et al. ІЭУО· Some alkyl 2-cyano-3-phenylacryl ic acids exhibits cytotoxic and 
antitumoral activity in microbiological studies (Foley et al. 1959; Viel and 
Doré 1972). 
A chemical carcinogenic effect specific to alkyl 2-cyanoacrylate adhesives 
could not be demonstrated (Hei ss 1970). The vapour of two commercial methyl 
2-cyanoacrylate adhesives was found to be mutagenic towards Salmonella 
typhimuriim TA100 in the Ames test (Andersen et al. 1982). 
Woodward (1968) proved that the histotoxic!ty of methyl 2-cyanoacrylate was 
more distinct than that of other alkyl 2-cyano-acrylates. Ethyl 2-cyanoacrylate 
adhesive was reported to cause skin and eye irritation among assembly-workers 
of an electronics factory (Calnan 1979)· 
Recently, we demonstrated experimentally, both in vivo and in vitro, 
a substantial reactivity of pure methyl 2-cyanoacrylate towards thiol compounds. 
Furthermore, this alkylating behaviour was also found for some methyl 2-cyano-
3-phenylacrylates (Rietveld et al. I985)· 
In view of the observed alkylating potency of the alkyl 2-cyanoacrylates, 
the present study was undertaken to assess the mutagenic potential of three 
pure alkyl 2-cyanoacrylates, three commercial alkyl 2-cyanoacrylate adhesives 
and three methyl 2-cyano-3-phenylacrylates with the Sa 1 mone 1 la/mi сrosóme 
mutagenicity assay. 
MATERIALS AND METHODS 
Chemiaals and synthesis. Dimethyl sulphoxide (DMSO), 2-aminoanthracene were 
purchased from Janssen Chimica, Beerse, Belgium. Nicotinamide adenine 
dinucleotide phosphate sodium salt (NADP), D-glucose-6-phosphate sodium salt, 
D-biotin and L-histidine monohydrochloride were obtained from Sigma Chemical 
Company, St. Louis, USA. Bacto agar was purchased from Difco Laboratories, 
Detroit, USA and nutrient broth No. 2 from Oxoid Ltd., Basingstoke, UK. 
Sodium azide, acetone (PA) and all inorganic chemicals were obtained from 
Merck, Darmstadt, FRG. 
Substances, structures and manufacturers of the tested compounds are listed 
in Table 1. Ethyl 2-cyanoacrylate, synthesized in our laboratory was prepared 
by addition of ethyl cyanoacetate to a refluxing mixture of paraformaldehyde, 
methanol, 1,2-dimethoxyethane and piperidine (Leonard et al. I966). 
The monomer obtained after redistillation was of high purity. The methyl 
2-cyano-3-phenylacrylates were synthesized by the so called Knoevenagel-Cope 
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Table 1. Substances, structures, manufacturers and concentration range of alkyl 2-cyanoacrylates 
and methyl 2-cyano-3-phenylacryIates. 
\ / 
c=c 
/ \ 
Alkyl 2-cyonoocrylales 
\ / 
,c=c 
Melhyl 2 - c y o n o -
-Э - phenyl a e r y lates 
Su 
1. 
2. 
3. 
h. 
5. 
6. 
7. 
8. 
9. 
bstance 
Methyl 2-cyanoacrylate 
Amicon's CY-2000 Methyl 
2-cyanoacrylate adhesive 
medium viscosity (70-80cps) 
Loctite cyanoacrylate 
adhesive 493 
Ethyl 2-cyanoacrylate 
D 
HistoacryP blue tissue 
adhesive 
Iso-butyl 2-cyanoacrylate 
Methyl 2-cyano-3-phenylacrylate 
Methyl 2-cyano-3-
(2-methylphenyl) acrylate 
Methyl 2-cyano-3-
(2-bromophenyl) acrylate 
R or R' 
-СНз 
-СНз 
-СНз 
-СН2СНэ 
-(СН2)зСНз 
-СН2СНСН3 
1 
СНз 
-н 
-СНз 
-Br 
Manufacturer 
Sigma 
St. Louis (U.S.A. 
Am i con corp. 
Lexington (U.S.A. 
Loctite Ltd. 
Dublin, Ireland 
present authors 
Braun Melsungen 
Melsungen (F.R.G. 
Sigma 
St. Louis (U.S.A. 
Present authors 
Present authors 
Present authors 
.) 
.) 
.) 
.) 
Purity 
>98% 
unknown 
unknown 
>Э8% 
>98% 
>98% 
33% 
33% 
33% 
c* Pure and sterile η-butyl 2-cyanoacrylate with blue-coloured additive (Heiss, 1970). 
condensation of methyl cyanoacetate with the required substituted-benzaldehyde 
in methanol and in the presence of pyridine (Zsolnai 1965)· The 2-cyano-3-
phenylacrylates were recrystal1ized from methanol. Purity controls were 
performed on a Hewlett-Packard 5750 gas Chromatograph, equipped with a flame 
ionization detector, and consisting of a glass column (1.8 m χ 't mm ID) packed 
with 3% OV 17 on Gaschrom Q (80 - 100 mesh). The carrier gas was helium 
(flow rate, 30 ml/min). Temperature: injection port 250 OC, column 150OC, 
detector 300 C. To prevent spontaneous polymerization, all the alkyl cyanoacry-
late adhesives contained small quantities of an inhibitor (e.g. in the case of 
isobutyl 2-cyanoacrylate 100 ppm A-methoxyphenol). 
Mutagenesis assay. The alkyl 2-cyanoacrylate adhesives and the methyl 2-cyano-
3-phenylacrylates were tested in the Salmone!la/microsome mutagenicity assay. 
The standard plate test was performed according to Ames et al. (1975), unless 
indicated otherwise, with Salmonella typhimuriian strains TA1535, TA1537, 
TAI538, TA98 and TAI00. 
The strains were grown overnight in the Oxoid nutrient broth in a shaking 
water bath at 37 С until an optical density of 0.1» at 700 nm was reached 
(0.5 - 1.0 χ 10 9 bacteria/ml). A trace amount of 0.09 |jmole/plate histidine 
was incorporated in the plates instead of in the top agar. The rat liver S9 
(9000 g supernatant) fractions were prepared from male Sprague-Dawley rats 
pretreated with Aroclor №Sk (Litton Bionetics Inc., USA). S9 mix contained 
0.1 ml S9 per ml. Protein content of the S9 mix was 2.1 i 0.1 mg/ml, 
estimated by a micro assay addapted from the method of Lowry et al. (Peterson 
1979). 
All tests were performed in triplicate on petri plates. Compounds were once 
tested with the Aroclor \25h induced S9 mix and once without the metabolizing 
system. The alkyl 2-cyanoacrylate adhesives were dissolved in acetone prior to 
use and 100 μΐ aliquots containing from 10 to ΊΟΟΟ yg of adhesive were delive­
red into the top agar. The methyl 2-cyano-3-phenyIacrylates were dissolved in 
DMSO and the required amount was delivered in 0.1 ml DMSO into the top agar. 
At least k concentrations were tested up to 1000 yg/plate. 
Solvent controls, positive controls and sterility controls for S9 mix were run 
with each experiment. After incubation the plates for kü h in the dark at 37 C, 
the number of revertant colonies was counted manually. 
Methyl, ethyl, n-butyl and iso-butyl 2-cyanoacrylate adhesives were also 
tested in a modification of the spot test for volatile compounds described by 
Anderson et al. (1982). This assay was carried out to test whether the mutagenic 
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activity of an alkyl 2-cyanoacrylate was due to the volatile monomer. 
As soon as the top agar with bacteria (TA100 only) and with or without S9 mix 
had hardened, a sterile polyethylene cover slip (20 mm in diameter) was placed 
in the middle of the plate. Hereafter a 5 μΐ or 20 u' drop of a alkyl 2-cyano­
acrylate was pipetted onto the cover slip. 
The petri plates were sealed with plastic tape. All the adhesives were examined 
with 3 plates for each drop size. The petri plates were incubated and counted 
as described above. 
RESULTS 
None of the alkyl 2-cyanoacrylate adhesives produced a significant increase in 
number of revertant colonies, which exceeded the spontaneous reversion rate, 
in any of the following Salmonella typhimuvium strains — TA1535, TA1537, TA1538 
and TA98 — by more than 2-fold. 
Mutagenic effects were observed in the plate incorporation assay with test 
strain TA100, as can be seen in Fig. 1 and Table 2. These results indicate that 
only methyl 2-cyanoacrylate containing adhesives were mutagenic towards the 
bacteria. Addition of the metabolizing system (rat liver S9) had no effect. 
All the alkyl 2-cyanoacrylate adhesives revealed toxic effects to the bacte­
ria with the higher amounts tested (>2000 yg/plate). The adhesives were con­
sidered to be toxic at a particular concentration, when the background lawn of 
bacteria was sparse. Methyl 2-cyanoacrylate adhesives exerted already a toxic 
effect with the lower amount of 500 pg/plate tested. Polymerization of each 
alkyl 2-cyanoacrylate in the top agar (3 ml) was observed when the amounts of 
alkyl 2-cyanoacrylate were larger than 1500 yg/plate. 
Only the bromo-substituted methyl 2-cyano-3-phenylacrylate had a direct 
mutagenic action on S. typhimurium strain TA1535 (Table 2). The other methyl 
2-cyano-3-phenylacrylates exerted a non-mutagenic response to S. typhimuriim 
strains TA1535, TA1537, TA1538, TA98 and TA100 even after activation with 
liver S9 mix derived from Aroclor ]ZS^ treated rats. 
The toxicity of each methyl 2-cyano-3-phenylacrylate for S. typkimurivm 
strains was further investigated. These compounds appeared to be non-toxic to 
the bacteria up to 1000 ug/plate. A higher amount of a methyl 2-cyano-3-phe-
nylacrylate crystallized in the top agar and could not, therefore, be tested. 
The methyl 2-cyano-3-phenylacrylates were not assayed in the spot test for 
volatile compounds, since their volatility is very low. 
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/ j g / P l a t e 
Fig. Ί. Number of revertant colonies per plate of Salmonella typhimuriim TA100 
in the Sa 1 mone 1 la/mi сrosóme plate assay, in the presence (0) and absence (·) 
of S9 mix. Experimental details were as mentioned in Materials and Methods. 
Mean values ±S.D. of determinations in triplicate. 
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Table 2. Number of revertant colonies per plate in the salmonella/microsome 
plate assay induced by methyl 2-cyanoacrylate adhesivos in strain TA100 and 
methyl 2-cyano-3-(2-bromophenyl)acrylate in strain TA1535 in the presence and 
absence of rat liver homogenate (S9 mix). 
Substance Strain S9 Dose of bubsunce per plate (μg) 
10 50 100 300 500 
Methyl cyano- TA100 
dcrylate 
Amicon* CY 2000 TA100 
LoctileR493 TA100 
99+ 9 111 + 11 111+ 4 
82± 5 126+ 3 144+ 3 
97+ 4 115+ 2 130+ 8 
95±21 124+11 121+13 
99+ 9 103±11 113 + 11 
82+ 5 139 + 29 153+ 7 
97+ 4 111+ 9 116+ 1 
95 4-21 120±13 126+ 6 
9 9 + 9 1 0 7 + 4 108 ± 9 
82± 5 131+23 1 5 9 i 6 
97+ 4 102+ 1 113 t 10 
95±21 127+10 147+ 5 
159+14 220+ 5 297 + 20 
160+10 236 + 22 210+26 
152 + 21 2 0 9 + 4 244 l 6 
137+15 201+24 225 + 21 
171 + 18 170+ 7 138+ 9 
153±14 171+ 8 145 ± 2 8 
147+ 8 164 + 12 157 1-18 
147+ 7 177+10 130 + 25 
133+ 9 193 + 14 185 ± 2 0 
140114 219±13 191 ± 2 9 
148±18 165 + 13 181±16 
123+16 186+22 199112 
Methyl 2-cyano-
3 (2 bromophcnyl)-
acrylate 
TA1535 
-
+ 
35 ± 2 
28+ 1 
31+ 7 
29± 2 
4 0 ± 1 0 52± 2 
31 ± 3 3 3 + 6 
4 3 + 9 5 3 1 7 
3 5 + 3 35 ± 6 
Mean value and standard deviation of triplicate 
Table 3. Mutagenicity towards the Salmonella ЬурЫтитіит strain TA100 in the 
spot test for volatile compounds . 
Adhesive tested Size of 
drop (μΙ) 
Number of his'*' revenants/ 
plate ь 
-S9 + S9 
Zone of inhibition c (cm) 
+ S9 
None 52± 4 52± 6 
Methyl 
2-cyanoacrylaie 
Amicon CY2000 
Loctne 493 
5 
20 
5 
20 
5 
20 
176 ± 1 3 
159 ± 3 7 
67± 6 
71 ± 7 
115±24 
84±27 
125±15 
164±30 
78± 4 
85+ 8 
114± 6 
130± 7 
3 2 ± 0 2 
4 7 ± 0 2 
37±06 
40 + 04 
50±04 
a
 For expenmenlal details see Materials and Methods 
ь
 Mean values ± S D of determinations in triplicate 
c
 Diameter of inhibition zone in the background lawn of bacterial growth around the polyethylene cover slip 
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The more volatile alkyl 2-cyanoacrylate adhesives were spot tested with test 
strain TA100. Mutagenic effects were observed with the three methyl 2-cyanoacry-
late adhesives (Table 3). No mutagenic response revealed the other alkyl 
2-cyanoacrylate adhesives. With each methyl 2-cyanoacrylate adhesive, there was 
an accumulation of the number of revertant his colonies near the edge of an 
area of toxicity around the polyethylene cover slip containing a drop of 
adhesive. The background lawn of bacterial growth was inhibited in the circular 
toxic area. Besides this inhibition zone, a white ring of polymerized adhesive 
was formed on the cover of the petri plate in case of each adhesive. 
As shown in Table 3 it appears that the pure methyl 2-cyanoacrylate formed 
the smallest inhibition zone both with and without S9 mix compared with the 
commercially available methyl 2-cyanoacrylate adhesives: Amicon CY-2000 and 
Loctite 493. 
DISCUSSION 
Using the standard Ames test, the mutagenic action of methyl 2-cyanoacrylate 
containing adhesives towards Salmonella typhimurium strain TA100 was assessed 
both with and without S9 mix (see Fig. 1). A lack of mutagenic potency of 
ethyl, η-butyl and isobutyl 2-cyanoacrylate was observed. 
In this study the pure methyl 2-cyanoacrylate and the isobutyl 2-cyanoacry­
late each contain only one additive, p-methoxyphenol to inhibit spontaneous 
polymerization. It seems likely, therefore, that the methyl 2-cyanoacrylate 
monomer is able to be direct mutagenic to the bacterium S. typhimurium TAI00. 
This suggestion is further supported by the recent report that additives 
isolated from two commercial methyl 2-cyanoacrylate adhesives, TIXO K100 
(Hapas A/S) and Cyanolite 102 (3M A/S), were not mutagenic in the Ames test 
(Andersen et al. I982). Moreover, alkyl methacrylates, well-known thickeners 
in commercial 2-cyanoacrylate adhesives (Calnan 1979; Fisher 1985), are 
reported to be non-mutagenic in the Salmone!la/mi с rosóme assay (Waegemaekers 
and Bensink 198'*)· These authors also reported that p-methoxyphenol and 
hydroquinone are not able to suppress a positive mutagenic response under the 
conditions of the standard plate test. 
Precipitation of polymers was observed when the various alkyl 2-cyanoacry-
lates were added to the top agar (concentration > 500 yg/ml). Also, inhibition 
of the background lawn of bacterial growth in the standard plate test occurred 
with already with smaller amounts of methyl 2-cyanoacrylate adhesive per plate 
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than of higher homologues. Leonard et al. (1966) found in vitro that in aqueous 
solution poly(akyl 2-cyanoacrylates) depolymerise into the toxic compounds 
formaldehyde and alkyl cyanoacetate. There is in vivo evidence that poly(methyl 
2-cyanoacrylate) may degrade to formaldehyde and methanol (Wade and Leonard 
1972). In contrast, under physiological conditions, poly(isobutyl 2-cyanoacry-
late) is degraded mainly by an enzymatic ester hydrolysis to polycyanoacryl¡c 
acid and isobutanol (Lenaerts et al. Ι98Ό. Lehman et al. (1966) suggested 
that the toxicity of alkyl 2-cyanoacrylates to bacteria may be caused by 
degradation products of the polymer. Eiferman and Snyder (1983) demonstrated a 
decreased bacteriostatic activity of n-butyl 2-cyanoacrylate after the adhesive 
was allowed to harden for 30 min. Mutagenicity and toxicity testing with the 
spot test for volatile compounds of polymerized alkyl 2-cyanoacrylate adhesives, 
as described by Andersen et al. (1982) revealed no toxic and mutagenic effect. 
Hence, these authors suggested that both bacteriotoxicity and mutagenicity are 
due to the methyl 2-cyanoacrylate monomer. 
Our spot test results confirm the findings of Andersen et al. (1982) and 
also seems to support the view that the volatile methyl 2-cyanoacrylate monomer 
is potentially mutagenic and toxic to 5. typhimuriim strain TAI00. However, 
the number of revenants per plate in our spot test was less than with the plate 
incorporation test. 
The inhibition of bacterial growth appeared to be in a zone around the poly­
ethylene cover slip containing the drop of adhesive. This finding is in agree­
ment with the results of Blum et al. (1975) and Eiferman et al. (I983). 
These authors suggested that the inhibition of the growth of some bacteria is 
possibly due to the monomer vapour of butyl 2-cyanoacrylate adhesives. 
The differences in diameter of the inhibition area are prominent among the 
various methyl 2-cyanoacrylate adhesives (see Table 3). These data suggest 
that the commercial adhesives contain additives, which retard the hardening of 
the polymer. This slowing-down of the hardening may result in a greater amount 
of free monomer in toxic concentrations. Consequently, the mutagenic action 
against the bacteria will be less pronounced and the growth inhibition zone 
will increased. 
This study includes the test results of the methyl 2-cyano-3-phenylacrylates. 
These compounds are structurally related to the methyl 2-cyanoacrylates. 
In the standard Ames Sa 1mone 1 la/mi сrosóme assay, with Salmonella typhimuriim 
tester strain TA100 with and without metabolizing system (S9 mix), a mutagenic 
effect was not observed for any of the tested methyl 2-cyano-3-phenylacrylates. 
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Also, a bacterial toxicity was not revealed for doses up to 1000 pg/test plate. 
Therefore, these substances cannot be implicated in the discussion of the 
bacteriotoxicity and mutagenicity of methyl 2-cyanoacrylates. 
It may be concluded from the results described here that the bacterial 
toxicity and mutagenicity of methyl 2-cyanoacrylate adhesives is due to the 
methyl 2-cyanoacrylate monomer. Carcinogenic properties of methyl and other 
alkyl 2-cyanoacrylate adhesives are not yet been demonstrated. However, it has 
been found that methyl 2-cyanoacrylate is highly histotoxic (Woodward 1968; 
Heiss 1970). Moreover, skin problems, such as irritant and chronic contact 
dermatitis are encountered (Calnan 1979; Fisher I985). In view of the high 
bacterio- and histo-toxicity, the direct mutagenic action to S. typhimurium 
TA100, and the possible skin effects of methyl 2-cyanoacrylate adhesives, it is 
very remarkable that these adhesives are recommended for use in the household 
and for hobbies. Because of this, less skilled people may come into contact 
with these highly hazardous adhesives with all detrimental consequences. 
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Chapter 2.5 
Glutathione conjugation and bacterial mutagenicity of 
racemic and enantiomerically pure cis and trans methyl 
epoxycinnamates. 
INTRODUCTION 
Since the 1920s methyl cinnamate (methyl 3-phenyIpropenoate) has wide use 
in fragrances and as a flavouring substance (Opdyke 1975)· Methyl cinnamate 
is predominantly biotransformed to cinnamic acid and subsequently to benzoic 
acid and hippuric acid (Fahelbum and James 1977)· Recently, it was found that 
in female rats methyl cinnamate is partly transformed to glutathione conjugates, 
probably catalyzed by glutathione-S-transferase, with the ultimate excretion in 
the urine as mercapturic acids (Delbressine et al. 1982). 
Potential primary metabolites of α,β-unsaturated carboxylic esters are the 
corresponding epoxides (glycidic esters) produced upon enzymatic oxidation. 
Epoxycinnamic esters (3-pheny1-2,3-epoxypropanoates) as well as aliphatically 
substituted epoxy-esters (glycidic esters) were investigated and they showed a 
considerable propensity to react with glutathione in vitro, while in vivo the 
enhanced urinary thioether excretions were only moderate (Delbressine I98I). 
However, hydroxymercapturic acids resulting from glutathione conjugation 
with epoxycinnamic esters could not be isolated as yet. 
The mutagenicities of a great number of aliphatic epoxides were determined 
by using the Salmonella typhimuri urn/mi сrosóme assay of Ames (Voogd et al. I98I; 
Simmon and Baden I98O; Wade et al. 1978). It appears that many aliphatic epoxides 
are potent mutagens in the Ames test. In general the mutagenic action of 
these epoxides in the Ames test depends on the substitution pattern of the 
three-membered ring. Mono-substituted epoxides, are the most potent mutagens 
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and electron withdrawing substituents increase the mutagenicity (Wade et al. 
1978). Mutagenicity was observed for ethyl trans-epoxycinnamate (ethyl trans-
3-phenyl-2,3-epoxypropanoate ) in the Ames test with strain TA 100, especially 
with metabolic activation by S9 liver fractions (Voogd et al. I98I). 
The aim of the present study was two-fold: Firstly, to investigate the 
ability of racemic as well as enanti omeri cally pure cis and trans methyl 
epoxycinnamates (methyl 3-phenyl-2,3-epoxypropanoates) (Fig.l) to undergo 
glutathione conjugation and subsequent excretion as mercapturic acids. 
Secondly, to study the mutagenicities of these epoxy esters in the Ames assay. 
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Fig.l. Structures and absolute configurations of the optically 
active trans and cis methyl epoxycinnamates 
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MATERIALS AND METHODS 
Chemicals. N-acety1-L-cysteine, DTNB = 5,5~dithiobis(2-nitrobenzoic acid), 
metaphosphoric acid, Titriplex III (EDTA), trichloroacetic acid, Folin-Ciocalteu's 
Phenol reagent, methyl chloroacetate, iodomethane, sodium methoxide, silver 
nitrate, silica gel 60H and 60 used for column chromatography and glass t.l.c. 
plates coated with silica gel рРгзі, were purchased from Merck AG (Darmstadt, FRG). 
Benzaldehyde, Diazogen (N-nitroso-N-methy1-p-toluenesulfonamide, precursor of 
diazomethane), NBP = ^-(p-nitrobenzyl)pyridine, 1,2-propanediol (propylene 
glycol) were obtained from Janssen Chimica (Beerse, Belgium). Reduced glutathione 
was supplied by Boehringer (Mannheim, FRG). All other reagents and solvents 
used were of analytical grade and were purchased from Merck AG (Darmstadt, FRG). 
Syntheses. Racemic methyl trans-3-phenyl-2,3-epoxypropanoate (J) was prepared 
by a Darzens condensation of benzaldehyde with methyl chloroacetate using sod i urn 
methoxide as the base (Johnson et al. 1953). 
Racemic methyl cis-3-phenyl-2,3-epoxypropanoate (IT) was synthesized 
according to Tung and Speziale (1963) a s follows: trans-epoxy-ester (l) was 
converted into methyl 2-hydroxy-3-bromo-3-phenylpropanoate with HBr in benzene. 
This compound was crystallized from hexane/diethy1 ether and subsequently 
purified by flash column chromatography using petroleum-ether: diethyl ether 
(60:'40=v/v) as eluent. Pure methyl 2-hydroxy-3-bromo-3-phenyl propanoate was 
suspended in water and solid МагСОз was added until a 7% solution was obtained, 
then acetone was added at a temperature of 50 С Racemic cis-epoxy-ester (TX) 
separated out as an oil. 
Sodium trans-3-pheny1-2,3-epoxypropanoate was prepared from the above 
trans-epoxy methylester by a Claisen-saponif¡cation (Claisen 1905)· 
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The stable sodium salt of the trans-epoxy acid thus obtained was reconverted 
into the original trans-epoxy methyl ester (J) as follows: the sod ι urn salt, 
dissolved in a minimal amount of water, was converted into the corresponding 
silver salt with AgNOs {^0% in water); the dry silver salt was treated 
with methyl iodide to give the methyl ester (J) (House et al. 1958). 
Enantiomerι cally pure sodium cis-and trans-3-phenyl-2,3-epoxypropanoates 
(sodium salt of cis-and trans-epoxy acids) were prepared in the Department of 
Organic Chemistry, University of Nijmegen, following modified literature 
procedures (Harada 1966; Harada and Nakajima ^Э7^*) . 
The methyl cis and trans-3-phenyl-2,3-epoxypropanoates were characterized 
by mass spectrometry, H-NMR and their purity was ascertained by g.l.c. ( > 99%) 
The following optical data ( Γα] )were obtained for the enantiomeric sodium salt 
of the cis- and trans-epoxy acids used in this investigation: (+) trans (2S, 3R) 
= +86.1 (c = 0.95, water), (-) trans (2R, 3S) = -87.2 (c = 0.95, water), (+) cis 
(2S, 3S) = +6.0 (c = 1, water), (-) cis (2R, 3R) = "5.7 (с = 1, water). 
N-Acetyl-S-(l-methoxycarbonyl-2-phenyl-2-hydroxyethyl)cysteine methyl ester 
(see Fig.3; VIII) was prepared by heating a mixture of 5 mmol of racemic trans-
epoxy methyl ester (J), 5 mmol of N-acetylcysteine, 5 mmol of МаНСОз and 50 ml 
of methanol under reflux for 2 weeks. The progress of the reaction was followed 
by t.l.c. The reaction mixture was cooled and diluted with water. 
The solution was adjusted to pH 8 and washed with diethyl ether. After acidifi­
cation to pH 1 with 2M HCl and saturation with NaCl, the organic material was 
extracted with chloroform (6 times with 100 ml). The combined chloroform extracts 
were dried (anhydr. МдЗОц), filtered and concentrated -in vacuo. Of the resulting 
syrupy oil 250 mg was dissolved in 5 ml of methanol and treated with 1 mmol of 
thionylchloride in 2.5 ml of chloroform during 20 min. After stirring the 
mixture for 30 min., the solvent was removed in vaauo. The residue was dissolved 
in chloroform and washed with a saturated МаНСОз solution. The organic layer was 
dried (anhydr. MgSOi^), filtered and concentrated in vaauo. The remaining oily 
residue was purified by flash column chromatography with ethyl acetate as eluent. 
A pale yellow oil was obtained in a yield of 50% (170 mg). 
By following the same procedure racemic cis-epoxy methyl ester II was 
converted in the corresponding compound VIII (Fig.3)· 
Animal treatment. Adult male Wistar rats (Cpb: WU, 180-200 g, 6 weeks old) from 
TNO-stock, Zeist, (The Netherlands) were used. At the beginning of the study 
the rats were divided into groups of four rats each and maintained on food 
(Hope Farms, Woerden, The Netherlands) and tap water ad libitum. 
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The animals were allowed to acclimatise to the individual stainless steel 
metabolism cages for one week prior to use in the experiments. The metabolism 
cages were placed in a temperature-regulated room (22 ± 2 C) with a relative 
humidity of 50% to 75% and light/dark cycle of 12h. 
The racemic epoxy esters (I and JI), were injected intraperitoneally as a 
single dose of 0.7 mmol/kg in propylene glycol. A group of four animals dosed 
with the solvent only served as control group. Urine samples were collected in 
2kh portions for two days and stored at -180C until required for analysis. 
For the isolation of the mercapturic acids of the epoxy esters I and IJ 
the same ¡.p. dose (0.7 mmol/kg) was administered daily for 2 weeks, except at 
weekends. 
Chromatography. Thin layer chromatography was performed on silica gel pF25i» 
layers (0.25 mm). The eluent was either dichloromethane: methanol: acetic acid 
(40:4:1 = v/v/v) or ethyl acetate. Plates coated with 0.5 mm layers were used 
for preparative chromatography with the same eluents. After development of the 
plates, the spots were detected by fluorescence quenching (254 nm) and by 
spraying with the reagent of Knight and Young (1958). 
Flash column chromatography (column chromatography under pressure: 2 kg/cm2) 
with silicagel 60H was used for the purification of the synthetic compounds 
with either pet.ether:diethyl ether (60:40 = v/v) or with ethyl acetate as 
eluent. 
Gas liquid chromatography was performed on a Hewlett-Packard Model 5750 gas 
Chromatograph equipped with a flame ionization detector (FID) and a glass column 
(1.2 m χ 3 mm ID) packed with 3% OMÌJ on Gaschrom Q (80-100 mesh). The carrier 
gas was helium (flow rate, 30 ml/min). Temperature: injection port 250 C, 
column 120-l60oC, detector 300oC. 
Spectra. Mass spectra were obtained with the Finnigan MAT 311A mass spectrometer 
(Finnigan MAT, Bremen, FRG) connected to the Finnigan MAT SS200 data system. 
Electron Impact (El) mass spectra of the various epoxy esters were recorded at 
70 eV using the direct insertion probe with standard quartz crucibles. 
The El spectra were obtained with a standard EI/CI ion source. Fast Atom 
Bombardment (FAB) mass spectra of VIII were obtained using a modified EI/CI ion 
source (M-scan Ltd., Ascot, U.K.). Samples were injected into a glycerol matrix 
on a stainless steel target and mixed under visual control. The primary ionizing 
beam of Xenon was produced from a probe type ion gun (M-scan Ltd.) operating 
at 10 kV and 100 μΑ discharge current. For all measurements the mass resolution 
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of the instrument was set to 1000. 
The H^NMR spectra of the epoxy esters were obtained with a 90 MHZ Varian 
EM390 NMR spectrometer. H-'-NMR spectra of compounds with structure VIII were 
recorded at ЗбО MHz on a Bruker AM-36O instrument equipped with an Aspect 3000 
computer. Tetramethyl si 1ane (TMS) was used as an internal standard (6= 0.00 p.p.m.). 
Isolation procedure for the mercapturic acids. Rat urine (500 ml) was acidified 
to pH2with 10M HCl and saturated with NH^Cl . The urine was continuously 
extracted with diethyl ether during 2k h. The diethyl ether layer was sepotated 
from the aqueous layer, and then dried with anhydr. MgS0 4, filtered and evaporated 
to cryness ir vacuo. The residue was dissolved in 2 ml of methanol. To this 
mixture 50 mg (0 .k2 mmol) of thionylchloride in 1 ml of chlo-o'jrm was added 
and which then was stirred for 30 min. The solvent was removed in vacuo, 
the residue dissolved in chloroform and washed with a saturated NaHCOa solution. 
The organic layer was dried with MgSOij, filtered and concentrated. 
The mercapturic acid methylesters, were separated from the remaining oil by 
thin layer chromatography (0.5 mm coated plates). Fractions having the same R f 
value as the synthetic reference substance were removed from the plate and the 
compound was isolated by extraction of the silica gel with 2-propanol followed 
by evaporation of the solvent. 
Determimiion of total thioethe™ excr^+inn in urine. Rats were treated with a 
single dose of the compound being investigated and 2k h urines were collected for 
2 days and diluted with water to a standard volume (20 ml J. 
The amount of mercapturic acid in the urine was determined according to 
Seutter-Berlage et al. (1979) and Rietveld et al. (I986) (see Chapter 2.2, 
Method A ) . The results were not corrected for recovery. 
Determination of glutathione conjugation. Determination of enzymatic glutathione 
conjugation of racemic trans-epoxy methyl ester I, racemic cis-epoxy methyl 
ester IJ and the various optically active enantiomers III, IV, V and VI was 
performed as described by Rietveld et al. (I986) (see Chapter 2.2). All the 
substances were dissolved in acetoni tri le. The reaction mixtures contained 1 mM 
of GSH and 1 mM of an epoxide. The incubation volumes were always 1 ml, namely 
O.5 ml liver homogenate supernatant, 0.5 ml buffer (O.I M КНгРОц/МагНРОі,) 
pH l.k. The reaction was started by adding the substrate (in 25 μΐ acetoni tri le). 
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Determination of N-alkylating activity. The N-alkylating activity of the racemic 
cis- and trans-epoxy esters (I and II) was determined following the procedure of 
Agarwal et al .(1979)· 
In this in vitro-test the conjugates of the various compounds with NBP, 
h-[p-nitrobenzylJ pyridine, were measured spectrophotometrically at 570 nm. 
High absorbance implies high N-alkylating potential. The measurements were 
performed in triplicate. 
Mutagenicity assay. The Salmone!la/microsome assay for mutagenicity was performed 
with S.typhimurium TA1535. TA1537, TA1538, TA98, and TA100, according to Ames 
et al. (1975). 
In the assays without rat liver homogenate racemic epoxy esters 
(I and II) and the optically active enantiomers (III, IV, V and VI) were 
dissolved in 0.1 ml of dimethyl sulfoxide (DMSO). At least five concentrations 
(ranging from 0 to 15 000 ug per plate) of I and II were tested. The enantiomers 
(III, IVj V and VI), added in two amounts (1500 and 3000 цд per plate) to the 
top agar, were tested only with tester strain TA100. All tests were performed on 
petri plates in triplicate. Solvent controls and positive controls (1.0 ug of 
sodium azide per plate; TA1535 = 356±7; TA100 = Ь9Ц±\аЦ) were run concomitantly 
with each experiment. 
Liver homogenate of Aroclor ^S't-induced rat (S9) was used in the tests 
with bioactivation. 0.5 ml S9 mix, consisting of 50 yl S9; 0.75 Щ glucose-6-
phosphate; 1.5 mg NADP; 0.1 ml 0.5 M NaaHPO^/KHaPO^, pHJ Л; 50 ul 0.33 M KCl; 
50 μΐ 0.08 M МдСІг and 0.25 m! distilled water was used per plate. Only the 
epoxy esters I and II were tested in the same concentrations as without S9 mix. 
As positive control 2-aminoanthracene (7 pg per plate; TA1535 = 171±8, TA1537 = 
248+Ί1, ТАІ5З8 = 1023+53, TA98 = 111li±i»7, TA100 = 2000±213) was used. Solvent 
controls and controls for S9 mix were run concomitantly with each experiment. 
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RESULTS 
In vitro the glutathione depletion was determined with incubation mixtures, 
containing an epoxy ester and rat liver homogenate (9000 χ g). The data listed 
in Table 1 show that under physiological circumstances (37 C, pH 7·Ί) the initial 
amount of glutathione decreased due to enzymatic action. In particular, the cis-
epoxy esters II, V and VI depleted glutathione much more than the corresponding 
trans-compounds I3 III and IV. The highest glutathione depletion was found for 
the pure enantiomer cis-epoxy cinnamic ester V (72 ± 3%)• 
An enhanced thioether excretion in urine of adult male rats was found after 
a single IP dose (0.7 mnral/kg, η = h) of racemic trans-epoxycinnamate I and of 
Table 1. Depletion of glutathione ^ with rat liver homogenate in 
phosphate buffer and the molar absorbance at 570 nm in the NBP-test. 
Compound Glutathione depletion Molar absorbance 
% 570 nm 
I (trans) 19 ± 2 d 6408 ± 288 d 
II (eis) 50 ± 2 2088 ± 168 
III (2S,3R) 26 ± 2 n.d. 
IV (2R,3S) 10 + k n.d. 
V (2R,3R) 72 ± 3 n.d. 
VI (2S,3S) Ή ± 2 n.d. 
a The GSH depletion is expressed as percentage decrease of the initial amount 
GSH (ImM) 
b The GSH depletion (5 min at 37 C) was enzymatic for all compounds 
с 0.1 M Na2HP0it/KH2P0l), pH 7-
it 
d Three independent determinations performed in triplicate (Mean ± S.D.) 
n.d. = not determined 
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Fig.2. Urinary thioether excretion (expressed in umol SH eq. ± SEM) 
of male rats (n = 't, con = control) in the first and second 2kb after 
a single dose of racemic trans methyl epoxycinnamate (0.7 mmol/kg I in 
propylene glycol, i.p.) or racemic cis methyl epoxycinnamate (0.7 mmol/kg 
II in propylene glycol, i.p.) Increase of urinary thioether excretion is 
significant for compounds I and II in the first 24h after dosing (P<0.05. 
Students t-test). 
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racemic cis-epoxycinnamate II (Fig.2). A significant increase in the urinary 
thioether amount was only found within the first 2k h. 
After repeated dosing of I and II sulphur-containing metabolites were isolated 
from combined urine extracts. The isolated substances were treated with thionyl-
chloride in chloroform: methanol (1:2, v/v) to esterify the carboxylic acids. 
D¡azomethane, a well-known methylation agent for acids caused decomposition of 
the primary S-containing products (mercapturic acids). This was also observed 
during the synthesis of the mercapturic acid methyl esters for reference 
purposes (compounds with structure VIII, Fig.3). 
The isolated sulphur-containing substances were assigned the structure VIII 
on the basis of a comparison of their chromatographic behaviour on TLC with the 
synthetic reference compounds 71JI. The Rf-value of the reference material VIII 
prepared from trans-epoxy ester I was O.kb (eluent ethyl acetate) and O.'tS for 
VIII obtained from the cis-epoxy ester II. 
The structure of compounds VIII was confirmed by fast atom bombardment mass 
spectrometry (FAB , Fig.'t). The H-NMR spectra of both reference compounds 
clearly revealed that they both consist of a mixture of two diastereomers. 
This points to a stereospecific opening of the epoxide function in the 
(racemic) epoxy esters upon reaction with N-acetylcysteine methyl ester. 
The synthesis of mercapturic acid methyl esters of the structure VII could 
not be accomplished by a reaction of a cysteine derivative and the epoxy ester 
(I or JJ). Evidently, the reaction of the thiol function in cysteine with the 
epoxy esters takes place regiospecificaily at the α-carbon atom of the epoxide 
group. 
The N-alkylating potential of the racemic cis- and trans-epoxy esters was 
determined using the NBP-test procedure (Table 1). The trans-epoxy ester I 
appeared to react much better with NBP than the cis-epoxy ester (II). 
As shown in Fig.5 and Fig.6, mutagenic effects of racemic trans-epoxy 
cinnamate I were observed in the plate incorporation assay (Ames test) with 
S.typhi muri urn strains TA1535, TA1537, TA1538 and TA100. Both racemic epoxy 
cinnamates I and II were found поп-mutagenic towards strain TA98 in the plate 
test. Racemic cis-epoxy cinnamate appeared to be поп-mutagenic (as pictured in 
Fig.5) towards the various S.typhimuriurn tester strains. No mutagenic responses 
were detected using any of the epoxy cinnamates with liver homogenate of the 
Aroclor induced rat (S9-mix). The number of his revertant colonies of the 
enant¡omerica!ly pure cis- and trans-epoxy cinnamates (IIT-7I) are plotted in 
Fig.6. The trans-epoxy esters III and 17 both were more mutagenic towards 
S.typhimurium strain TA100 than the cis-isomers 7 and 71. 
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Fig.6. The mutagenicity of racemic and individual enantiomers of eis and 
trans methyl epoxycinnamates towards S. typhimuriwn TA100 in the Salmonella/ 
microsome plate assay without metabolic activation. Experimental details 
were as mentioned in Materials and Methods. Mean values ± S.D. of 
determinations in triplicate. 
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No bacteriotoxicity was observed by microscopic examination of the background 
lawn of test plates up to 15 mg of any methyl epoxy cinnamate per olate 
(5 mg/ml top agar) . 
DISCUSSION 
An important well established detoxication route for many aromatic and aliphatic 
epoxides is conjugation with glutathione (GSH) and subsequent biotransformation 
to mercapturic acids as urinary metabolites (Chasseaud 1979; Hayakawa 1975). 
The epoxy carboxylic esters (glycidic esters) constitute a special class of 
epoxide by the presence of the strong electron-withdrawing alkoxycarbonyl 
(ester) substituent. Therefore, it is justified to establish the ability of 
epoxy cinnamates (3-phenyl-2,3-epoxypropanoates) to undergo glutathione 
conjugation by investigating the glutathione depletion in rat liver homogenates 
and the enhanced urinary mercapturic acid excretion of these epoxy esters. 
For such an investigation it is essential to study the respective geometrical 
isomers and stereo-isomers separately (compound J-72, Fig.1). 
The conjugation of these epoxy esters, in vitro, was almost completely 
catalyzed by glutathione transferases. The cis-epoxy ester 22 (racemic, as well 
as the individual enantiomers V and 72) in which the ester function is positioned 
cis to the phenyl group depletes GSH considerably better than the trans-epoxy 
ester 2 (racemic, as well as the individual enantiomers 222 and 27) having the 
ester function and the phenyl group in a trans relationship. By comparing the 
behaviour of the respective enantiomers it appears that the epoxy esters with 
the 3R configuration (222 and 7) deplete GSH more effectively than both 3S 
enantiomers (27 and 72). The results in Table 1 clearly indicate that the 
transition state of the GSH depletion process is strongly influenced by 
stereochemical factors. Also these results show that for comparison of the 
bio-activity of substrates their stereochemical features should be taken into 
account. 
The higher reactivity of the cis-epoxy esters when compared with the 
corresponding trans isomers seems to contrast with the results described by 
Haykawa et al. (1975) concerning methyl substituted styrene oxides in GSH 
depletion experiments. Trans-methyl styrene oxides show, in vitro, a higher 
reactivity towards GSH catalyzed by glutathione-S-transferases than the 
corresponding cis-isomers. Earlier, Oesch et al. (1971) reported that cis-1,2-
disubstituted epoxides are better substrates for the epoxide hydrolyse system, 
a principal detoxication system of epoxides. On the basis of these observations 
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Hayakawa et al. (1975) suggested that transferases have a complementary 
activity to that of epoxide hydrolases. It is clear that epoxy esters do not 
fit into this pattern, in all probability due to the presence of an ester 
function which influences the reactivity of the epoxide function drastically. 
Therefore, in comparing the bio-behaviour of epoxides extreme care should be 
exercised when different types of substituents are considered. 
A significantly enhanced thioether excretion in urine of male rats was observed 
after administration of the racemic epoxy cinnamates I and 11 (see Fig.2). 
This finding that the cis epoxy ester II gives a higher urinary thioether 
excretion than the trans-isomer is in accordance with the preference found for 
the glutathione depletion of epoxy cinnamates in vitro. 
The thioether substances isolated from the urinary extracts (after esterifi-
cation) were assigned the structure VIII (Fig.3). It should be emphasized that 
the use of diazomethane as reagent to convert mercapturic acids into the 
corresponding methyl esters - a frequently used standard procedure - cannot be 
applied in the present case as it leads to disastrous decomoosition of the 
hydroxy mercapturic acids (see section results). This observation may have 
considerable consequences for the conclusions of the study of the biotransforma-
tion of methyl cinnamate (and other substituted acrylic esters) (Delbressine 
et al. 1982) where, in attempts to isolate hydroxy mercapturic acia, 
diazomethane was used for esteri fication. It was claimed that methyl cinnamate 
was not metabolized via the corresponding epoxy esters because the then 
expected hydroxy mercapturic acids were not isolated but in view of the results 
presented here, this should be re-invest¡gated. 
The results of the NBP test (Fig.2) as well as the difference in 
rate of the reaction of N-acetyl cysteine with the isomeric epoxy cinnamates 
(see section results, preparation of VTII) revealed a higher reactivity for the 
trans-epoxy ester I in comparison with the cis-isomer IT. These chemical 
reactivities correlate well with the mutagenicities of the respective racemic 
epoxy cinnamates in the Ames assay with different S.typhimurium bacteria as 
tester strains (Fig.5 and 6 ) . 
Correlations between the mutagenic potency in different bacterial strains 
and the alkylating activity of epoxides, using NBP and other N-nucleophiles, 
are well documented. Many epoxide-containing compounds including aliphatic 
epoxides elicited alkylating activity and mutagenicity (Hemminki and Falck 1979; 
Hemminki et al. I98O, Sugiura and Goto I98I). Evidence for an alkylating activity 
appeared to be always indicative of bacterial mutagenicity (Hemminki et al. I98O). 
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It is noteworthy in the present study that especially the trans-epoxy ester 
(racemic as well as optically act! ve) were mutagenic to S.typhLrnuvium TA100 in 
the Ames test (Fig.6). Wade et al. (1978) found in their Ames test for 
mutagenicity of aliphatic epoxides that trans-1,2-disubstituted epoxides were 
non-mutagenic to strain TA100 and TA1535, while the cis-isomers tested were 
weakly mutagenic in strain TA100 only. This apparent difference in mutagenic 
behaviour of epoxy esters and non-functionalized epoxides must be attributed 
to the presence of the ester function which influences the bio- and chemical 
properties of the epoxide function drastically. In addition our findings suggest 
that enzyme systems in the S9-mix are able to detoxify the epoxides preventing 
attack on the bacterial DNA. 
By comparing the mutagenicity and the enzymically catalyzed glutathione 
conjugation it follows that the activity of the respective enantiomers JJJ-7J 
takes an opposite order (see Fig.7). 
CeHf 
Ч
ч/0\/Н 
c-c, 
ODOCH, 
2R,3R 
СвЧбД рООСНэ 
vi J:—¿L 2s,3s 
N Д pООСНз 
Ш 'θ—С' 2S.3R 
ІУ 
с^д/н 
І-Г ТІООСН, 
2R.3S 
Mutagenicity 
(Ames test) 
glutathione 
conjugation 
(enzyme catalyzed) 
Fig.7. The mutagenicity of the optically active methyl epoxycinnamates III, 
IV, V and VI towards S.typhimurium TA100 and the depletion of glutathione 
•in vitro obtained for the respective epoxycinnamates 
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From the present study it is concluded that methyl epoxy cinnamates 
are able to undergo enzyme-catalyzed glutathione conjugation. 
This conjugation process leads to exclusive epoxide ring-opening by nucleophilic 
attack at C-2 (adjacent to the ester function) and is subjected to considerable 
stereochemical constraints with a preference for the R- configuration at С-З-
Hydroxy mercapturic acids were isolated and identified as metabolites in 
urinary extracts using an effective work-up procedure. Furthermore the 
epoxy esters in this study were shown to be mutagenic to S.typhimurium 
bacteria and therefore they may bind covalently with nucleic acids and proteins 
in biological systems. Glutathione conjugation forms a protect i ve mechanism for 
Hie detoxicatlon in living organism of the potentially toxk epoxy esters. 
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PART III 
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Chapter 3.1 
Mercapturic acids as metabolites of aromatic aldehydes 
and alcohols. 
INTRODUCTION 
Aromatic aldehydes and alcohols are important industrial chemicals and in 
addition they are used as flavours and fragrances in food and cosmetics (Furia 
and Bel lanca 1975)-
Especially, aldehydes are potential contact sensitizers. This implies, 
that these substances, or their metabolites, are capable of binding covalently 
to proteins, thus acting as haptene (Turk and Parker 1978). In this way a 
conjugate with the tripeptide glutathione may also be formed, resulting in the 
excretion of a mercapturic acid in the urine (Boyland and Chasseaud 1969; 
Wood 1970; Chasseaud 1979)· An enhanced thioether excretion after administration 
of a xenobiotic substance to an animal can be interpreted as a first indication 
of the alkylation capacity of a substance in vivo. 
The aim of this study is to investigate whether a) the administration of 
aromatic aldehydes or alcohols leads to an increase in urinary thioether 
excretion, and b) the position or nature of the substituents in these substances 
influences the capacity of mercapturic acid formation. 
MATERIALS AND METHODS 
Chemicals. Silica gel 60 (70-230 mesh) and glass TLC plates coated with silica 
gel PF251», sodium borohydride and propylene glycol were purchased from Merck AG 
(Darmstadt, FRG). Diazogen (N-methyl-N-nitroso-p-toluenesulfonamide, precursor 
of diazomethane), N-acetyl-L-cysteine and all aromatic aldehydes and most 
aromatic alcohols were purchased from Janssen Chimica (Beerse, Belgium). 
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The substances used for administration were purified before use if necessary. 
Purity controls were performed by g.l.c. 
Syntheses. The mercapturic acids were synthesized by firstly reacting the 
benzyl alcohols with HBr in toluene (Vogel 1972) and then conversion of 
thus-obtained benzyIbromides with N-acetyl-L-cysteine (Clapp and Young 1970). 
The methylester of N-acetyl-L-cysteine was prepared by methylation of 
N-acety1-L-cysteine with diazomethane (de Boer and Backer 1963)· The methyl-
esters of the benzylmercapturic acids were prepared by methylation of the 
corresponding mercapturic acids with diazomethane or were synthesized by 
reaction of benzyl bromides with N-acetyl-L-cysteine methylester. 
Non-commercially available alcohols were prepared from the corresponding 
aldehydes by NaBHi, reduction (Vogel 1972). 
2-lodobenzaldehyde was prepared from the corresponding alcohol by N32^207 
oxidation in dioxane:water (1:1, v/v) (Lee and Spitzer 1970)· 
Animals. Adult male rats (±200 g, about 6 weeks old), TNO-stock (Zeist, The 
Netherlands) were used. The animals were housed in individual stainless steel 
metabolism cages with free access to water andfood (Hope Farms, Woerden, The 
Netherlands). Urine samples were collected daily and stored at -18 С until 
required for analysis. 
The substances were administered IP in propylene glycol (1.5-2.2 mmol/kg) 
as a vehicle; in continuous administration (3 days a week for 2 weeks) of 
2-methoxy-, 2-nitro- and 2-chlorobenzaldehyde the dose was 1.0 mmol/kg. 
The influence of the dose on the urinary mercapturic acid excretion was 
studied after IP dose of 2-chlorobenzaldehyde ranged from 0.05 to Ο.Ί mmol/rat. 
In inhibition studies the animals were injected IP with pyrazole ¡n 
propylene glycol (3-0 mmol/kg) 30 min previous to injection with the 2-chloro-
benzyl alcohol. 
Chromatography. Column chromatography was performed over silica gel 60 with 
diethyl ether as eluent. Thin layer chromatography of the mercapturic acids 
was performed on 0.25 mm layer of silica gel PF2514 coated glass plates with 
dichloromethane : methanol : acetic acid (ΊΟ:'*:! = v/v/v) as eluent; the same 
type of glass plates was used for the chromatography of the methylesters of 
mercapturic acid, with diethyl ether as eluent. Preparative thin layer 
chromatography with diethyl ether as eluent was performed on glass plates 
coated with 0.5 mm layers. After development of the plates, the spots were 
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detected by UV absorption {25b nm) and by spraying with 0.1 M К2СГ2О7: 
glacial acetic acid = 1:1 (v/v) and then with 0.1 M АдМОз (Knight and Young 
1958). 
Spectra. Mass spectra (El) were obtained with a LKB gas chromatograph-mass 
spectrometer type 9000 at ISO С ion source temperature and 20 eV. 
The materials were introduced by direct probe insertion at hO C. Ion source 
-ц 
pressure was 1.5 x 10 Pa. 
Nuclear magnetic resonance spectra were obtained with compounds dissolved in 
CDCI3, using a 90 mHz Brucker LH90 n.m.r. spectrometer, and tetramethylsi lane 
(TMS) as an internal reference (6 = 0.00 p.p.m.). 
Isolation of mercapturio acids from urine. Urine (750 ml - 1,000 ml) was 
acidified to -H 2 with 10 M HCl and saturated with МНцСІ. The urine was 
continuously extracted with diethyl ether during 2k h. The organic extract was 
concentrated by evaporation and then treated with excess diazomethane in 
diethyl ether. After washing twice with NaCl solution and drying over MgSOij, 
the solvent was evaporated in vacuo. The resulting brown oil was fractionated 
by column chromatography (silica gel 60) with diethyl ether as an eluent. 
The portions giving a positive reaction with the reagent of Knight and Young 
(1958) were combined and evaporated in vacuo and the remaining oil was 
separated on TLC plates (0.5 mm). The fractions having the Rf value of the 
methylester of the synthetic reference substance were removed from the plate 
and the compound isolated by extraction of the silica gel with methanol and 
evaporation of the solvent. 
Determination of total mercapturic acid excretion in urine. Rats were treated 
with a single dose of the compound under investigation and 2k h urines were 
collected during 3 days and diluted with water to a standard volume (20 ml). 
Mercapturic acid in the urine was determined according to Seutter-Berlage et al. 
(I978, 1979, see also Chapter 2.1). 
Standard series of synthesized reference compounds (see Table 5) were 
dissolved in 0.05 M KHjPOi, buffer pH 8.0. These solutions were added to centri-
fuged urine samples (3000 r.p.m.). The diluted urine samples were subjected to 
the same procedure. 
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RESULTS 
After a single dose of ortho- or para-substituted benzaldehydes or the 
corresponding benzyl alcohols to rats in some cases an enhanced urinary 
thioether excretion was observed. 
Non-significant (student t-test, Ρ > 0.05) increases were observed with the 
para-substituted benzaldehydes. Significant increases with the ortho-substituted 
substances were restricted to the first 2k hours. The results are represented in 
Tables 1 and 2. 
The amount of urinary thioether was determined spectrophotometrically after 
alkaline hydrolysis (1 M NaOH and 100 OC). The optimum time of this hydrolysis 
was 120 min (Fig. 1). 
There was a linear relationship between the amount of urinary thioether and 
dose of an ortho-substituted substance (see for example Fig. 2). The substances 
were mostly administered IP in a single dose of 2.0 mmol/kg rat. 
Mercapturic acids were isolated from the urines after continuous dosing 
with 2-methoxy-, 2-nitro- and 2-chlorobenzaldehyde and with corresponding alcohols. 
The structures of the methylesters of the isolated substances were confirmed 
by N.M.R. and mass spectra and were identical with those of the methylesters of 
2-methoxy-, 2-nitro- and 2-chlorobenzyImercapturic acid (Table 3 and k 
respectively). 
The synthetic mercapturic acids (Table 5) were dissolved in diluted urine 
and were subjected to the same procedure as the urine samples of treated rats. 
The recovery values are represented in Table 6. 
Table 7 shows the urinary mercapturic acid excretion in % dose, corrected 
for recovery. 
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Table 1. Urinary thioether excretion after a single dose of o-substituted 
benzaldehydes. 
CHO Dose in 
mmoI/an ima 1 
Increase in 
umol SH eq. in 
fi rst 21* hours 
% dose ± SEM 
0.ko 
O.hO 
O.hO 
O.M 
O.kh 
0.40 
O.Mt 
0.40 
0.30 
0.30 
3.93 ± 1.39 
9.58 ± 2.27 
19.M ± 3.84 
23.63 ± 3.16 
30.38 ± 4.11 
37.63 ± 7.34 
31.27 ± 6.38 
1.0 ± 0.3 (n=4) 
2.2 + 0.5 (n=4) 
4.4 ± 0.9 (n=3) 
5.9 ± 0.8 (n=4) 
6.9 ± 0.9 (n=4) 
9.4 ± 1.8 (n=4) 
10.4 ± 2.1 (n=3) 
(n=4) 
No significant increase, Ρ > 0.05 (students t-test) 
Table ?.. Urinary thioether excretion after a single dose of o-subst i tuted 
benzyl alcohols. 
Dose in 
mmol/an ima) 
Increase in 
μιποΙ SH eq. ¡n 
first 24 hours 
% dose ± SEM 
R = OCH3 
R = NO2 
R = CH3 
R = Cl 
R = I 
R = C00H 
0.44 
0.44 
0.40 
0.40 
0.30 
0.30 
21.53 ± 5-74 
ЗІ.75 ± 8.18 
28.63 ± 5.25 
52.25 ± 8.17 
41.94 ± 9.21 
4.9 ± 1.3 (n=4) 
7.2 ± 1.9 (n=4) 
7.2 ± 1.3 (n=4) 
ІЗ.І ± 2.0 (n=4) 
14.0 ± 3.1 (n=4) 
No significant increase, P > 0.05 (students t-test) 
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/imol of SH eq 
hydrolysed 
/nercapturic acid 
time (mm ) 
Fig. 1. Time-dependent alkaline hydrolysis (1 N NaOH, 100oC) 
of a known amount 2-lodobenzyImercapturic acid in urine of 
rats. Each point is the mean ± S.E. of three experiments. 
40· 
30· 
20-
10· 
«mol 
mercaptunc acid 
mmol of 2-chlorobenzaldehyde 
0,1 0,2 0,3 0,4 
Fig. 2. Influence of the dose of 2-chlorobenzaldehyde on 
the mercapturic acid excretion. Each point is the urinary 
2-chlorobenzyl mercapturic acid excretion of one rat. 
102 
Table 3. N.m.r. data of the reference compounds. 
Assignment 
C 6H 4 
NM 
CH 
OCH3 
-CH2S 
СООСНэ 
S-CH2-CH 
СО-СНз 
A 
p.p.m.a 
6.77-7.З8 (m) 
6.1Й (d) b 
i(.77-it.96 (m) 
3.85 (s) 
3.73 (s) 
3.73 (s) 
2.9О and 2.96 (m) 
1.99 (s) 
7. 
it. 
с 
Ρ 
.18-
67· 
В 
.p.m.c 
-8.09 
6.53 
-'t.91 
it.09 
3.75 
2.98 
2.03 
ι 
(m) 
(d) b 
(m) 
(s) 
(s) 
(m) C 
(s) 
С 
p.p.m.a 
7.15-7.^7 (m) 
6.60 (d) b 
l|.71-it.96 (m) 
3.85 (s) 
3.73 (s) 
2.96 (m) c 
2.02 (s) 
Abbreviations: s = singlet, d = doublet, m = multiplet 
A: methyl ester of o-methoxy-benzyImercapturic acid 
В: methyl ester of o-nitro-benzylmercapturic acid 
С: methyl ester of o-chloro-benzylmercapturic acid 
aln CDCI3, internal reference: TMS, δ = 0.00 p.p.m. 
bJ = 8.0 Hz 
CJ = 5.0 Hz 
Table 4. Relative abundance of M and prominent fragments (m/e) of the methyl 
esters of the reference compounds at 20 eV, by direct insertion3. 
Compound 
A 
В 
С 
M+ 
297 (17) 
312 (0.5) 
301/303 (18) 
Prominent fragments 
121 (100) 176 ( 8) 
176 (100) 136 (59) 
176 (100) 2^ 2/2ΐιΊ (55) 
(m/e) 
238 ( 7) 
253 ( 7) 
125/127 (Ί6) 
Relative abundance in brackets 
A: methyl ester of o-methoxy-benzylmercapturiс acid 
B: methyl ester of o-nitro-benzylmercapturic acid 
C: methyl ester of o-chloro-benzylmercapturic acid 
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Table 5. Yield of syntheses, m.p., Rf values and mass spectrometric data of the reference compounds. 
Compound3 Yield 
R % 
F 85 
OCH3 30 
NO2 60 
Cl 9^ 
CH3 86 
Br 96 
I 99 
m.p. 
0C 
ізэ-і^о 
^ 
141-1І»3 
135-137 
ÌSZ-ÌSk 
151-15^ 
І69-І7О 
a
 ^T^YCHJ-S-CHJ-CH-NHCOCHJÍCOOH) 
WAR 
«,
ь 
0.21 
0.24 
0.19 
0.23 
0.21 
0.22 
0.21 
М
+ с 
271 
(43) 
283 
(Π) 
298 
(9) 
287/289 
(36/13) 
267 
(14) 
331/333 
(40/37) 
379 
(19) 
Other m/e 
212 
(62) 
224 
(32) 
___ 
228/230 
(60/22) 
208 
(50) 
272/274 
(71/65) 
320 
(75) 
values (rel. 
162 
(71) 
162 
(4) 
162 
(37) 
162 
(100) 
162 
(42) 
162 
(100) 
162 
(22) 
, intensities %) 
109 
(100) 
121 
(100) 
136 
(100) 
125/127 
(95/34) 
105 
(100) 
169/171 
(79/87) 
217 
(100) 
In dichloromethane: methanol: acetic acid = 40:4:1 (saturated separate room) 
Relative abundance of M and prominent fragments (m/e) of the reference compounds at 20 eV, by 
direct insertion 
соон 
I 
CH2-S-CH2-CH 
NHCOCH3 
f 
R 
F 
OCH3 
NO2 
Cl 
СНэ 
Br 
I 
% Recovery 
68 
64 
60 
78 
72 
73 
49 
Table 6. Recovery values of substituted 
benzylmercapturic acids in diluted urine 
after 2 h hydrolysis by 1 N NaOH and at 
100 C. Expressed as % recovery of known 
amount mercapturic acid. 
& 
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Table 7. Urinary mercapturic acid excretion in rats 
in % of dose (0.3-0.Ί4 nmol/animal) after recovery 
correction. 
R 
OH 
H 
F 
OCH3 
NO2 
CI 
СНэ 
Br 
I 
соон 
сно 
r Y R 
к^  
Ζ Dose ± SEM а 
_с 
-
1.5 ± О.А 
3.4 ± 0.8 
7-3 ± 1.5Ь 
8.7 ± 1.0 
9-6 ± 1.3 
12.3 ± 2.3 
21.1 ± к.гь 
-
С Н 2 О Н 
^ ι Γ " U1 
1 Dose ± SEM а 
n . d . d 
n.d. 
n.d. 
7.6 ± 0.2 
12.0 ± 3.2 
16.8 ± 2.6 
10.0 ± 1.8 
n.d. 
28.5 ± 6.3 
-
N=4, excretion in first 2h hours 
N=3, excretion in first 24 hours 
No significant increase, Ρ > 0.05 
Not determined 
DISCUSSION 
Generally, benzyl alcohols are metabolized to benzaldehydes which in vivo are 
then oxidized to the corresponding carboxylic acids. The latter are excreted 
either directly or in conjugated form (Williams 1959). As a minor alternative 
an aldehyde group can also be metabolically reduced to the alcohol (Wong and 
Sourkes 1966; Strand and Sheline 1975; Shiobara 1977). 
As metabolites of ortho-substituted benzyl alcohols and benzaldehydes we 
found thioethers which were identified as the corresponding benzylmercapturic 
acids (N-acetyl-S(benzyl)-L-cysteines). 
A direct alkylation of an SH-group by an alcohol is extremely unlikely. 
However, it is known that from primary alcohols monoalkyl sulphates can be 
formed in vivo (Roy 1971; Vestermark and Boström 1959, I960; Law et al. 1963). 
Moreover, monoalkyl sulphates are excellent alkylating agents for SH-groups 
(Gil ham et al. 1970; Gil ham 1971, 1973; Сlapp and Young 1970; Woodman and 
Young 1971 ; Kaye 197'*). There it seems acceptable to postulate monoalkyl 
sulphates as active intermediates in the metabolism of benzaldehydes to 
benzylmercapturic acids. 
From the wide range of substituants selected for this study it appears that 
the formation of the mercapturic acids cannot be attributed to electronic 
effects (see Tables 1, 2 and 7). 
The size of the various ortho-substituents is probably more important than 
its electronic nature. From this and the fact that only an ortho-substituted 
benzyl alcohol or benzaldehyde yield a significant mercapturic acid excretion 
it follows that steric hindrance slows down the oxidation to a benzoic acid to 
such an extent that the reduction of the aldehyde, the conjugation of the 
alcohol with sulphate and subsequently the alkylation of glutathione became 
of greater importance. Apparently, for this oxidation to benzoic acid a 
specific enzyme/substrate interaction is required which is hampered by the 
presence of a sterically filled substituent on the ortho-position. 
This explanation is supported by the fact that if oxidation of the alcohol 
to the aldehyde is deminished by the preadministration of an alcohol-dehydro­
genase inhibitor like pyrazole even a stronger urinary thioether excretion 
was observed, (see Chapter 3-2). 
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Chapter 3.2 
Mechanism of formation of mercapturic acids from 
aromatic aldehydes in vivo. 
INTRODUCTION 
Generally benzyl alcohols are metabolized to benzaldehydes which are subse-
quently oxidized to the corresponding benzoic acids. The latter are excreted 
either directly or in conjugated form (Gilette 1959; Williams 1959)· 
In some cases substituted benzaldehydes are reduced to the alcohols in vivo 
(Wong and Sourkes 1966; Strand and Sheline 1975; Shiobara 1977). Recently, 
we showed that from substituted benzaldehydes and benzyl alcohols the 
corresponding benzylmercapturic acids were formed in vivo (Rietveld et al.1980). 
This means that during the biotransformation of the mentioned compounds at 
some stage conjugation with glutathione occurs, spontaneously or with the aid 
of glutathione S-transferases (Chasseaud 1976, 1979; Wood 1970). 
From the quantitative data we concluded (Seutter-Berlage et al. 1982) that 
the aromatic alcohols caused a higher mercapturic acid excretion than the 
corresponding aldehydes and the ortho-substituted compounds a higher mercaptu-
ric acid excretion than the para-substituted ones. 
Since a direct alkylation of the SH-group of glutathione by an alcohol is 
unlikely we postulated (Rietveld et al. 1980) a more reactive intermediate, 
probably a sulphate ester, which is known to be formed in vivo from a primary 
alcohol (Vestermark and Boström 1959, I960; Boström and Vestermark I960; 
Law et al. 1963)· Moreover, aralkyl sulphate esters are well-known substrates 
for the glutathione S-aralkyltransferase enzym (Boyland and Chasseaud 1969) 
giving ultimately mercapturic acids (Gilham et al. 1970; Gilham 1971, 1973; 
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Clapp and Young 1970; Woodman and Young 1971)-
The aim of the investigation was to gain more insight in the mechanism of 
the formation of mercapturic acids from substituted aromatic aldehydes. 
MATERIALS AND METHODS 
Chemicale. Silica gel H60 (70-230 mesh), silica gel pF^so coated TLC glass 
plates, sodium borohydride and propane-l,2-diol were purchased from Merck AG 
(FRG). N-acety1-L-cysteine, o-bromo-, o-chloro-, o-fluoro-, and p-chloro-
benzaldehyde and o- and p-chlorobenzy1 alcohol were purchased from Aldrich 
Europe (Belgium). o-Bromo- and o-fluorobenzy1 alcohol were obtained from the 
corresponding aldehydes by NaBHij reduction (Vogel 1972). Pentachlorophenol 
(PCP) was obtained from Aldrich (USA) and pyrazole was purchased from Aldrich 
Europe (Belgium). The sodium salts of o-chloro- and p-chlorobenzyI sulphate 
were synthesized according to Clapp and Young (1970). The substances used were 
purified before administration if necessary. Purity controls were performed 
by g.l.c. ( > 97%). 
Syntheses of the veferenoe compounds. The mercapturic acids were synthesized 
by bromination of the benzyl alcohols with HBr in toluene (Vogel 1972) and 
reaction of the benzyl bromi des with N-acetyl-L-cysteine (Clapp and Young 1970). 
Yield m.p. in С Rf-value 
o-FluorobenzyImercapturic acid (J) 
o-ChlorobenzyImercapturic acid (JI) 
o-Bromobenzylmercapturic acid {III) 
p-ChlorobenzyImercapturic acid (IV) 
In dichloromethane: methanol: acetic acid = Ί0:4:1 
Animal experiments. Adult male rats (± 200g, about 6 weeks old), TNO-stock, 
Zeist (The Netherlands) were used. The animals were housed in individual 
stainless steel metabolism cages with free access to water and food (Hope Farms) 
Urine samples were collected daily and stored at -18 С until required for 
analysis. 
The aromatic aldehydes and alcohols were either IP administered once in a 
85% 
9 1»* 
96% 
75% 
ізэ-і^о 
135-137 
isi-is* 
105-106 
0.64 
0.68 
0.65 
0.65 
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dose of 2.0-2.2 mmol/kg in propylene glycol as a vehicle, or of o-fluoro-, 
o-chloro-, and o-bromobenzaldehyde 1 mmol/kg was IP administered daily on 
5 days a week during 2 weeks. 
In inhibition studies the animals were injected with pyrazole in propylene 
glycol (3-00 mmol/kg) 30 min previous to injection with o-chlorobenzyl alcohol 
or o-chlorobenzaldehyde. Ethanol in water (30% v/v) was administered 2 times 
orally (5.0 mmol/kg each time) within 7h. o-Chlorobenzaldehyde and o-chloro­
benzyl alcohol were injected after the 1st ethanol administration as 
described before. 
Pentachlorophenol (PCP) in propylene glycol (0.05 mmol/kg) was administered 
IP ^5 min preceding injection with o-chlorobenzyl alcohol. 
The sodium salt of o-chloro- and p-chlorobenzyl sulphate were dissolved in 
physiological saline solution and administered IP in a dose of 1 mmol/kg. 
In all experiments the animals injected with the solvents only served as 
control group. 
Chrcmatography. Column chromatography was performed over silica gel НбО with 
methanol: dichloromethane (1:9 = v/v) as eluent. Thin layer chromatography was 
performed on glass plates coated with a 0.25 mm layer of silica gel pFzs^ with 
dichloromethane: methanol: acetic acid CtO:1»:! = v/v/v) as eluent; plates 
coated with 0.5 mm layers were used for preparative chromatography with the 
same eluent. After development of the plates, the spots were detected by UV 
absorption (25** nm) and by spraying with the reagent of Knight and Young (1958). 
Spectra. Mass spectra (El) were obtained with a LKB gas Chromatograph - mass 
spectrometer type 9000 at 150 С ion source temperature and 20 eV. The materials 
were introduced by direct probe insertion at 40 C. Ion source pressure 1.5 x 
.'t 
10 Pa. Nuclear magnetic resonance spectra were obtained with compounds 
dissolved in CD3OD or d6-DMS0, using a 90 MHz Brucker LH90 NMR spectrometer 
and tetramethylsilane (TMS) as an internal reference (δ = 0.00 p.p.т.). 
Isolation of mercocpturic aoids from urine. Urine (750-1,000 ml) was acidified 
to pH2with 10 M HCl and saturated with NH4CI . Subsequently the urine was 
extracted 3 times with ethyl acetate (500 ml) and 3 times with dichloromethane 
(SOD ml). The combined organic extracts were evaporated to dryness in vacuo. 
The residue was dissolved in 25 ml ethyl acetate and the mixture extracted 
2 times with 10 ml I M sodium bicarbonate solution. The combined organic layers 
were acidified and evaporated to dryness in vacuo. Sometimes the residue 
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(brown oil) was fractionated by column chromatography (silica gel НбО) with 
methanol: dichloromethane (1:9 = v/v) as eluent. The fractions giving a 
positive reaction with the reagent of Knight and Young (1958) were combined 
and evaporated in vacuo and the remaining oil was separated by preparative 
TLC. The fraction having the R,-value of the synthetic reference substance 
was removed from the plate and the compound isolated by extraction of the 
silica gel with 2-propanol or methanol and evaporation of the solvent. The 
isolated mercapturic acids were recrysta)1ized from methanol.'water. 
Determination of total meroapturia acid excretion in urine. Rats were treated 
with a single dose of the investigated compound and Ih h urines were collected 
during 3 days and diluted with water to a standard volume (20 ml). 
The amount of mercapturic acid in the urine was determined according to 
Seutter-Berlage et al. (1978, 1979). Standard series of synthesized reference 
compounds added to urine samples and subjected to the same procedure, gave for 
o-f luorobenzylmercapturic acid (l") , o-chlorobenzyImercapturic acid {II) , 
o-bromobenzylmercaptur¡c acid (III) and p-chlorobenzyImercapturic acid (ТУ) 
respectively 83 ± 1%, 87 i 1%, 91 ± 1%, and 8? ± 1% recovery. The results 
have been corrected for these values. 
RESULTS 
After a single IP administration of o-fluorobenzaldehyde (F), o-chlorobenzal-
dehyde (VI), and o-bromobenzaldehyde (VII) to rats a significant increase in 
urinary excretion of thiocompounds was observed (see Table 1). This in contrast 
to p-chlorobenzaldehyde (VIII), which gave a small but not significant 
increase in the amount of urinary thioethers in comparison with control rats. 
After repeated dosing of V, VI, and VII sulphur containing metabolites 
were isolated from combined urine-extracts and their structures identified by 
Rf-values on thin layer chromatograms and confirmed by synthesis, Ή NMR-
and mass-spectra (see Tables 3 and h). They appeared to be o-fluorobenzyl­
mercapturic acid (J), o-chlorobenzyImercapturic acid (JJ), and o-bromobenzyl-
mercapturic acid ( J U ) . 
After IP administration of the sodium salts of o-chlorobenzyl sulphate (X) 
and p-chlorobenzyl sulphate (XI) the urinary excretion of thioether compounds 
increased (see Table 2). 
From the urine mercapturic acids were isolated and identified by synthesis, 
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J. Increase of urinary thioether excretion of rats in the first 24 h 
after a single dose of substituted benzaldehydes 
Compound" 
o-Fluorohen/aldelnde (V) 
o-Chlorobcnzaldeh\dc (\I) 
o-Bromobenz.ildehvde (VII) 
p-Chlorobcnzaldchvde (VIII) 
J
 Administered ι ρ in propylene ekcol (n = -1) 
Dose in 
mmul kg 
2 0 
2 0 
2 0 
2 0 
Incre.iv: in 
umol SH eq 
4 7 ± 1 7 
27 1 ± 3 6 
41 3 ± 8 1 
3 8 ± 0 5 
'7 Dose ± 
SEM 
1 3 ± 0 4 
6 8 ± 0 9 
10 4 ± 2 0 
0 9 ± 0 1 
Table 2. Increase of urinary thioether excretion of rats in the first 2k h 
after a single dose of the sodium salts of o-chloro-and p-chlorobenzy1 sul 
Compound1 Dose in Increase in 
mmol/kg μπιοί SII eq 
<%• Dose ± 
SEM 
Sodium ()-(.hlorobenz\l sulphate (X) 1 0 
Sodium p-chloroben7\l sulphate {XI) 1 0 
42 6 ± 3 7 
29 0 ± 2 3 
21 2 ± 18 
145 ± 1 2 
1
 Administered ι ρ in 0 9Γί· sdirne (л = 4) 
Table 3. Ή η.m. r. data o f the reference compounds
 R_( t 
SHCOCH 
ι 3 
M H 
С ООН 
No 
ƒ 
TMS js internal reference (ό - 0 00 ρ ρ m lJ 
¡и 
IV 
о; 
α. 
2 00 (s, 3 H) 2 78 l , c (1 H). 2 97" < ( I H). 
3 m (s. 2 III, 4 64' « (1 H). 6 92-7 50 (m. 4 H) 
2 00 (s, 3 H). 2 79" < (1 H). 2 98b e (1 H) 
3 89 (s, 2 H), 4 64' ' (1 H), 7 18-7 47 (m, 4 H) 
2 00 (s. 3 H). 2 79ь [ (I II), 2.99b · (1 H), 
3 89 (s. 2 H), 4 64e · (1 H), 7 04-7 62 (m. 4 H) 
1 80 (s. 3 H). 2 52 (1 H). 2 73 (1 H), 
3 66 (s. 2 H). 4 33 (1 H), 7 25 (s, 4 H), 
8 20 (d. 1 H) 
Abbreviations s = singlet, d = doublet, m = multiplet 
I o-fluorobenzylmcrcaptunc acid 
II. o-chlorobenzylmercaptunc acid 
III* o-bromobenzylmcrcapturic acid 
IV. p-chlorobcnzylmercatunc acid 
* In ΟΟ,ΟΟ. proton of COOH or NH exchanged with CD3OD, resulted in no chemical shift 
assignment, compound IV in d6-DMSO 
" JAB - JBA = 16 0 Hz 
' J B X = 9 0 Hz 
• JA» = 5 5 Hz 
Table 4. Relative abundance of M+ and prominent fragments (m/e) of the 
reference compounds at 20 eV, by direct insertion 
( ompuund M Prominent fragments (me) 
1 
II 
I I I 
\\ 
2-\ (-41) 
:S7:H9 оьт) 
H I 313 I4W17) 
:S7'2S9 (41) 10) 
212 (62) 
228/23(1 (6(1/22) 
272 274 (71 65) 
228 230 (4(1,14) 
162 (71) 
162 (100) 
162 (100) 
162 (90) 
109 (100) 
I2S,I27 (95'34) 
169/171 (79 87) 
12V127 (100/1Ï) 
'Retami: .ibundam-i. in brackets ( 4 ) 
I и nunroben7>linercaptunc .icid 
M о chlorobenzilmcrcapturic acid 
I I I o bromoben/ilmertaptunt acid 
IV ρ Lhlorobenzilmerc ipturic acid 
100 
о 
60· 
40-
20· 
umol SH ее; 1 
ι-Η 
con 
— t — I 
PCP IX 
IX 
PCP 
Fig. 1. Urinary thioether excretion (expressed in ymol SH eq. ± SEM) of male rats 
(n = 4, con. = control) in the first 24 h after a single IP dose of o-chlorobenzy1 
alcohol (1.0 mmol/kg IX in propylene glycol) with and without pentachlorophenol 
pretreatment (0.05 mmol/kg PCP in propylene glycol, IP, 45 min prior to 
administration of IT) 
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100 
о 
60 
40 
20 
umol SH eq. 
con руг IX 
IX 
* 
руг 
VI 
—ι— 
VI 
руг 
Fig. 2. Urinary thioether excretion (expressed in ymol SH eq. ± SEM) of male rats 
(w = 't, con. = control) in the first 2h h after a single dose of o-chlorobenzy 1 
alcohol (2.0 mmol/kg IX in propylene glycol, IP) or o-chlorobenzaldehyde 
(2.0 mmol/kg VI in propylene glycol IP) with and without pretreatment with 
pyrazole (3-0 mmol/kg in propylene glycol, IP, 30 min prior to IX or VI) 
100-
80-
60· 
40 
20 
umol SH eq 
con eth IX 
IX 
eth VI 
VI 
eth. 
Fig. 3. Urinary thioether excretion (expressed in umol SH eq. ± SEM) of male rats 
(и = h, con. = control) in the first Ih h after a single dose of o-chlorobenzy1 
alcohol (2.0 mmol/kg IX in propylene glycol, IP) or o-chlorobenzaldehyde 
(2.0 mmol/kg VI in propylene glycol, IP) with or without simultaneously 
treatment with ethanol (2 χ 5.0 mmol/kg in water, oral) 
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Ή NMR- and mass-spectra as respectively o-chlorobenzylmercapturic acid (JI) 
and p-chlorobenzylmercapturic acid {IV) (see Tables 3 and Ό , which were 
identical with those obtained after administration of the corresponding benzyl 
alcohols or benzaldehydes. 
Pretreatment with pentachlorophenol (PCP) resulted in a drastica! decreased 
urinary thioether excretion after a single IP dose of o-chlorobenzyl alcohol 
(IX). PCP treated controls showed no difference with other controls in this 
regard (Fig. 1). 
Pretreatment with pyrazole caused an increase in urinary thioether excretion 
after the same dose of o-chlorobenzyl alcohol, whereas after a single IP 
administration of o-chlorobenzaldehyde a slight but significant decrease in 
thioether excretion was observed. Again no difference due to pretreatment was 
found in controls (Fig. 2). 
Though ethanol administration did not influence the thioether excretion in 
controls, its administration simultaneous with that of o-chlorobenzyl alcohol 
or o-chlorobenzaldehyde resulted in a significant increase in the amount of 
urinary thioethers (Fig. 3). 
DISCUSSION 
Based on previous results of our work and data from the literature (see 
INTRODUCTION) a metabolic pathway was postulated for the biotransformation of 
a substituted aromatic aldehyde to the corresponding benzylmercapturic acid 
via a sulphate ester. 
This reaction sequence is represented in Scheme 1. 
In accordance with this postulate a clear increase in urinary thioether 
excretion was observed after administration of the sodium salts of o-chloro­
benzyl sulphate and p-chlorobenzy1 sulphate. The mercapturic acids, isolated 
from the urines were identical with those, isolated after administration of 
the corresponding o- and p-substituted benzaldehydes and benzyl alcohols. 
Moreover, pretreatment of the rats with pentachlorophenol, a selective 
inhibitor (Mulder and Meerman 1978) of the sulphotransferase-system (Roy 1971) 
(step c, Scheme 1), produced a strong decrease in mercapturic acid excretion 
compared with a group to which o-chlorobenzyl alcohol had been administered 
only. 
From these experiments we can conclude, that a metabolic pathway, giving 
the same mercapturic acids via a different ester as intermediate (for instance 
113 
Scheme 1. Metabolic pathway of aromatic aldehydes and alcohols to mercapturic 
acids 
COOH 
acetate or glucuronide) is improbable. 
A theoretically possible route via a direct addition of the glutathione to 
the aldehyde and subsequently a reductive step, yielding the same mercapturic 
acids could also be excluded, as from this route after pretreatment with 
pyrazole, an inhibitor (Goldberg and Rydberg 1969) of the alcohol dehydrogenase 
system (McMahon 1971) (step b, Scheme 1) a rise in thioether excretion would 
have resulted after administration of o-chlorobenzaldehyde, whereas a fall was 
observed. 
Bray et al. (1958) showed that administration of p-substituted (OCH3, NO2, 
CI) benzyl alcohols resulted in a hardly perceptible urinary thioether excre-
tion (0-3% dose) in the rabbit and recently the same result was obtained by 
v. Doorn et al. (I98I) after administration of p-methylbenzyl alcohol to rats 
(1.3% dose). 
We showed that especially the ortho-substituted and not the para-substitu-
ted benzyl alcohols and benzaldehydes caused an enhanced thioether excretion 
(Rietveld et al. I98O; Seutter-Berlage et al. 1982). 
IIS 
From the chemical structure and the work of Blomquist (I966) and Jacobs et 
al. (IS??) it might be expected that an electron-withdrawing group in either 
ortho or para position in an aromatic aldehyde would promote the reduction of 
the aldehyde to the corresponding alcohol and so the mercapturic acid excretion 
in both cases. However, Table 1 shows that within a series of substituents with 
growing electron-withdrawing properties (F > CI > Br) the substituents 
appeared to stimulate the formation of mercapturic acids according to size 
(Br > CI > F) and o-chlorobenzaldehyde caused a much higher mercapturic acid 
excretion than p-chlorobenzaldehyde. 
From this we can conclude that the formation of the mercapturic acids 
cannot be attributed to electronic effects only but mainly depends on the 
size of the substituent in ortho-position. This influence of steric hindrance 
in o-position is in accordance with the work of Shiobara (1977) who found 
that an aromatic aldehyde bearing a carboxyl-group in the ortho-position 
attached either directly or indirectly to the benzene nucleus is mainly reduced 
to the corresponding alcohol in vivo, whereas a carboxyl-group in meta- or 
para-position led mainly to the oxidized metabolites. 
The latter biotransformation, the oxidation of an aldehyde to the corres-
ponding acid (step a, Scheme 1) is catalyzed by aldehyde dehydrogenase 
(McMahon I97I)· Ethanol is oxidized in the organism to acetaldehyde and 
subsequently to acetic acid. This means that in simultaneous administration 
of ethanol with o-chlorobenzyl alcohol (IX) or o-chlorobenzaldehyde (Vi) the 
ethanol and acetaldehyde will act as competitive substrates for the mentioned 
enzyme-systems, so that less acid is formed from, IX and VI and more 
mercapturic acid should be expected. In simultaneous administration of either 
IX or VI with ethanol the excretion of mercapturic acid indeed increased. 
In summary we may conclude that biotransformation of an aromatic aldehyde 
via alcohol and a reactive sulphate ester to the corresponding mercapturic 
acid depends on 
a) the steric hindrance due to a substituent in ortho-position, 
b) (competitive) inhibition of aldehyde dehydrogenase. 
The toxicological consequence of this biotransformation is that sulphate 
esters are formed as intermediates, which generally act as alkylating agents, 
so, that in the absence of a sufficient offer of SH-groups, such as of 
glutathione, other groups might be alkylated. 
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Chapter 3.3 
Substituent effects during the rat liver aldehyde 
dehydrogenase catalyzed oxidation of aromatic 
aldehydes. 
INTRODUCTION 
The aromatic aldehydes in this study belong to the chemically reactive carbonyl 
compounds. The human body can be exposed to these exogenous aldehydes directly 
by ingestion, inhalation or via skin contact. However, more often the aldehydes 
are produced during the biotransformation of other compounds, commonly metabolic 
precursors such as p-xylene, 2-chlorobenzylidene malononitri le (CS) and 
It.ó-benzyl idene-a-D-glucose (BC) (Patel et al. 1978; Rietveld et al. 1983; 
Kochi et al. I985). 
In general, the aldehydes are potentially toxic substances or intermediates 
(O'Donnel 1982). Detoxication or inactivation of aldehydes in an organism can 
occur usually via more than one metabolic pathway. The main biotransformation of 
substituted benzaldehydes in the mammalian cell is the NAD-dependent aldehyde 
dehydrogenase catalyzed oxidation to corresponding carboxylic acids (Weiner I98O; 
McMahon 1982). The acids are excreted as such or as conjugates (Caldwell 1982). 
A minor competitive metabolic transformation is the enzymatic reduction of 
benzaldehydes to benzylalcohols essentially by two aldehyde reducing systems: 
the NAO(H)-dependent alcohol dehydrogenases and the NADPH-dependent aldehyde 
reductases (McMahon 1982; Bosron and Li 1980; von Wartburg and Wermuth I98O). 
Recently, we reported, that in vivo ort&o-substituted benzaldehydes can be 
biotransformed to N-acetyl-S-iort/io-substi tuted benzyl )cysteines (Seutter-
Berlage et al. I982). Furthermore, it appeared that the urinary excretion of 
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these mercapturic acids by rats administered with ortho-substituted benzaldehydes 
enhances upon an increase in the size of the substituent (e.g. Br > CI > F). 
On the contrary the administered para-substituted compounds were hardly excreted 
in the urine as mercapturic acids. Therefore, we suggested that steric hindrance 
slows down the enzyme-catalyzed oxidation to the benzoic acid, consequently the 
enzymatic reduction to benzyl alcohol becomes more important. Further conjugation 
of the alcohol presumably with sulfate and subsequent reaction with glutathione, 
results ultimately in the formation of benzyImercapturic acid (Rietveld et al. 
1983). 
The above suggestion is in accordance with the findings, of Shiobara (1977) 
and Shiobara and Ogiso (1979), who found ¡n vivo and in vitro that 
phthalaldehydic acid, bearing an ortfto-carboxyl group is predominantly reduced 
to the corresponding alcohol. The meta- and para-carboxyl substituted isomers, 
however, were largely oxidized via the main metabolic pathway for aromatic 
aldehydes (Weiner I98O; McMahon 1982). 
The present paper deals with the measurement of aldehyde dehydrogenase 
activity in yeast and subcellular rat liver fractions with ortho- and para-
substituted halobenzaldehydes. In addition, we describe and evaluate the steric 
influence of ortTzo-subst ¡ tuents on the in vitro oxidation of benzaldehydes. 
MATERIALS AND METHODS 
Chemicals. Substituted benzaldehydes, 2-iodobenzyl alcohol, pyrazole, 
p-toluidine and propylene glycol were purchased from Janssen Chimica, Beerse, 
Belgium. Silicagel 60 (70-230 mesh) for column chromatography, trichloroacetic 
acid, 2-mercaptoethanol, Fol in-Ciocalteu Phenol reagent, triton X-100 
(polyoxyethylene p-6-octylphenol ) and all inorganic chemicals were products of 
Merck AG. Darmstadt, FRG. NAD, free acid, grade II, 98% and aldehyde 
dehydrogenase from yeast, EC 1.2.1.5, (specific activity of 15 units/mg protein) 
were obtained from Boehringer Mannheim B.V., FRG. Albumin bovine 98 - 99%. 
rotenone 95 - 98% were supplied by Sigma Chemical Company, USA. 
Synthesis of iodobenzaldehydes. 2-lodobenzaldehyde was synthesized by oxidation 
with sodium d¡Chromate of the corresponding 2-iodobenzyl alcohol according to 
Lee and Spitzer (1970). k-lodobenzaldehyde was synthesized from p-toluidine 
(Vogel 1979). 
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Animals. Male adult Wistar rats (6 weeks old, about 200 g) from TNO-stock 
(Zeist, The Netherlands) were used. 
Apparatus. All spectrophotometric measurements were performed with a Gary 118 
spectrophotometer ultraviolet/visible. Suprasil quartz cuvettes (3 nil, 10 mm) 
no. IIO-QS (Helma Benelux, Den Haag, The Netherlands) were used. 
An IEC/B-60 ultracentrifuge, Damon/IEC Division (Mass., USA) was used for 
fractionation of rat liver. 
Subaellular fractionation of rat liver. Male adult Wistar rats were killed by 
decapitation. The livers were removed immediately after perfusion with 
physiological saline solution and put into a plastic bag on ice. All further 
steps were carried out at 0 to k C. The weighed 1ivers were put into ice-cold 
buffer containing 0.25 M sucrose, 10 mM sodium phosphate (pH 7·^) and 2 mM 
mercaptoethanol (referred to hereafter as sucrose solution). In the sucrose 
solution the livers were cut into small pieces and were homogenized in a 
Potter-Elvehjem type homogenizer to make a 101 (w/v) homogenate. Further 
fractionation was in principle by the method of Koivula and Koivusalo (1975)· 
The homogenate was centrifuged for 5 min at 700 χ g. The pellet was resuspended 
in 30 ml sucrose solution and was centrifuged as before. The combined 
supernatant was centrifuged for 10 min at ¿»500 χ g and the pellet was washed 
twice with 30 ml of the sucrose solution. The final pellet containing the 
mitochondria was resuspended in 8 ml sucrose solution and was quickly frozen 
with solid carbon dioxide/acetone mixture (Mitochondrial fraction). The combined 
supernatants were centrifuged for 15 min at 12000 χ g. The new supernatant was 
carefully decanted and the pellet containing most of the lysosomes was discarded. 
Next the supernatant was centrifuged for 60 min at 100 000 χ g. The supernatant 
was decanted and frozen with solid carbon dioxide/acetone (Cytosolic fraction). 
The pellet was resuspended in 8 ml sucrose solution and was frozen like the 
cytosolic fraction (Microsomal fraction). All fractions were stored at -80 C. 
Isolation of aldehyde dehydrogenase from the mitoohondria. Solubilization of 
the membrane bound enzymes was performed with the help of a detergent 
(Triton X-100) and sonication according to Dehlinger and Schimke (1971)· 
During the isolation the fraction containing the enzymes was kept on ice. 
The frozen mitochondrial fraction was thawed and a volume of 0.16 M KCl 
solution was added until twice the original liver weight (w/v) was reached. 
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This suspension was homogenized with a Potter-Elvejhem homogenizer (1000 rev/min). 
To the homogenate 1^ 0 ul Triton X-100 was added and this mixture was shaken 
until homogeneously. Hereafter the homogenate was sonicated 30 sec and 
subsequently centrifuged for 60 min at 100 000 χ g. The supernatant containing 
the aldehyde dehydrogenase was divided into 2 ml portions and further purification 
was not attempted. Both the supernatant and the pellet were frozen in with solid 
carbon dioxide/acetone and stored at -80 C. 
Isolation of aldehyde dehydrogenase from the microsomes. All the procedures 
below were performed at 0 to 4 С The frozen microsome fraction was thawed and 
sucrose solution added until twice the original weight of the liver was reached. 
This suspension was homogenized and 140 μΐ of Triton X-100 added. This detergens 
was divided homogeneous by shaking. After sonication (30 sec) the homogenate 
was centrifuged for 60 min at 100 000 χ g. The supernatant containing the 
aldehyde dehydrogenase and the pellet were frozen with solid carbon dioxide/ 
acetone. Both fractions were stored at -80 С The thawed supernatant was used 
for determinations of the microsomal dehydrogenase activity. 
Enzyme assays. All assays were performed in duplicate at 22 С or 37 C. 
The aldehyde dehydrogenase activity was assayed spectrophotometrically with 
halobenzaldehydes as substrates by following the reduction of NAD at 340 nm 
(езі.о for NADH is 6220 M^.cm" 1). 
The enzyme assay of yeast aldehyde dehydrogenase activity was in principal 
according to Deitrich et al. (1962). The reaction mixture (3 ml) contained 
10 mM sodium pyrophosphate (pH 9.6), 0.5 mM NAD, 30 pg/ml enzyme and 50 u' of 
an aldehyde solution in propylene glycol. 
The reaction was started by the addition of a certain benzaldehyde solution 
and the assay was performed at 22 С The reference cuvette contained only 1OmM 
sodium pyrophosphate (pH 9·6)· 
The rat liver aldehyde dehydrogenase activity was assayed by a modification 
of the method of Tottmar et al. (1973)· The assay mixture (3 ml) contained 
50 mM sodium pyrophosphate (pH 9·6), 0.5 mM NAD, 0.1 mM pyrazole, 2 yM rotenone, 
50 μΐ of an aldehyde solution in propylene glycol and 100 - 300 μΐ enzyme 
fraction (protein content about 6 mg/ml). 
Pyrazole was included in all reaction mixtures to inhibit alcohol dehydroge­
nase activity. The mitochondrial NADH-oxidase inhibitor rotenone dissolved in 
methanol was added to the assay mixtures (0.2% of the final volume) containing 
the cytosolic or mitochondrial enzyme fractions. 
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The cuvette containing the mixture without enzyme was warmed up (37 С or as 
otherwise indicated) for 5 min before the reaction was started by the addition 
of the enzyme fraction. The reference cuvette contained 50 mM sodium 
pyrophosphate (pH 9.6). 
Protein determination. Protein was determined by the method of Lowry et al. 
(1951) using bovine serum albumin as a standard. 
Evaluation of initial vates and kinetics of halobemaldehyde oxidation. 
Initial rates of the various aldehyde dehydrogenase-catalyzed oxidations of 
ortho- and para-substituted halobenzaldehydes were determined by measuring the 
rate of increase in absorbance of NADH. The reaction rates were linear for at 
least 3 minutes. The rates were corrected for a substrate independent blank 
reaction and for the absorbancy of some benzaldehydes when necessary. 
Initial rates of oxidation of the halobenzaldehydes were compared using a 
para/ortho specificity factor according to Pelsy and Klibanov (1983). 
These authors defined this factor as the ratio of the initial rate of the 
enzymatic oxidation of para-substituted benzaldehydes to that for the ortho-
isomer. Maximal rates of oxidation and apparent К values for the aldehyde 
dehydrogenase from the various rat liver fractions and yeast with the 
halobenzaldehydes were determined at first from double-reciprocal plots. 
Final kinetic constants were calculated statistically by fitting the data to 
equation ν = V . S /К + S , by assuming equal variances for the observed 
velocities (22). The calculations were performed on the Olivetti Personal 
Computer MZ^ t using a nonlinear least squares program (MULTI), which provided 
К , V and the standard deviations of their estimates (Yamaoka et al. I98I). 
m max 
Rotational energy of the sigma bound aromatic carbon-carbonyl carbon of some 
ortho- and pora-halobenzaldehydes was computed, using Chem-X, developed and 
distributed by Chemical Design Ltd, Oxford, England, as available of CAOS/CAMM 
Centre, University of Nijmegen. 
RESULTS 
least aldehyde dehydrogenase. The activity with various ortho-haiobenzaIdehydes 
as substrates was determined. 
The initial rates of oxidation were measured over a period of at least 
3 minutes with different concentrations of aldehydes ranging from 10 to 200 μΜ. 
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Inhibition of the oxidation rate was observed at higher benzaldehyde 
concentrations (>10 mM). 
As presented in Table 1, it was possible to obtain the maximal rates of 
oxidation (V ) and apparent К values of some ortfto-halobenzaldehydes. 
max
 r r
 m 
The Michaelis constants of the 2-fluoro-, 2-chloro- and 2-bromobenzaldehyde 
varied hardly. The maximal oxidation rates, however, were drastically decreased 
upon an increase of the size of the halogen atom (Br< CI < F ) . 
Cytoplasmic fraction of rat liver. This unpurified fraction could oxidize the 
various aldehydes in this study. 
The initial reaction velocities for the enzyme catalyzed oxidation of the 
ortho- and para-halobenzaldehydes were determined (results are not shown). 
However, the activity of the crude cytoplasmic aldehyde dehydrogenase preparation 
differed significantly after each isolation and with different substrate 
concentrations. It appeared further that the blank reaction was much faster than 
the oxidation of a certain benzaldehyde. 
Pyrazole was added, without showing any effect. The presence of rotenone did 
enhance slightly the activity of the aldehyde dehydrogenase in this liver 
fraction. 
It was not possible to determine the К and V values with reasonable r
 m max 
precision. 
Mitochondrial fraction of rat liver. Aldehyde dehydrogenases in the mitochondrial 
fraction were not purified. The various crude enzyme preparations could be 
investigated for their halobenzaldehyde specificity. 
The double reciprocal plots used initially for determination of К and V 
r r
 ' m max 
values were curved, suggesting the presence of more than one enzyme. 
It can be seen from the data (Table 2) that there were probably two enzymes 
in this subcellular liver fraction. Enzyme J with low К values (uM) and 
' m 
enzyme IT with high К values (mM) for the respective halobenzaldehydes. 
The Michaelis constants and V values for enzyme JJ were computed with some 
max '
 r 
degree of reliability according to Tottmar et al. (1973)· Enzyme I might exercise 
some influence on the reaction rates at higher aldehyde concentrations. 
As shown in Table 2, it appeared that there were differences between the 
maximal rates of oxidation (V ) of the various ortho- and para-substituted 
max ^ 
compounds, both with mitochondrial enzyme I and JJ. 
From the К values for enzyme J presented in Table 2 it is apparent that the 
values are increased upon an increase in the size of the halosubstituent. 
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Table Ί. Michaelis constants (К ) and maximal velocities 
m
 Ь (V ) a for yeast aldehyde dehydrogenase with various 
benzaldehydes at 220C and pH 9.6. 
The reaction mixture (3 ml) contained 10 mM sodium pyrophosphate 
(pH 9.6), 0.5 mM NAD, 3C vg/m\ enzyme and 50 μΐ of benzaldehyde 
soin, in propylene g'yco". 
SUBSTRATE 
benzaldehyde 
2-f1uorobenza1dehyde 
2-ch1orobenza1dehyde 
2-bromobenza1dehyde 
2-¡odobenzaldehyde 
К ± S.D. 
m 
13 
16. 
17 
16 
(wM) 
± 2 
5 ± 0.8 
± k 
± 3 
с 
(nmol 
V i S.D. 
max 
NADH/min/mg protein) 
168 ± 17 
166 ± k 
35 ± 3 
17.2 ± 0.6 
_ с 
Corrected values: see materials and methods 
Measurements performed with lyofilisate of aldehyde 
dehydrogenase (l'i.7 mg/123 mg protein) 
C
 2-lodobenzaldehyde precipitated in reaction mixture 
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Table 2. К and the standard deviations of their estimates for rat liver aldehyde dehydrogenase of the 
mitochondrial fraction {Enzyme I and Enzyme JJ ) and the rat liver aldehyde dehydrogenase of the microsomal 
fraction (Enzyme JJl) with various o- and p-halobenzaldehydes at 370C and pH 9.6. 
The reaction mixture (3 ml) contained 50 mM sodium pyrophosphate (pH 9.6), 0.5 mM NAD, 0.1 mM pyrazole, 
2 μΜ rotenone, 50 μ) of a benzaldehyde soin, in propylene glycol and 100 μ) enzyme fraction. 
SUBSTRATE 
ENZYME I 
К 
m 
(μΜ) 
max 
(nmol NAD/min 
per mg protein) 
ENZYME IIa 
К 
m 
(μΜ) 
max 
(nmol NADH/min 
per mg protein) 
ENZYME IIJ 
К 
m 
(μΜ) 
max 
(nmol NADH/min 
per mg protein) 
benzaldehyde 20 ± 8 
2-fluorobenzaldehyde 8 ± 1 
2-chlorobenzaldehyde 6 ± 2 
2-bromobenzaldehyde 
2-i odobenza1dehyde 
Jt-fluorobenzaldehyde 12 ± 2 
ll-chlorobenzaldehyde 31 ± 2 
't-bromobenzaldehyde 39 ± 7 
't-i odobenza 1 dehyde 81 ± 2 
12 ± 3 
А Ь 
n.d. 
8.9 ± 0.9 
32.8 ± 0.6 
28.9 ± 0.9 
14.1 ± 0.7 
n.d.b 
7.5 ± 0.2 
20.9 ± 0.6 
24.5 ± 1.7 
35.9 ± 5-9 
1805 ± 279 
703 ± 321 
_c 
379 ± 109 
n.d.b 
2057 ± 214 
826 ± 45 
616 ± 60 
1103 ± 386 
38.9 + 4.3 
18.8 ± 1.9 
_c 
1.3 ± 0.1 
n.d.b 
39-7 ± 1.9 
30.6 ± 1.0 
23.6 ± 1.7 
12.8 ± 3.5 
733 ± 520 
822 ± 227 
63 ± 18 
67 ± 47 
n.d.b 
859 ± 355 
1159 ± 307 
617 ± 56 
241 ± 29 
45 ±17 
20 ± 3 
1.60 ± 0.08 
1.7 ± 0.2 
n.d.b 
56 ±13 
139 ± 23 
112 ± 5 
82 ± 3 
К , V values calculated according to Tottmar et al. (1973). 
n.d. = not determined, compound precipitated in the reaction mixture. 
Kinetic parameters could not be determined with some exactitude, but 700 > К > 400 and 18 > V > 2. 
r
 m max 
For enzyme II the К values were obtained with the same substrates. 
' m 
These values were in the mi 11¡molar range and decreased from fluoro-substi tuent 
to iodo-substi tuent. 
Miarosomal fraction of rat liver. The aldehyde dehydrogenase-catalyzed oxidations 
of para- and ort/zo-halobenzaldehydes were measured. 
The К and V values for this subcellular liver fraction could not be 
m max 
determined with accuracy with 2-chloro- and 2-bromobenzaldehyde. 
Table 2 (enzyme JIJ) shows that the maximal oxidation rates of these two 
substrates were relatively low as compared with 2-fluorobenzaldehyde. 
Initial rates were not affected by addition of rotenone to the reaction mixture. 
The addition of 0.1 mM pyrazole resulted in somewhat higher oxidation rates for 
the various benzaldehydes than without the alcohol dehydrogenase inhibitor. 
The kinetic parameters of the respective ortho- and pora-halobenzaldehydes 
are presented in Table 2 (enzyme JJJ). 
Positional specificity of aldehyde dehydrogenases. The microsomal and 
mitochondrial liver fraction could be examined for the positional specificity 
of aldehyde dehydrogenases in the oxidation of halobenzaldehydes to corresponding 
benzoic acids. 
The para/ortho specificity factor of Pelsy and Klibanov (1983) was used. 
With different concentrations of ortho- and pom-halobenzaldehydes the 
initial reaction rates of oxidation (mean, η = 3) were determined for the 
enzymes in both subcellular liver fractions (Table 3). 
DISCUSSION 
From influence of the steric hindrance of halogensubstituents was 
investigated in vitro by measuring the activity of aldehyde dehydrogenase of 
yeast and of unpurified subcellular rat liver fractions with series ortho-
and para-halobenzaldehydes as substrates. 
From the results presented in Table 1 it is apparent that the К values 
of the various ort/20-halobenzaldehydes for yeast aldehyde dehydrogenase are 
between 10 and 20 μΜ. However, the difference in the maximal rate of oxidation 
of 2-fluorobenzaldehyde in comparison with the related halobenzaldehyde is 
remarkable. It appears that the aldehyde oxidation of 2-fluorobenzaldehyde 
(and benzaldehyde) occurs much faster than with the other aldehydes. 
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Table 3 Positional specificity of the various aldehyde dehydrogenases in the 
mitochondrial and microsomal fractions of rat hepatic cells in the reaction 
with halobenzaldehydes. 
Condi tions: 0.05 or 0.5 mM Halobenzaldehyde, 0.5 mM NAD , 50 mM sodium pyro­
phosphate (pH 9-6), 0.1 mM pyrazole, 2 μΜ rotenone, 100 μΐ enzyme fraction at 37 C. 
I = mitochondrial enzyme I3 II = mitochondrial enzyme IT. 
BENZALDEHYDE CONCENTRATION 
(mM) 
para/ ortho 
MITOCHONDRIAL MICROSOMAL 
Fluoro 
Chloro 
Bromo 
0.05 
0.5 
0.05 
0.5 
0.05 
0.5 
I 
0.2 
0.5 
1.1 
I + I 
0.3 
1.0 
2.1 
3.0 
26 
36 
Fig. 1. R o t a t i o n a l energy (van der Waals) of some o r t h o -
and para-halobenzaldehydes. 
energy 
ORTHO-MLOGENBENZALDEHYDE PARA-HALOGEHBENZALDEHYDE 
Η χ к chloro · · · bromo o o o iodo 
β о 
о о 
о « • о 
О К » β 
О«. „ в
 я
 в * · . 0_ о 0 o o o o o 0 и
 # # \ 0Ооооо° 
М М « * . " « " ' · · " " " « « д к , " 
"i;;joo0oeoooooj;.>««»;;;oooooooojj;;.>« 
- 1 8 0 o - 9 0 · 9 0 * ΙΘΟ* -180° 
-90* О" 9 0 ° 180* 
angle ОСу-С^С^ 
13<» 
Taft (1952) demonstrated that H and F as ortfro-substituents did not exercise 
a steric influence during the hydrolysis of benzoates. When the same comes 
about during the enzyme oxidation of oriuo-halobenzaldehydes, it can be concluded 
that the oxidation is strongly influenced by steric bulky groups in the ortho-
position of the benzene ring. The findings in Table 1 confirm the results of 
Pelsy and Klibanov (1983) that according as the size of the halogen increases 
there is a decrease in the enzymatic oxidation of the ortfto-halobenzaldehyde. 
The investigation of the unspecific aldehyde dehydrogenase activity in the 
rat liver was possible after fractionization of rat liver homogenate in three 
different enzyme-containing fractions, which contain probably five different 
types of aldehyde dehydrogenase; two in cytoplasm, two in mitochondria and one 
in microsomes (Koivula and Koivusalo 1975)· 
There was some aldehyde dehydrogenase activity in the cytoplasmic fraction 
with the various halobenzaldehydes. However, the cytoplasmic aldehyde dehydro­
genase activity can account only for 10% or less of the total aldehyde 
dehydrogenase activity when measured at mil limolar aldehyde concentration 
(Koivula and Koivusalo 1975; Tottmar et al. 1973). 
It can be concluded from the results presented in Table 2 that the 
mitochondrial aldehyde dehydrogenase activity is high. This activity may 
account for kS - 50% of the total aldehyde dehydrogenase activity in the rat 
liver (Koivula and Koivusalo 1975). According to the results of Tottmar et al. 
(І97З) it is demonstrated that there are at least two unspecific aldehyde 
dehydrogenases. One enzyme is probably in the mitochondria with low К {I) for 
halobenzaldehydes and the other with high К -activity (IT), membrane bound 
outside the mitochondria (Table 2) (Koivula and Koivusalo 1975; Tottmar et al. 
І97З)· The activity of enzyme II contributed slightly to the total mitochondrial 
aldehyde dehydrogenase activity, when measured at low aldehyde concentrations. 
Furthermore, it is notable that there was a large affinity of ortuo-halobenzal-
dehyde for enzyme J. It seems that the affinity for this enzyme is promoted by 
halogen-substituents in ortho-position. This may be the reason that the maximal 
rates of oxidation of 2-fluoro- and 2-chlorobenzaldehyde were higher than those 
of the pora-isomers. However, the V values of the various halobenzaldehydes 
tend to indicate that the enzymatic oxidation slows down for both enzymes 
(I and 11) when the size of the halogen in ortfco-position increases from 
fluoro to iodo. 
According to Tottmar et al. (1973) a high К aldehyde dehydrogenase for 
benzaldehydes in the mil limolar range was present in the microsomal fraction 
of rat liver. This subcellular fraction can contain even 35 - ^SX of the total 
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aldehyde dehydrogenase activity, when measured at high aldehyde concentration 
(Koivula and Koivusalo 1975). 
It can be seen from the data in Table 2 that probably steric effects 
contribute to the low maximal oxidation rates of 2-chloro- and 2-bromobenzalde-
hyde. Further, it is apparent from the same data that 2-bromobenzaldehyde is 
oxidized slightly faster then the chi oro-isomer. This may be explained by 
considering the orientation of the various halobenzaldehydes to the microsomal 
enzyme as a part of the mechanism for aldehyde dehydrogenase oxidation. 
We studied the rotational energy (van der Waals), needed to get a suitable 
orientation of the electrophi1ic carbonyl carbon atom of a certain aldehyde to 
the aldehyde dehydrogenase. It can be concluded from the data in Fig. 1 that 
the rotation about the sigma-bound aromatic carbon-carbonyl carbon of both 
2-bromo- and '•-bromobenzaldehyde requires less energy in comparison to the 
respective chloro- and iodo-isomers. This means that probably the orientation 
of the carbonyl-carbon of each bromosubstrate is easier then of the other halogen 
substituents. A push-pull mechanism proposed by Deitrich et al. (1962) 
demonstrates that indeed orientation of the aldehyde may play an important role 
in a reaction mechanism. 
Finally, it is evident from the para/ortho specificity factors shown in 
Table 3, that particularly for the aldehyde dehydrogenase in the microsomal 
fraction this factor greatly increases upon an increase in the size of the 
halogen from fluoro to bromo. 
In summary the enzymatic oxidation of the microsomal aldehyde dehydrogenase 
is strongly influenced by steric effects of benzaldehydes, bearing a halogen in 
ortho-position. The rate of oxidation greatly decreases upon an increase in the 
size of the halogen. Therefore, we think that the microsomal aldehyde dehydro-
genase might be the principal enzyme responsible for oxidation of halobenzalde-
hydes in rat 1 i ver. 
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Chapter 3.4 
Metabolism and toxicokinetics of 2-chlorobenzaldehyde 
after intravenous and epicutaneous administration in 
the rat. 
INTRODUCTION 
The use of benzaldehydes for the synthesis of various important products in 
chemical industry and laboratory is very considerable. Moreover, the 
benzaldehydes are also produced in the living organism by enzymatic or 
non-enzymatic transformations of a large number of xenobiotics. 
From toxicological point of view the aromatic aldehydes belong to the 
potentially toxic compounds. Already, at medium dose they may cause distur­
bances of the respiration, the digestion, the blood pressure and the muscle 
contractions (Opdyke 1976; Kluwe et al. 1983). The benzaldehydes, e.g. 
't-methylbenzaldehyde, can inactivate in vivo the pulmonary and hepatic 
cytochrome Рц5о (Opdyke 1976; Patel et al. 1979)· Benzaldehyde, like other 
aldehydes and aldehyde containing essential oils may have strong irritating 
effects on the skin (Thomas 1958). 
Cutaneous exposure to benzaldehydes can be expected under certain 
circumstances. So 2-chlorobenzaldehyde might be produced when a moist skin is 
exposed to "CS-gas" (Corson and Stoughton 1928). CS and its chemical relatives 
react very fast with water (Patai and Rappoport 1962; Rietveld et al. 1986). 
Both in vitro and in vivo CS-hydrolysis to 2-chlorobenzaldehyde and malononitri le 
occurs (Cucine!1 et al. 1971; Jones 1972 and Leadbeater 1973). It is of interest, 
however, if despite the wellknown excellent barrier function of the skin 
(Scheuplein and Blank 1971; Montagna and Parakkel 197Ό , the lipophylic 
2-chlorobenzaldehyde penetrates through the skin whether or not coupled with 
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cutaneous biotransformation (idson 1975; Pannatier et al. 1978; Bronaugh 1985)· 
To our knowledge no quantitative data are available with respect to the 
percutaneous absorption and the cutaneous biotransformation of 2-chlorobenzal-
dehyde. Therefore, the present study was carried out to determine the 
percutaneous absorption, biotransformation and elimination of ll*C-label led 
2-chlorobenzaldehyde applied to the clipped dorsal skin of rats. 
MATERIALS AND METHODS 
Chemicals. 2-Chloro(carbonyl 1'*C)benzaldehyde was obtained from Amersham (UK). 
The specific activity of the compound was 7Ί0 MBq/mmol (20 mCi/пнтюі). This 
specific activity was reduced by addition of pure unlabelled material to 
10.2 MBq/mmol (0.275 mCi/mmol). Radiochemical purity was at least 98£. 
Non-labelled 2-chlorobenzaldehyde, 2-chlorobenzyl alcohol, 2-chlorobenzoic acid 
and glycine were purchased from Janssen Chimica (Beerse, Belgium). 
Instagel blue and Soluene 350 were supplied by Packard (Groningen, The 
Netherlands). Ethanolamine, N-acetyl-L-cysteine, aluminium TLC plates coated 
with silica gel H-60 (20x20cm) and all other reagents and solvents employed were 
of analytical grade obtained from Merck AG (FRG). 
2-Chlorobenzylmercapturic acid was synthesized by bromination of the benzyl 
alcohol with HBr and reaction of 2-chlorobenzylbromide with N-acetyl-L-cysteine 
(Clapp and Young 1970)· 2-Chlorohippuric acid was prepared on the analogy of 
the synthesis of hippuric acid (Vogel 1979). 
Animals. Male Wistar rats (Cpb-WU, l80-200g about 6 weeks old), TNO stock, 
Zeist (The Netherlands) were used. The animals were provided with food (Hope 
Farms, Woerden, The Netherlands) and water ad libitum throughout the course 
of the experiment. 
Under anesthesia (Sodium pentobarbital, dose IM 60 mg/kg) polyethylene 
catheters (I.D. O.'* mm, O.D. 0.8 mm) were placed into the femoral artery and 
the jugular vein and led subcutaneously to the nuchal area where they went out 
of the body. Rats were used for experiments after recovery from this operation. 
Minimal three days prior to experiments the rats were housed in individual 
glass metabolism cages (own construction Fig. 1), designed to separate urine 
from faeces and to trap expired air. Air was drawn through the metabolism cage 
(volume 2h 1) at a rate of ^00 ml/min by means of a peristaltic pump, so that 
the pressure inside the cage was somewhat lower than outside. This air was led 
TtO 
Fig.l. Schematic picture of the used metabolic cage of glass. 
NS 29 
NS 29 
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from the metabolism cage subsequently through three gas-washing bottles; 
the first one was emty and put on ice to trap expired water; the next two 
bottles contained 20% water in ethanolamine (v/v) to trap expired CO2. 
The trap solution was renewed every 6 hours. 
Injection studies. For the intravenous administration 25 vl/kg of the 
radiolabelled 2-chlorobenzaldehyde (specific radioactivity 1.83 mCi/ml) 
dissolved in 1 ml of a 2% aqueous solution of Tween-60, was injected via an 
infusion of about k minutes into the jugular vein cathether. The dose, 
administered intraperitoneally to rats, was 37-5 μΐ/kg. 
The time course of radioactivity in blood was compared with that after skin 
application. Urine, faeces and gas-washing bottle samples containing expired 
'''СОг were collected over the 2k h experimental period. 
Skin application of ^C-2-chlorobenzaldehyde. 16 Hours before topical 
applications of ^C^-chlorobenzaldehyde, hair on a part of the right dorsal 
area was shaved carefully with a clippers. 
For the percutaneous application a glass cup (I.D. 16 mm, O.D. 2k mm, 
heigth 10 mm) was fixed to the shaved ratskin with cyanoacrylate adhesive 
(Amycon's CY 2000, medium viscosity, Aldrich, Belgium) 1 hour before the start 
of the experiment (Fig.2). The cup was glued in such a way that no contact 
between the glass or the adhesive with the treated skin was possible. 
The radiolabelled benzaldehyde (dose 75 μΐ/kg; 1.83 mCi/ml) was pipetted 
undiluted in the cup, which was closed immediately afterwards with a glass-cover 
with the cyanoacrylate adhesive. The use of the glass cup prevented oral uptake 
and inhalation of the applied radioactive compound. The cup on the animal was 
fixed firstly by two pieces of crossed elastic adhesive bandages of 1.0 cm 
width (Leukoplast , Beiersdorf AG, FRG). Secondly crepebandage (width 6 cm, 
D 
Mölnlycke, FRG) and elastic adhesive bandage of 7-5 cm width (Tensoplast , 
Smith and Nephew Ltd., UK) was wound around the animal in such a way as not to 
hinder its respiration. 
At the end of the experiment the rats were killed by an intravenous overdose 
of sodium pentobarbital (Narcovet ). 
Sample collection. Blood was collected from femoral artery at time intervals 
during the experimental period of 2k h (or 72 h) after injection (or skin 
application) of 11,C-2-chlorobenzaldehyde. 
The blood samples were taken by connecting the arterial catheter outside the 
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Fig.2. Rat with a glass cup on a shaved part of the right dorsal skin. 
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cage with a syringe filled with heparinized saline and drawing the piston until 
the catheter was completely filled with freshly obtained blood. Then the 
connection was interrupted and with a second syringe filled with some grains of 
héparine the required amount of blood (0.1 ml) was collected. The catheter was 
again connected with the first syringe and the content of the catheter and 
0.1 ml saline was injected into the animal. 
Rat urine was collected at regular time intervals for 2k h (or 72 h) after 
the application. Faeces was collected quantitatively at daily intervals during 
the experiment. Samples from the gas-washing bottles were taken frequently via 
syringe-connected catheters without interruption of the air flow. 
Measurement of radioaotivity ^ C . The radioactivity was measured using a liquid 
scintillation counter, Packard TRICARB model Ί60 CD (Packard Instruments Co., 
Downers Grove, IL, USA). The counting efficiency was determined by an internal 
standard. 
Blood samples were fractionated in plasma and cells by centrifugation and 
they were stored at 4 С for less than 6 h. Bloodplasma was dissolved and 
counted in lnstagel/0.5 M HCl (9:1, v/v). Erythrocytes were dissolved in a 
mixture of soluene 350 and 2-propanol (1:1, v/v), bleached by addition of 
35% hydrogen peroxide and counted in lnstagel/0.5 M HCl (9:1. v/v). 
Urine and ethanolamine-C02 samples were weighed and counted directly in 
scintillation liquid (Instagel). Weighed samples of faeces were homogenized 
after addition of an equal volume of water. Aliquots of the faecal suspension 
were successively dissolved in soluene 350 at 50 0 C for 2 h, cooled at k С 
for 5 min, mixed with 2-propanol, bleached with 35% hydrogen peroxide counted 
in lnstagel/0.5 M HCl (9:1, v/v). Samples which were not directly processed 
were stored at -20 С 
The glass-cup used by the percutaneous experiments, was rinsed with methanol. 
The rinsing fluids were collected in glass-scintillation vials until counting 
(Instagel). The exposed skin was widely excised, cut into small pieces and 
solubilized in Soluene 350 at 50 С for 2 h. After cooling 2-propanol was 
added and the mixture was bleached by addition of 35% hydrogen peroxide. 
Duplicate samples were counted using a mixture of Instagel and 0.5 M HCl 
(9:1, v/v). 
Détermination of metabolite pattern in vrine. For the qualitative and 
quantitative determination of metabolites in urine, a thin layer chromatography-
radioautography method was used. The method consist of mixing concentrated HCl 
\hk 
and МНцСІ with urine samples (250 μΐ) with known radioactivity pH 3, extraction 
3 times with ethyl acetate and evaporation of the combined organic layer with 
a smooth stream of N2. The residue dissolved in 10 yl methanol was separated on 
aluminium thin layer plate (20x20 cm), coated with silica gel H-6O and with 
dichloromethane - methanol - acetic acid (20:4:1, v/v/v) as the eluent. 
A standard mix, containing unlabel led reference compounds (2-chlorobenzaldehyde 
and its known urinary main metabolites) dissolved in methanol, was also applied 
to the TLC-plate. After development of the TLC-plate the reference compounds, 
visible under UV-light, were marked with ^C-radloactive ink. Then in the dark 
a Kodak X-Ray film (no. XAR 5) was laid on the plate and kept in a cassette 
at -70 С for five days. The film was developed and the ll4C-label led metabolites 
were visible as black spots. These spots were copied on the TLC-plate with 
pencil and carbonpaper. The marked spots were cut from the TLC-plate, eluted with 
methanol and the radioactivity was counted after addition of Instagel. 
The metabolic pattern and quantity of the various metabolites was determined in 
the urine after percutaneous, intravenous and intraperitoneal dose of 
^С-2-chlorobenzaldehyde. 
RESULTS 
Kinetic studies. Cutaneously administered ll,C-2-chlorobenzaldehyde (75 yl/kg; 
60x106dpm) was well absorbed by the skin of rats as indicated by plasma 
radioactivity levels (Fig.3) and the high total recovery of radioactivity 
(Table 1). Figure 3 represents the time course of radioactivity in rat plasma 
of two individual experiments after cutaneous application of the labelled 
2-chlorobenzaldehyde. The slow increase in plasma-radioactivity was shown in 
all cutaneous experiments (n= 8) and the peak plasma concentrations of 4000-6000 
dpm/g (approximately 0.1% of the dose) were reached 10-15 h post dosing. 
Thereafter the plasma-radioactivity declined slowly with а С half-life ranged 
between 20 and 40 h. 
Following IV (25 vl/kg) and IP (37-5 yl/kg) 1'*C-2-chlorobenzaldehyde 
administration to rats, the radioactivity in plasma declined in a bi-exponential 
fashion over a 24 h period (Fig.4). The plasma radioactivity-time profiles after 
IV dose were very similar with those after IP dosing. The rate of elimination of 
plasma-radioactivity during the first elimination phase was rapidly with a ll*C 
half-life of 15.6 min; followed by a more slower second phase. No radioactivity 
was retained in the red blood cells upon administration of ^C^-chlorobenzaldehyde. 
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Fig.S. Plasma radioactivity profiles of total 1цС-1аЬе1led 
substances, in two rats after cutaneous application 
of 75 μΐ lltC-2-chlorobenzaldehyde/kg (60x106 dpm) . 
The curves were fitted to the sum of 2 or 3 exponentials 
using the nonlinear computer program Farmfit. 
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147 
The major portion of radioactivity was excreted in the urine. Small amounts 
were found in the faeces and in the exhaled air (Table 1). The cutaneously 
administered radioactivity was mainly recovered from urine, faeces and glasscup 
over a 3-day period. Urinary excretion of the radioactivity was found about kS% 
within the first 2k h post dosing: About ^5% of the 75 μΐ/kg dose of І Ц С - 2 -
chlorobenzaldehyde (60x106 dpm) was found in the glasscup and on the skin. 
The exhalation of ^ С О ^ over a period of 72 h was minimal, approximately 1% of 
the dose. 
Excretion of the l H C radioactivity administered via the two systemic routes 
(IV and IP) to rats was complete (>99^) within 2Ц h and proceeded largely by 
the renal route. The majority of the radioactivity ( 90%) was recovered in the 
0-6 h urine (Table 1). 
Metabolie studies. The results of the thin-layer radiochromatography analyses 
of the urinary metabolites extracted with ethyl acetate from rat urine 
(different time intervals), following cutaneous, intravenous and intraperitoneal 
administration of 'MC-2-chlorobenzaldehyde are shown in Fig.5- This figure shows 
that the TLC of the ethyl acetate extracts of the urine samples obtained with 
solvent chloroform - methanol - acetic acid (ΣΟ:**:! = v/v/v) resulted in several 
radioactive spots but no-one was attributable to ^C^-chlorobenzaldehyde 
(compound 1,Rr= 0.91, Fig.5)· The applied ethyl acetate-extraction from the 
acidified urine appeared to be efficient; more than 95% of the radioactivity was 
ethyl acetate-extractable. 
The metabolic patterns of urinary excreted metabolites following cutaneous 
application and systemic administration (IV an IP) of 1 ^ C^-chlorobenzaldehyde 
to rats were quite similar, apart from some quantitative differences. 
The majority of radioactivity on the aluminium thin-layer plate had the R, value 
0.55 and was designated as 2-chlorohippuric acid (reference compound 5, Fig.5). 
The other ^C-label led spots having R, values of 0.63, 0.76 and 0.85 co-migrated 
with the synthetic reference compounds 2-chlorobenzylmercapturic acid, 
2-chlorobenzoic acid and 2-chlorobenzy1 alcohol (compounds Ί, 3 and 2, Fig.5), 
respect ively. 
Radioactivity measurements of the radioactive spots on the TLC-plate allowed 
calculation of the percentage of the total urinary radioactivity attributable 
to the individual metabolites in the urine samples examined. The percentage 
distribution of the main metabolites of ^C^-chlorobenzaldehyde in the urine 
of rats after cutaneous and systemic administration is presented in Fig.6, 
7 and 8. The figures show that the principal metabolite in rat urine was 
ЙЗ 
Table 1. Percutaneous absorption and excretion of radioactivity in urine, 
faeces and exhaled air following percutaneous, intravenous (IV) and 
intraperitoneal (IP) administration of 2-chloro-(carbonyl 1 ц С ) benzaldehyde 
to male rats. 
% of administered radioactivity 
Dose (ul/kg) 
Urineb 0-12h 
12-2i»h 
24-1^ 
l»8-72h 
Total 
Faeces Total 
ll,C02 Total 
(exhaled) 
Glasscup 
On skin 
In skin 
Recovery 
Skin 
(n=8) 
75 
21.1±lit.62c 
2Ί.3± 6.33 
22.7± 6.65 
13.0+ 6.25 
81.1+13.98 
3.1± 1.25 
1.1+ O.W 
11.7± 8.27 
4.1+ 5.15 
1.6+ 1.27 
102.7± 9.12 
IV 
(n=6) 
25 
88.7±4.59C 
8.8+2.33 
97.5±3.57 
2.2+0.91 
0.4+0.32 
ІОО.І+З.56 
95, 
6. 
101, 
2 
0 
104 
IP 
(n=2) 
37.5 
.8+0.71c 
.0+0.28 
.8+0.99 
.4±0.14 
.3±0.00 
.5±0.85 
a For experimental conditions see Materials and Methods. 
b Urine collection time intervals for IP/IV experiments: 0-6h and 6-24h. 
с Values are means ± S.D. 
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a d m i n i s t r a t i o n o f ^ C ^ - c h l o r o b e n z a l d e h y d e . 
The b lack p o i n t s represent the m i g r a t i o n s o f the v a r i o u s reference 
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Fig.6. Excretion {% of total urinary radioactivity, 0-72h) of the main 
metabolites in successive urinary time intervals of two rats after 
cutaneous application of 75 ul ^C-a-chlorobenzaldehyde/kg (60xl06 dpm), 
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Fig.?. Excretion (% of total urinary radioactivity, 0-2Ah) of the main 
metabolites in 0-6h and in 6-2'*h urine of two rats (mean values) 
after IV and IP administration of 1'*C-2-chlorobenzal dehyde (25 μΐ/kg 
and 37-5 μΐ/kg, respectively). 
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Fig.8. T o t a l u r i n a r y e x c r e t i o n o f r a d i o a c t i v e m e t a b o l i t e s {%) by r a t s 
(mean o f two r a t s ) a f t e r c u t a n e o u s ( I ; 75 u l / k g ) , i n t r a v e n o u s 
( I I ; 25 μ ΐ / k g ) and i n t r a p e r i t o n e a l ( I I I ; 3 7 - 5 μ ΐ / k g ) d o s i n g o f 
l l t C - 2 - c h l o r o b e n z a l d e h y d e . 
153 
2-chlorohippuric acid. The radioactivity derived from 1',C-2-chlorobenzy 1 alcohol 
was mostly excreted in the second-day urine of the cutaneously treated rats 
(Fig.6). The same metabolite was found in much smaller amounts in the urine of 
rats administered IP or IV (Fig. 7 and 8 ) . About 15% of the total urinary 
radioactivity was eliminated as 2-chlorobenzyl alcohol and 2-chlorobenzoic acid 
into urine within 2k h (IP and IV) and 72 h (cutaneous) (Fig. 8 ) . 
DISCUSSION 
The present investigation is concerned with the percutaneous absorption and the 
elimination kinetics, including biotransformation of 2-chlorobenzaldehyde in 
intact rat skin. The rat is chosen as animal model, although it is known that 
in general the skin penetration of various chemical substances is larger in 
animals then in man (Wester and Maibach 1983; Calabrese 1984; Bronaugh and 
Maibach I985). 
From the many methods known to study percutaneous absorption (Bartek et al. 
1972; Nugent and Wood I98O) we used an experimental methodology with application 
of ^C^-chlorobenzaldehyde to the shaved part of the rat skin on the dorsal 
site. A non-occluding glass cup was used to keep the rat from removing the 
applied radioactive substance (Fig.2). This made it possible to detect volatile 
^C^-chlorobenzaldehyde as well as ^ С О г , quantitatively (Table 1 ) . 
2-Chlorobenzaldehyde was slowly absorbed into the rat skin. After cutaneous 
application of 75 μΐ/kg ^С-г-сЫогоЬепгаІdehyde, the plasma radioactivity 
was increased until 10 h post dosing, followed by low plasma levels over a 
period of three days. Concomitant with the slow absorption the overall 
elimination of ^C-radioactivi ty was also slow from rats administered with a 
single cutaneous dose of 2-chlorobenzaldehyde, with the primary route of 
elimination being urinary excretion. The average urinary recovery of over 80% 
of the dose of 1 1*C-2-chlorobenzaldehyde, however, indicates that the aldehyde 
was well penetrated through the rat skin. Moreover, based on the total 
recovery of ll*C presented in table 1 we can assume that no part of the applicated 
ll
*C-rad ioact i vi ty dose was incorporated into skin macromolecules with long 
b i о 1og i ca 1 ha 1 f-1 i ves. 
Plasma ^C-radioactivity versus time curves for the rat after IP and IV 
administration were very similar with regard to plasma radioactivity decline 
over the time period studied. The rapid increase in plasma radioactivity was 
followed by an elimination in a bi-exponential fashion. The ^C-radioactivity 
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was rapidly eliminated from rat blood after the intravenous administration as 
well as after the intraperitoneal dosing to rats. This indicates a high metabolic 
elimination of ll*C-2-chlorobenzaldehyde and a high renal excretion of its 
metabolites by rats. Excretion of radioactivity was seen mostly in urine within 
2k h post dosing. Only small amounts of ^ C were recovered in exhaled air and 
faeces. 
The time course of ^C-radioactivity in rat blood following cutaneous 
application of ^C-Z-chlorobenzaldehyde demonstrates a long period of absorption, 
attainment of a low peak level and subsequently slow elimination due to slow 
absorption. Unfortunately, it wasn't possible to describe the time course of 
1
'*C-2-chlorobenzaldehyde specifically within plasma, because of the rapid 
metabolic elimination. Moreover, the doses administered systemically and via 
the dermal route were not equivalent (Table 1). Consequently, the extent to 
which the dose of ll*C-2-chlorobenzaldehyde was absorbed, the bioavailability 
i.e. the percutaneous absorption, could not be determined by the ratio of the 
areas under the plasma radioactivity versus time curves following intravenous 
and cutaneous administration (Wester and Maibach 1983; Andersen and Keller ІЭв2*). 
The percutaneous absorption of ^C-Z-chlorobenzaldehyde was determined after 
measuring the amount of radioactive substance on the skin surface and the 
residual amount of radioactivity in the glass-cup. The difference between the 
applied dose and residual dose is the amount of ll*C-2-chlorobenzaldehyde 
absorbed, approximately 85% of the dose (Wester and Maibach I983)· 
Rats biotransformed extensively 2-chlorobenzaldehyde, giving rise to a 
number of urinary metabolites. The composition of radioactive metabolites in 
the urine after cutaneous application was roughly the same as that seen after 
the injection studies, apart from some quantitative differences. After the 
cutaneous application of ^C^-chlorobenzaldehyde, the cumulative elimination 
by urinary excretion of ^С-г-сЫогоЬепгуІ alcohol was larger than after 
intravenous and intraperitoneal dose (Fig.8). This difference might be caused 
by the different doses administered over different time-periods IV/IP 
(25-37.5 yl/kg) and cutaneously (75 wl/kg). It is also conceivable that 
cutaneously applied 1цС-2-сЫогоЬепга1гіеЬугіе was biotransformed differently 
from that applied IV/IP. The skin has been shown to possess a metabolically 
active layer, the viable epidermis, that has the ability to metabolize 
cutaneously applied xenobiotics before they become in the systemic blood 
circulation (Panatier et al. 1978; Wester and Maibach 1983; Baron and Kawabata 
1983; Bronaugh and Maibach 1985). 
Based on the results obtained from the TLC-autoradiography of urinary 
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extracts, more than S0% of the cutaneously applied ^С-г-сЫогоЬепгаІ dehyde 
was excreted as metabolites by the kidneys, but no part of urinary ^ C was 
present as unchanged compound. The major urinary metabolite was 2-chlorohippuric 
acid. Oxidation of the carbonyl group and subsequent conjugation with glycine 
is a well-known main metabolic pathway of aromatic aldehydes (Mc Mahon 1982). 
The reductive reaction in this study was quantitatively of minor importance. 
It is of interest, however, that for the most part the total urinary amount of 
the reductive metabolite, 2-chlorobenzyl alcohol, appeared in the second day 
urine, following cutaneous application of 1:*C-2-chlorobenzaldehyde (Fig.6). 
A feasible explanation for this finding might be that in the first instance 
^С-г-сЫогоЬепгуІ alcohol, is retained in the skin. As a consequence the 
skin-release of the ^C-metabol i te into the blood circulation and subsequent 
urinary excretion is retarded. By comparison, benzyl alcohol is reported to be 
retained in epidermal and dermal layers of the skin (Bronaugh and Maibach 1985). 
2-Chlorobenzyl alcohol plays also an important role as intermediate 
metabolite in the metabolic pathway of 2-chlorobenzaldehyde to 2-chlorobenzyl-
mercapturic acid in rats (Rietveld et al. 1983). The TLC-autoradiography results 
in the present study confirm our earlier findings (Seutter-Berlage et al. 1982; 
Rietveld et al. 1983) that in rats 2-chlorobenzaldehyde and related benzaldehydes 
are biotransformed to corresponding benzylmercapturic acids. In contrast with 
^С-г-сЫогоЬепгуІ alcohol, however, the percentage of the total urinary 
radioactivity attributable to 2-chlorobenzylmercapturic acid following cutaneous 
application of ll*C-2-chlorobenzaldehyde was not clearly different from that 
after both systemic administrations. 
In summary, ^C^-chlorobenzaldehyde was almost entirely absorbed into the 
rat-skin, although the percutaneous absorption process was slow. The total 
radioactivity was excreted mainly by renal route. The ll*C-aldehyde was extensive­
ly biotransformed and no part of the urinary radioactivity was present as parent 
compound. Oxidation of the carbonyl group and subsequent conjugation with 
glycine was the main metabolic pathway. Quanti tat ively, the reductive reaction 
was of minor importance, however, the urinary excretion of 'l,C-2-chlorobenzyl 
alcohol following cutaneous application differed substantially from that after 
the systemic administration. Finally, there was no evidence for storage in the 
skin or skin toxicity of 2-chlorobenzaldehyde following cutaneous application. 
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SUMMARY 
This thesis deals with the study of the metabolism of cyanoacrylic compounds 
with special emphasis on the conjugation of these potentially alkylating 
substances with the endogenous tripeptide glutathione and subsequent formation 
of urinary mercapturic acid metabolites. The principal aim of the investiga-
tions was to study a possible relationship of the chemical structures of the 
cyanoacrylic compounds or their degradation products with the biotransformation 
and the toxicity of cyanoacrylic compounds after percutaneous as well as 
systemic administration to the rat. 
In the introductory Part I the formation of glutathione conjugates from 
body-foreign compounds (xenobiotics) and their biotransformation to mercapturic 
acids are briefly reviewed. Also the results of previous investigations on the 
biotransformation of acrylates (esters of acrylic acid, methacrylic acid and 
phenylacry1ic acid) and of acrylonitri le derivatives are summarized. In this 
thesis cyanoacrylic compounds and their degradation products are investigated. 
The following model compounds were included in this study: chlorobenzyl¡dene 
malononitri les (including "CS-gas"), methyl 2-cyano-3-phenylacrylate (methyl 
2-cyanocinnamates), alkyl 2-cyanoacrylates, methyl epoxycinnamates (epoxides 
of methyl 3-phenylacrylates/methy1 cinnamates) and substituted benzaldehydes. 
In Part JJ the biotransformation and the bacterial mutagenicity/toxicity 
of the cyanoacrylic compounds are described. 
In Chapter 2.1 2-chlorobenzylidene malononitri le (CS) is the object of 
this study. Adult male Wistar rats administered ¡.p. with (CS) excreted one 
mercapturic acid in urine. The amount of mercapturic acid was determined 
gaschromatographically. The structure of the mercapturic acid methylester 
was identified by t.l.c. and confirmed by synthesis and mass-spectrometry. 
The acid appeared to be 2-chlorobenzyImercapturic acid N-acetyl-S-
(2-chlorobenzyl)-L-cysteine . CS and some of its metabolites were also tested 
in the Ames Salmone!la/mi с rosóme assay. Both mutagenic and toxic effects were 
measured with strain ТА 100 as the indicator organism. No mutagenic effects 
were found with any of the tested substances. At dosages of CS, higher than 
1,000 pg/plate a bacteriotoxicity was revealed. The presented data together 
with the results from recent literature suggest that it is highly unlikely 
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that CS or any of its metabolites exhibits mutagenicity or carcinogenicity in 
the 1 i ving organi sm. 
The aim of the study described in Chapter 2.2 was to investigate whether, 
besides CS related chlorobenzy1idene malononitri les (chloroBMNs) are biotrans-
formed to urinary mercapturic acid and if so to which kind of mercapturic acid. 
The relationship between the rate of hydrolysis and the formation of mercap-
turic acids is discussed. The glutathione conjugation of 2-chloro-, 3-chloro-, 
't-chloro- and 2,6-dichlorobenzyl idene malononi tri le was investigated in vitro. 
In incubation mixtures containing rat liver cytosol (9000 g ) , the decrease in 
the initial amount of glutathione due to the various chloroBMNs occurred both 
enzymatically and spontaneously at physiological conditions. 2,6-DichloroBMN, 
however, depleted glutathione largely spontaneously. The steric hindrance of 
the two chlorosubstituents probably plays an important role during the glu-
tathione-S-transferase catalyzed reaction. The hydrolysis of the chloroBMNs 
to the corresponding chlorobenzaldehydes and malononitri le was studied. 
The rate of hydrolysis of 2,6-dichloroBMN was slower than those of the related 
chloroBMNs. This means that 2,6-dichloroBMN will be the most stable compound 
in the presence of water. Only IP administration of 2-chloroBMN (CS) to adult 
male Wistar rats gave enhancement of urinary thioether excretion. After IP 
administration of 2-chloro- and 3-chlorobenzaldehyde to rats benzylmercapturic 
acid excretion in the urine was found. Administration of the related it-chloro-
and 2,6-dichlorobenzaldehyde, however, resulted in no urinary mercapturic 
acid excretion. These results suggest that in rats the initial biotransforma-
tion of chloroBMNs is mainly hydrolysis to corresponding chlorobenzaldehydes, 
leading in the case of 3-chloro-, A-chloro- and 2,6-dichloroBMN to no mercap-
turic acid excretion in the urine. Nevertheless, 2,6-dichloroBMN will be the 
most reactive compound with proteins and therefore the best haptene in 
comparison with the related chloroBMNs. 
Chapter 2.3 deals with the biotransformation of methyl 2-cyano-3-phenyl-
acrylates (CPAme's) with special emphasis to thioether and thiocyanate forma-
tion in the rat. After IP administration of some CPAme's and 2-cyano-3-phenyl-
acrylic acid (CPA) to rats thioether excretion in the urine was found. 
Pre-administration of a carboxylesterase inhibitor TOTP led to a dramatic 
decrease of the enhanced urinary thioether excretion. Apparently ester hydro-
lysis is an essential reaction prior to the formation of thioether adducts. 
Isolation of the adducts from the urine was unsuccessful. Also during the 
attempted synthesis such thioethers appeared to be unstable. In incubation 
mixtures containing rat liver cytosol (9000 g ) , the decrease in the initial 
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amount of glutathione due to the various CPAme's did not occur. However, the 
conjugation of the same compounds with both L-cysteine and N-acetylcysteine 
was found. Most surprising was the finding that only CPA did decrease the 
initial level of glutathione and N-acetyIcysteine in incubation mixtures. 
The hydrolysis of the series of CPAme's to the corresponding benzaldehydes and 
methyl cyanoacetate was studied. In contrast to the CPAme's, CPA was not 
hydrolysed under physiological condition«;. No evidence was found for the 
formation of thiocyanate after IP administration to rats of CPAme and methyl 
cyanoacetate. It is suggested that the formation of thioether adduct is a 
Michael type addition of glutathione (or other non-protein thiol compound) to 
CPA produced by enzymatic hydrolysis of CPAme. 
Chapter 2.4 deals with the assessment of the mutagenic potential of three 
alkyl 2-cyanoacrylate adhesives, three commercial alkyl 2-cyanoacrylate adhe-
sives and three methyl 2-cyano-3-phenylacrylates with the Salmonella/mlcrosome 
mutagenicity assay. Compounds were tested with and without Aroclor 1251* 
induced rat liver homogenate (S9). The methyl 2-cyanoacrylate adhesives were 
mutagenic in the standard plate test with S. Ьуркггр гмп strain TA100 with and 
without (S9). Methyl 2-cyano-3-(2-bromopheny1)acrylate revealed a direct 
mutagenic action to S. typhimicri-um strain TA1535· The most toxic compounds 
towards the bacteria S.typhimurium were the methyl 2-cyanoacrylate adhesives. 
All alkyl 2-cyanoacrylate adhesives were tested in a modified spot test for 
volatile compounds with tester strain TA100. Mutagenic and toxic effects were 
observed with the three methyl 2-cyanoacrylate adhesives. The results allow 
the conclusion that the bacterial toxicity and mutagenicity of methyl 2-cyano­
acrylate adhesives is probably due to the methyl 2-cyanoacrylate monomer. 
In Chapter 2.5 the ability of racemic as well as enantiomerically pure ois 
and trans methyl epoxycinnamates (methyl 3-pheny1-2,3-epoxy-propanoates) to 
undergo glutathione conjugation is described. In incubation mixtures contai­
ning rat liver cytosol (9000 g ) , the decrease of the initial amount of 
glutathione due to the epoxy esters occurred enzymatically. The highest 
glutathione depletion was found for the eis-epoxy cinnamic esters. Rats ad­
ministered IP with a single dose of racemic trans- and cis-epoxy cinnamates 
excreted thioethers in urine. The higher urinary thioether excretion was found 
after the cis-epoxy ester dosing. The structures of the thioether metabolites 
isolated from the urinary extracts were established by t.l.c. and confirmed 
by synthesis and mass spectrometry (FAB ). The thioethers appeared to be 
hydroxy mercapturic acids. The N-alkylating potential of the racemic epoxy 
esters was determined using It-(p-ni trobenzyl )pyrid ine (= NBP). 
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The trans-epoxy ester appeared to react much better with NBP than the ais-
compound. Mutagenic effects of racemic trans-epoxy cinnamate as well as the 
enantiomerically pure rrans-epoxy cinnamates were observed in the Ames-test 
with S.typhimurium strains TAI535, TA1537, TAI538 and TA100. No mutagenic 
responses were detected using any of the epoxy cinnamates with S9 activation. 
By comparing the mutagenicity and the enzymatically catalyzed glutathione 
conjugation it follows that the activity of the respective enantiomeric methyl 
cinnamates takes an opposite order. These findings confirm the protective role 
of glutathione in living organism against potentially toxic compounds, such as 
methyl epoxy cinnamates. 
In Part JJJ the results of biotransformation studies with substituted ben-
zaldehyde metabolites of the chloroBMNs and the CPAme's are presented. 
The investigation described in Chapter 3-1 was performed to see whether 
the administration of aromatic aldehydes or alcohols resulted in an increase 
in urinary thioether excretion. Special attention was paid to influence of 
the position and nature of the substituents in these compounds on the capacity 
of mercapturic acid formation. After administration of substituted (CH3, OH, 
OCH3, F, CI, Br, I, NO2) benzaldehydes or benzyl alcohols in the rat an enhan-
ced urinary thioether excretion was found in some cases. With p-substituted 
benzaldehydes only occasionally a slight increase could be shown, but with 
o-substituted aldehydes and alcohols thioether excretions amounted up to 13% 
of the dose. Mercapturic acids were isolated and identified by synthesis, 
mass-, and n.m.r.-spectrometry as the arylmethyl thioethers of N-acetyIcysteine. 
In order to gain more insight in the mechanism of the formation of mercap-
turic acids from substituted benzaldehydes their behaviour in biotransformation 
was investigated (Chapter 3·2). After a single administration of the sodium 
salts of o- and p-Cl-benzy1 sul furic acid a significant mercapturic acid excre-
tion was found. By pretreatment with pyrazole (alcohol dehydrogenase inhibitor) 
the mercapturic acid excretion increased after administration of o-Cl-benzyl 
alcohol whereas a significant decrease was found after administration of 
o-Cl-benzaldehyde. After simultaneous administration of ethanol with o-Cl-
benzyl alcohol and o-Cl-benzaldehyde an increase in mercapturic acid excretion 
was observed. After previous administration of pentachlorophenol(inhibí tor of 
sulfate transferase enzym system) a significant decrease in urinary mercapturic 
acid excretion for o-Cl-benzyl alcohol and o-Cl-benzaldehyde was found. These 
findings are in accordance with a metabolic pathway of substituted benzaldehy-
des via benzyl alcohols, subsequently sulphate esters to the corresponding 
benzylmercapturic acids. 
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The influence of the steric hindrance of halogen substituents was investi-
gated in vitro by measuring the activity of yeast aldehyde dehydrogenase and 
of aldehyde dehydrogenases in subcellular rat liver fractions with a series 
of ortho- and pam-halosubst i tuted benza Idehydes as substrates. The results 
described in Chapter 3-3 show that upon an increase in the size of the halogen-
substituent (F, Cl, Br), the reactivity of yeast aldehyde dehydrogenase to 
ortho-substituted benzaldehydes decreased drastically. The same phenomenon was 
observed with the unspecific aldehyde dehydrogenases in three rat liver frac-
tions; cytoplasm, mitochondria and microsomes. These findings are in accordance 
with the suggestion that the steric hindrance of bulky ortuo-sübst ituents of 
benzaldehydes account for the slowing down of the aldehyde dehydrogenase-
catalyzed oxidation of benzaldehydes to corresponding benzoic acids. The enzy-
matic oxidation of microsomal aldehyde dehydrogenase is strongly influenced 
by steric effects of benzaldehydes, bearing a halogen substituent in the 
ortho-pos'\ ti on. 
2-Chlorobenzaldehyde may be produced when a moist skin is exposed to the 
riot control agent CS. Therefore, Chapter 3.k deals with the percutaneous 
absorption, biotransformation and elimination of C-labelled 2-chlorobenzal-
dehyde applied to the clipped dorsal skin of rats. Following cutaneous admi-
nistration a slow skin penetration occurred as indicated by plasma radioacti-
vity levels. A slow increase in plasma radioactivity was followed by a slow 
decline of radioactivity in plasma over a 3-day period. Most of the radio-
activity was found in the urine with low levels in faeces and exhaled air. 
For the qualitative and quantitative determination of metabolites in urine, 
a thin layer chromatography-radioautography method was used. The metabolic 
patterns of urinary excreted metabolites following cutaneous application and 
systemic administration of ll,C-2-chlorobenzaldehyde to rats were very similar. 
No parent compound was recovered from the rat urine. 2-Chlorohippuric acid 
was the principal urinary metabolite. Quantitatively, the urinary excretion 
of ll*C-2-chlorobenzyl alcohol following cutaneous application differed 
substantially from that after the systemic administration. There was no 
evidence for storage in the skin or skin toxicity of 2-chlorobenzaldehyde 
following cutaneous application. 
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I6ít 
SAMENVATTING 
In de laatste jaren is het aantal in gebruik zijnde acryl verbindingen sterk 
toegenomen. Vertegenwoordigers van deze groep 1ichaamsvreemde stoffen worden 
medisch (o.a. tandprothesen, kunstgewrichten, pleisterkleefstoffen, contact-
lensen, weefsel 1 ijm), cosmetisch (haarlak, nagellak, reukstof), industrieel, 
bouwtechnisch en ambachtelijk (o.a. textiel, drukinkt, verven, kunstrubbers, 
kunstglas, superi ijm) toegepast. Als grondstoffen worden hiervoor gebruikt 
o.a.: acrylaten, methacrylaten, phenylacrylaten, acryIoni tri 1, acrylamiden, 
cyanoacrylaten en derivaten hiervan. 
Het toepassen van deze verbindingen vormt een toenemend probleem in de 
geneeskunde, bedrijfsgeneeskunde en de arbeidsdermatologïe. Zo is van de 
acrylamiden bekend, dat zij sterk neurotoxisch werken, terwijl het acryloni-
tril er van verdacht wordt niet alleen mutagene, maar waarschijnlijk ook 
carcinogene eigenschappen te bezitten. Een belangrijke groep vormen de acryl-
esters (acrylaten), die zowel toxische als allergische reacties op de huid 
teweeg kunnen brengen. Methylmethacrylaat schijnt zelfs neurotoxisch te 
kunnen werken. Daarnaast kan ethyl 2-cyanoacrylaat lijm soms huid en oog 
irritaties veroorzaken. 
In het algemeen is van 1ichaamsvreemde stoffen bekend, dat zijzelf dan wel 
tijdens de biotransformatie, zeer toxische verbindingen kunnen vormen 
(carbonium ionen, radicalen, epoxyden ), welke op grond van hun chemische 
reactiviteit een covalente binding kunnen aangaan met macromoleculen in het 
organisme. Meestal zijn dit eiwitten, maar ook phospholi piden, RNA en DNA 
komen hiervoor in aanmerking: er ontstaat een chemische laesie. Er zijn aan-
wijzingen dat dergelijke chemische leasies een rol spelen bij het ontstaan 
van weefsel beschadigingen, allergische reacties en zelfs kanker. 
Eén van de afweermechanismen waarover het organisme tegenover reactieve 
verbindingen beschikt, is de mogelijkheid tot koppelen (conjugeren) van de 
stoffen, met het endogene tripeptide glutathion. De ontstane koppelings-
produkten worden na verdere biotransformatie in gal en/of urine als thioether-
verbindingen (overwegend als mercaptuurzuren) uitgescheiden. 
Dit proefschrift handelt over de bestudering van het metabolisme (biotrans-
formatie) van cyanoacrylverbindingen met speciaal de nadruk op de conjugatie 
165 
van deze potentieel alkylerende stoffen met het tripeptide glutathion en 
daaropvolgende vorming van mercaptuurzuur metabolieten, die met de urine 
kunnen worden uitgescheiden. Het hoofddoel van de onderzoeken was aan hand 
van model verbind!ngen (cyanoacrylverbindingen en eventuele degradatieprodukte 
na te gaan of er een relatie bestaat tussen de chemische structuur enerzijds 
en de biotransformatie en toxiciteit van cyanoacrylverbindingen anderzijds, 
na zowel percutané als systemische toediening aan het proefdier de rat. 
DEEL I 
Het inleidende deel behandelt in een kort overzicht de vorming van glutathion 
conjugaten van 1ichaamsvreemde stoffen (xenobiotica) en hun biotransformatie 
tot mercaptuurzuren. Tevens worden de resultaten van voorafgaand onderzoek 
naar de biotransformatie van acrylaten (esters van acrylzuur, methacrylzuur 
en phenylacrylzuur) en van acrylonitril derivaten gepresenteerd. Bij de onder 
zoeken, beschreven in dit proefschrift, werden de volgende modelstoffen be-
trokken; chloorbenzylideen malononitrilen (o.a. "CS-gas"), methyl 2-cyano-3-
phenylacrylaten, 2-cyanoacrylaten, methyl epoxycinnamaten (epoxyden van 
methyl 3-phenylacrylaten/methy1 cinnamaten) en gesubstitueerde benzaldehyden. 
DEEL JI 
In dit deel II worden de biotransformatie en de bacteriële mutageni teit/ 
toxiciteit van de cyanoacryl verbindingen behandeld. 
Hoofdstuk 2.1 behandelt het biotransformatieonderzoek dat is verricht aan 
2-chloorbenzylideen malononitril ("CS-gas"). Deze stof werd in de rat tot 
thioether (2-chloorbenzylmercaptuurzuur) gebiotransformeerd. De hoeveelheid 
mercaptuurzuur in de urine werd gaschromatografisch bepaald. Verder werden 
CS en enkele metabolieten in de Ames Salmonella/microsoom-test met bacterie 
stam TA100 op hun mutagene en toxische effecten bestudeerd. Geen van de 
geteste stoffen veroorzaakte mutageniteit bij de bacteriën TA100. Echter wel 
bleek CS bij hogere doseringen een bacterie-toxisehe werking te hebben. 
Uit de gepresenteerde resultaten, aangevuld met de gegevens uit recente 
literatuur, komt naar voren dat het hoogst onwaarschijnlijk is dat CS of één 
van de metabolieten mutageniteit of carcinogen!teit ¡η het organisme kan 
veroorzaken. 
Het doel van het ¡n hoofdstuk 2.2 beschreven onderzoek was te onderzoeken 
of naast CS verwante chloorbenzylideen malononitrilen (chloroBMNs) tot 
mercaptuurzuren kunnen worden gebiotransformeerd en indien het geval dan tot 
welke mercaptuurzuren. Verder wordt de relatie tussen de hydrolyse snelheid 
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en de mercaptuurzuur vorming bediscussieerd. Van een reeks chloroBMNs werd 
de mate van glutathion conjugatie onderzocht. Alle verbindingen bleken zowel 
enzymatisch als spontaan de glutathion concentratie in incubatiemengsels met 
rat leverhomogenaat (9000 g) te verminderen. De sterische hindering van de 
chloorsubstituenten bij de 2,6-dichloroBMN kan de mogelijke oorzaak zijn voor 
de opvallend geringe enzymatische glutathion depletie. De hydrolyse van de 
chloroBMNs naar de overeenkomstige chloorbenzaldehyden en malononitril werd 
bestudeerd. De hydrolyse snelheid van 2,6-dichloroBMN was langzamer dan die 
van de derivaten. Deze verbinding zal dus het meest stabiel zijn in aanwezig-
heid van water. Van alle chloroBMNs bleek uitsluitend de intraperitoneale (IP) 
toediening van 2-chloroBMN (CS) aan ratten een verhoogde thioetheruitscheiding 
in de urine te geven. Echter na IP toediening van 2-chloor- en 3_chloor-
benzaldehyde aan ratten werden overeenkomstige benzyImercaptuurzuren in de 
urine gevonden (zie tevens hoofdstukken 3.1 en 3·2), terwijl dezelfde toedie-
ningswijze van 'i-chloor- en 2,6-dichloorbenzaldehyde aan ratten resulteerde 
in geen mercaptuurzuur uitscheiding in de urine. Uit de resultaten blijkt 
dat in ratten de chloroBMNs in eerste instantie tot overeenkomstige chloor-
benzaldehyden worden gehydrolyseerd. In het geval van 3-chloor-, h-cMoot— en 
2,6-dichloor- substitutie leidt dit niet tot de uitscheiding van mercaptuur-
zuren in de urine. Desondanks is het 2,6-dichloor-derÏvaat de meest reactieve 
verbinding met eiwitten en het beste hapteen in vergelijking met de verwante 
chloroBMNs. 
Hoofdstuk 2.3 behandelt de biotransformatie van methyl 2-cyano-3-phenyl-
acrylaten (CPAme's) in de rat. In vivo, na intraperitoneaal (IP) toedienen 
van de CPAme's 2-cyano-3-phenylacrylzuur (CPA) aan ratten werd een thioether-
uitscheiding in de urine gevonden. Voorbehandeling met een carboxy1-esterase 
remmer (TOTP) leidde tot een drastische daling van de verhoogde thioether-
uitscheiding in de urine. Hieruit bleek dat de ester hydrolyse een essentiële 
reactie is voorafgaande aan de thioether adductvorming. Isolatie van thioethers 
werd niet met succes bekroond. Bij de synthese van mercaptuurzuren (N-acetyl-
cysteine-adducten) kwam naar voren dat de thioethers niet stabiel waren. 
Stabiele thioethers werden niet gevonden. In incubatiemengsels met leverhomo-
genaat van ratten (9000 g) werd met de reeks CPAme's geen glutathionconcentra-
tie daling gevonden. Wel werd conjugatie met L-cysteine en N-acetylcysteine 
vastgesteld. Meest opvallend was dat CPA de hoeveelheid glutathion (c.q. 
N-acetylcysteine) in incubatiemengsels deed verminderen. De hydrolyse van de 
dubbele koolstof-koolstof band van de CPAme's bleek een belangrijk omzetting 
(in vitro, fys. omstandigheden). CPA daarentegen bleek niet hydrolyse-gevoelig 
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en kon in de urine van ratten worden gedetecteerd. Tenslotte werden geen 
bewijzen gevonden voor thiocyanaatvorming (cyanide-release) na IP toediening 
van CPAme en methyl cyanoacetaat aan ratten. Een toxiciteit van cyanide is 
daarom niet te verwachten. Met de nodige voorzichtigheid kan worden veronder­
steld dat de thioethervorming kan plaatsvinden via Michael additie van gluta­
thion (of andere niet-eiwit SH-verbinding) aan het stabiele CPA. De reactie 
is echter omkeerbaar (Retro-Michael reactie). 
Uit het onderzoek beschreven in hoofdstuk 2Λ is gebleken, dat van de 
onderzochte alkyl 2-cyano-acrylaten (methyl, ethyl, η-butyl en iso-butyl) 
uitsluitend methyl 2-cyanoacrylaat (in zuivere vorm of in commercieel 
verkrijgbare superlijmen) een mutageen effect vertoonde in de Ames-test 
(standaard plaattest, als ook spottest) met 5. typhimurium TA100 met en 
zonder leverhomogenaten van ratten (S9) . De mutageniteit en de vastgestelde 
bacteriële toxiciteit van methyl 2-cyanoacrylaat bevattende lijmen kunnen 
waarschijnlijk aan het methyl 2-cyanoacrylaat monomeer worden toegeschreven. 
Van de onderzochte CPAme's bleek uitsluitend het 2-broom-derivaat zwak 
mutageen te zijn. 
In hoofdstuk 2.5 worden de resultaten van het onderzoek met methyl epoxy-
cinnamaten (epoxyden van methyl 3-phenylacrylaat) beschreven. Hierbij werd 
nagegaan of er een relatie bestaat tussen enerzijds het vermogen van racemisch 
als ook enantiomeer pure "is en trans methyl epoxycinnamaten om met glutathion 
te conjugeren en anderzijds de mutageniteit van deze verbindingen in de 
Salmonella/microsoom test (Ames-test). In incubâtiemengsels met rat leverhomo-
genaat (9000 g) werd de hoogste uitsluitend enzymatische glutathion concen-
tratie daling met de öis-epoxy esters gevonden. Dezelfde esters bleken ook 
de hoogste thioether excretie in de urine van ratten te veroorzaken. 
De thioether metabolieten werden vanuit urine extracten geïsoleerd en vervol-
gens geïdentificeerd (dunne laag chromatografie). De structuren van de thio-
ethers werden via synthese en massaspectrometrie (FAB ) bevestigd en bleken 
hydroxy mercaptuurzuren te zijn. De N-alkylerende mogelijkheid van de race-
mische epoxy esters werd met behulp van '(-(p-ni trobenzy 1) pyridine) (=NBP) 
bepaald. De trans-epoxy esters reageerden veel beter met NBP dan de cis-
verbindingen. Mutagene effecten van zowel racemisch trans-epoxy cinnamaat 
als de enantiomeer zuivere trans-epoxy esters werden in de Ames-test met 
Salmonella typhimurixm stam TA100 met en zonder metabole activatie waarge-
nomen. Geen mutagene effecten werden gedecteerd, wanneer de verschillende 
epoxy esters samen met geïnduceerd rat leverhomogenaat (S9) werden getest. 
Uit de resultaten komt naar voren dat de volgorde in activiteit van de 
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respectievelijke enantiomere methyl cinnamaten waargenomen bij de bacteriële 
mutageniteit tegenovergesteld is aan die gevonden bij de enzymgekatalyseerde 
glutathion conjugatie. Deze bevindingen bevestigen dat verbindingen, zoals 
de potentieel toxische methyl epoxy cinnamaten in een levend organisme door 
glutathion onschadelijk kunnen worden gemaakt. 
DEEL III 
In dit deel worden biotransformatie-studles in de rat beschreven waarbij 
gesubstitueerde benzaldehyden, metabolieten van de chloroBMNs en CPAme's, 
centraal staan. 
In hoofdstuk 3·1 wordt een onderzoek naar de thioether vorming van ortho-
en para-gesubstitueerde benzaldehyden en benzylalkoholen in de rat beschreven. 
De aandacht kreeg hierbij of de mate van verhoging van thioetherui tschei.ding 
in de urine wordt beïnvloed door de positie en de aard van de substituenten 
aan de benzeenkern van de benzaldehyden. Met para-gesubstitueerde benzalde-
hyden werd soms een geringe verhoging in de thioetheruitscheiding in de urine 
gevonden, terwijl met de ortfo-gesubst¡tueerde benzaldehyden en alkoholen de 
uitscheiding van thioether-metabolieten zelfs tot ca 13% van de dosis kon 
oplopen. Mercaptuurzuren werden uit urine-extracten geïsoleerd. Na synthese, 
massa- en n.m.r-spectrometrie konden de mercaptuurzuren als de N-acetyl-S-
benzylcysteines worden geïdentificeerd. 
In hoofdstuk 3-2 wordt een onderzoek beschreven, waarbij het doel was 
inzicht te verkrijgen in de vorming van mercaptuurzuren van benzaldehyden. 
Significante mercaptuurzuuruitscheidingen werden in de urine van ratten 
gevonden na een enkelvoudige toediening van de natriumzouten van 2-chloor-
en ¡»-chloorbenzyl sul faat. Voorbehandeling van ratten met pyrazol , een 
remmer van het al kohol dehydrogenase systeem, deed de mercaptuurzuuruitschei-
ding in de urine, na toedienen van 2-chloorbenzylalkohol verhogen, terwijl 
juist een significante daling na injectie van 2-chloorbenzaldehyde werd 
gevonden. Pentachloorphenol (PCP; een selektieve remmer van het sulfotrans-
ferase systeem) behandeling van ratten veroorzaakte een daling in de 
mercaptuurzuur excretie, zowel na 2-chloorbenzaldehyde als 2-chloorbenzyl-
alkohol toediening. Orale verstrekking van ethanol simultaan met enkelvoudige 
toediening van beide stoffen aan ratten deed de mercaptuurzuur excretie in 
de urine stijgen. Deze resultaten zijn in overeenstemming met de eerder voor-
gestelde route voor biotransformatie van benzaldehyden via benzylalkoholen en 
vervolgens benzyl sulfaten tot uiteindelijk de overeenkomstige benzyImercaptuur-
zuren. 
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In hoofdstuk 3·3 worden de resultaten van een in vitro onderzoek met ortho-
en pai'a-halogeen gesubstitueerde benzaldehyden besproken. In vitro werd de 
invloed van de sterische hindering van halogeen gesubstitueerde benzaldehyden 
door metingen van de activiteit van gist aldehyde dehydrogenase en aldehyde 
dehydrogenases in subcellulaire rat leverfracties onderzocht. Naarmate de 
grootte van de halogeen substituent (F, Cl, Br) toenam, werd een daling in de 
reactiviteit van gist aldehyde dehydrogenase met ortho-gesubstitueerde benzal-
dehyden geconstateerd. Hetzelfde fenomeen werd met de aldehyde dehydrogenases 
in drie rat leverfracties (cytoplasma, mitochondria en microsomen) waargenomen. 
De resultaten van dit onderzoek komen overeen met de suggestie dat de sterische 
hindering van grote ortho-substituenten van benzaldehyden verantwoordelijk 
zijn voor het vertragen van de enzym-gekatalyseerde oxydatie van benzaldehyden 
naar overeenkomstige benzoëzuren. De enzymatische oxydatie gekatalyseerd door 
het microsomale aldehyde dehydrogenase werd sterk door de sterische effekten 
van ort^o-substituenten beïnvloed. 
In hoofdstuk З·'* wordt een onderzoek naar de huidabsorpt ie (huidpenetratie) 
van ^C-gelabeld 2-chloorbenzal dehyde in de rat beschreven. Epicutane toe­
diening toonde een langzame huidpenetratie van ^l'C-2-chloorbenzal dehyde. 
Plasma radio-akti vi teit nam direkt na applicatie langzaam toe, waarna een 
verval van de radio-akti vi teit in het plasma over een periode van 3 dagen 
werd waargenomen. Bij alle experimenten werd de radio-aktivi teit voornamelijk 
in de urine gevonden. Voor de kwalitatieve en kwantitatieve bepaling van de 
metabolieten in de urine werd een dunne laag chromatografie/radioautografie 
methode gebruikt. De metabole patronen van de urine metabol ieten van 1L,C-2-
chloorbenzaldehyde bleken na verschillende applicaties aan ratten vergelijk­
baar. 2-Chloorbenzaldehyde werd niet in de urine aangetroffen. Het hoofdmeta-
bol iet in de urine was 2-chloorhipuurzuur. De excretie van li*C-2-chloorbenzy 1-
alkohol in de urine na epicutane toediening bleek in kwantiteit te verschillen 
met die na systemische toediening. Er werden geen bewijzen gevonden voor de 
persistentie van 1LfC-2-chloorbenzaldehyde in de huid dan wel huidtoxische 
effekten. 
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STELLINGEN 
1. Het gebruik van methyIcyanoacrylaat lijmen als hobbylijm is niet verantwoord, 
gezien de mutagene werking van het methylcyanoacrylaat monomeer in Salmonella 
typhyrm-.rtim bacteriën TAI00 (Ames test). 
Dit proefschrift. 
2. Gezien het feit dat chloorbenzvlideen malononltrtlen ("CS-gas" derivaten) met 
water snel reageren tot overeenkomstige benzaldehyden en malononitri I, dienen 
de toxische effekten van de hydrolyse-produkten te worden vastgesteld. 
Dit proefschrift. 
3. De bepaling van cyanide en thiocyanaat in urine met de spectrofotometrische 
methode van Upadhyay en Gupta is aan twijvel onderhevig, daar de omzetting 
van cyanide c.q. thiocyanaat in cyanogeenbromide gevolgd door een reactie met 
pyridine, leidt tot de vorming van glutaconaldehyde, dat na condensatie met 
anthraniIzuur een geel-oranje kleur zou moeten geven. 
Upadhyay S, Gupta VK (1984) Analyst 109:1619-1620. 
't. De synthese van het reactieve chinonmethide van S.S-di-tert.butyl-^-hydroxy-
tolueen (BHT) is mogelijk door middel van oxydatie van BHT met kaliumferri-
cyanide en natriumhydroxyde in een water-benzeen mengsel, maar het drogen 
van de afgescheiden benzeenlaag met calciumchloride bij -10 С is onmogelijk. 
Volod^kin AA, Ershov W (1978) Bull Academy Sciencee USSR 2:448. 
Kudinova LI, Volod^kin AA, Ershov W (1978) Bull Academy Sciences 
USSR 7:1452. 
5. Watabe en medewerkers kennen ten onrechte aan het enantiomeer zuiver styreen-
oxyde met een positieve specifieke draaiing in oplossing (het oplosmiddel 
wordt niet vermeld) de R-configuratie toe. 
Watabe T, Ozaua N, ïoshikaua К (1981) Biochem Pharm 30:1695. 
Watabe T, Ozaua N, Hiratauka А (1983) Biochem Pharm 32:777-786. 
Dupin C, Dupin J (1970) Buil de la Soc Chim de France 1:249. 
6. Bij het vaststellen van het metabolisme van mononitrotoluenen in de rat, 
benaderen de experimentele gegevens verkregen uit IN VIVO-biotransformatie-
onderzoek meer de realiteit dan de gegevens uit IN VITRO-biotransformatie-
onderzoek. 
Chism JP, Turner Jr. MJ, Riokert DE (1984) Drug Meteo Dispos 
12:596-602. 
Don DeBethizy Jy Riokert DE (1984) Drug Metab Dispos 12:45-50. 
7. Voor het onderzoek naar het metabolisme van nitrotoluenen dient niet alleen 
rekening te worden gehouden met de verschillen in metabole activiteit van 
de darmflora van verschillende soorten laboratoriumdieren en de mens, maar 
ook met verschillen in darmflora binnen één diersoort. 
Chism JP, Riokert DE (1985) Drug Metab Diapos 13:651-657. 
Rowland IR, Mallett AK, Bearne CA, Farthing MJG (1986) Xenobiotioa 
16:519-523. 
8. Gezien de te verwachten financiële situatie van studenten in de nabije toekomst, 
zal het niet moeilijk zijn voor klinisch-farmacologisch onderzoek proefpersonen 
te verkrijgen. 
9. Diergeneesmiddelen-onderzoek moet binnen het HW-TNO worden gezien als de 
kleinste big aan de laatste mem. 
10. Het gebruik van de term metabolisme kan in discussies tussen fysiologen en 
farmacologen tot misverstanden leiden. 
11. De zakelijkheid bij Berlage en het rationalisme bij Rietveld komen in dit 
proefschrift wederom tot uiting. 
Afscheidscollege van Pieter Singelenberg, KUN 26 april 1985. 
Nijmegen, 11 februari I988 E.C. Rietveld 


